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Human papillomavirus (HPV) infection of the skin or mucosal surfaces leads to the
formation of warts or papillomas. Cutaneous warts frequently persist for several
months, even in immunocompetent individuals, suggesting that the virus has
developed strategies to evade the normal immune responses of the host. Most
evidence indicates that cell mediated immunity is more important than humoral
immunity in controlling the extent of HPV infection and its resolution. This study
investigated systemic and local cell mediated immunity to HPV in patients with
cutaneous warts in order to understand the basis for their persistence or regression.
The aim of the first part of the project was to examine HPV-specific
lymphoproliferative responses from the peripheral blood of patients with cutaneous
HPV infection. Proliferative T cell responses towards purified HPV in vitro were
demonstrated in some individuals but frequently responses were weak or non
existent. Patients whose warts were regressing (or had fully resolved) did not show
increased lymphoproliferative responses towards purified HPV in vitro compared
with patients whose warts showed no change. HPV-specific T cell clones were not
obtained either directly from peripheral blood mononuclear cells stimulated with
purified HPV, or after expansion of these cells with anti-CD3 and anti-CD28
antibodies.
Any HPV-specific modulation of immunity may be more apparent locally in the
lesion, than in systemic circulation. Therefore three studies were conducted in order
to investigate local immunity in cutaneous warts. In the first, an
immunohistochemical approach was taken. The density of Langerhans' cells was
reduced in the epidermis of warts compared with normal skin. Epidermal
keratinocytes did not express intercellular adhesion molecule-1 (ICAM-1) in
cutaneous warts, but the vascular expression of ICAM-1 and E-selectin was
increased in the dermis of warts compared with normal skin. This may account in
part for the observed increase in numbers of T cells in the dermis of warts compared
with normal skin. However, few T cells were found in the epidermis of warts,
compared with an inflammatory skin disease such as psoriasis. The second approach
was to use a frozen section adhesion assay to investigate functional properties of
adhesion molecules expressed in cutaneous warts. It was found that activated T cells
bound to wart sections in numbers similar to those bound to sections of normal skin.
Reduced numbers of Langerhans' cells and the lack of T cell trafficking into the
epidermis of cutaneous warts may be due to local cytokine modulation by HPV. In
the third study therefore, mRNA expression of granulocyte macrophage colony
stimulating factor, tumour necrosis factor-a, transforming growth factor-p ,
interleukin (IL)-la, IL-ip, IL-4, IL-8, IL-10, IL-12 p40, IL-1 receptor antagonist, y-
interferon and the keratinocyte growth factor, amphiregulin, was compared in warts
and normal skin. Semi-quantitative analysis by reverse transcription polymerase
chain reaction showed significantly increased levels of IL-1 a mRNA in warts
compared with normal skin, while IL-10 mRNA was significantly reduced in
cutaneous warts compared with normal skin. Induced IL-1 a expression was found to
correlate with amphiregulin mRNA expression within cutaneous warts, which may
account for the hyperproliferative nature of these lesions.
Finally preliminary in vitro experiments modelling the early stages of HPV infection
of keratinocytes were initiated to test whether HPV directly modulates the
expression of cytokine mRNA in infected keratinocytes. Although no conclusion
was reached, these experiments have highlighted the need for further study.
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The following study describes an investigation into the role of cell mediated
immunity (CMI) in human papillomavirus (HPV) infections of the skin. The
introduction outlines the skin immune system, HPV structure and function, natural
infection, and CMI towards HPV. A more detailed discussion of the literature
relevant to particular aspects of the practical work appears in each experimental
chapter.
1.1 The skin immune system
Skin was originally considered to function purely as a physical barrier; however it is
now known to be a highly immunoreactive organ, which defends the body from
invading pathogens. The skin and its associated lymphoid tissues (SALT) were first
described nearly 20 years ago (Streilein, 1978) and are represented diagramatically
in Figure 1.1. The epidermis and dermis are the two principal compartments of the
skin and are separated by a basement membrane. Keratinocytes (KC) make up 80%
of the cells in the epidermis forming a stratified multilayered epithelium. The KC
adjacent to the basement membrane are predominantly undifferentiated rapidly
proliferating stem cells. As KC become committed to differentiate, they detach from
the basement membrane, lose their capacity to proliferate and migrate through the
supra-basal layers towards the stratum corneum. Terminally differentiated KC are
finally shed from the stratum corneum as dead cornified squames.
In addition to forming a physical barrier KC have an important immunoregulatory
role. KC can be stimulated in culture to secrete many cytokines including
interleukin (IL) -1 (Kutsch et al 1993), tumour necrosis factor-a (TNF-a), IL-8
(Matsushima et al 1989), IL-6 and granulocyte macrophage colony stimulating
factor (GM-CSF) (Schrader, 1994). Although cytokines are not expressed
constitutively by KC in vivo they can be induced by a variety of stimuli.
Furthermore, expression of cell surface molecules such as major histocompatibility
(MHC) class II antigens or intercellular adhesion molecule-1 (ICAM-1) are induced
on KC in inflammatory reactions of the skin (Barker et al 1989). MHC class II+ KC
can also present bacterial superantigens, Mycobacterium leprae and herpes simplex
virus antigens to T cells in vitro (Nickoloff et al 1993; Mutis et al 1993;
Cunningham et al 1989), thus emphasising the potential role of KC in regulating the
skin immune system.
In addition to KC, the other components of the skin include Langerhans' cells (LC),
leucocytes, endothelial cells, melanocytes and mast cells. Langerhans' cells are
CDla+, MHC class 11+ dendritic cells derived from the bone marrow which form a
semi-continuous network between epidermal KC and are the main antigen
presenting cells (APC) of the skin. Unlike KC, LC are a migratory population of
cells and do not permanently reside in the epidermis. Immature LC in the epidermis
develop the capacity to become potent APC after migration from the skin to the
draining lymph node where they process and present antigens to naive T cells
(Streilein, 1990). In a secondary response, antigen presentation to memory T cells
may then occur within the skin by LC, macrophages or fibroblasts (Streilein, 1983).
Invading pathogens, contact sensitisers or ultraviolet B light (UVB) exposure can all
induce LC to migrate from the epidermis. TNF-a has been proposed to initiate the
movement of LC from the skin to the draining lymph node (Cumberbatch et al
1995). Dermal dendrocytes are another population of CDla+ dendritic cells which
are thought to contribute to antigen presentation in the skin (reviewed by Lappin et
al 1996).
T cells, macrophages and other leucocytes enter the dermal and epidermal
compartments from dermal blood vessels. The majority of T cells within normal
skin comprise equal numbers of CD4+ and CD8+ subsets and are located
perivascularly in the dermis. In contrast only 2% of the T cells in normal skin are
found in the epidermis and are predominantly CD8+ (Bos et al 1987). Most
cutaneous T cells express a/(3 T cell receptors (TCR) (Foster et al 1990) whereas
cells expressing y/8 are rare. However, a unique population of dendritic epidermal
T cells with y/5 TCR dedicated to epithelial immunosurveillance does exist in
rodents (Janeway et al 1988), but an equivalent cell population has not been
identified in humans.
Endothelial cells make up the dermal blood vasculature and play a central role in
cutaneous inflammation. Cytokines such as IL-1 and TNF-oc rapidly induce
endothelial cells to perform inflammatory functions by the expression of leucocyte
adhesion molecules. The cell adhesion molecules ICAM-1, vascular cell adhesion
molecule-1 (VCAM-1), and E-selectin differ in their specificity for leucocytes and in
the timing of their expression after activation of endothelium. There is also
evidence that cutaneous leucocyte antigen (CLA) expressed on CD4+, CD45RO+ T
cells acts as a skin-specific homing receptor through its interaction with E-selectin
vascular endothelial cells (Berg et al 1991; Picker et al 1991) (discussed in more
detail in chapter 3, section 3.1.1).
Melanocytes are neural crest-derived cells present in the basal layer of the
epidermis. Their primary function is to protect the body from UV irradiation by the
production and transfer of melanin to KC. When stimulated, melanocytes respond
to many cytokines and secrete IL-la, (3, transforming growth factor-(3 (TGF-(3), IL-8
and monocyte chemotactic protein-1 (MCP-1) (reviewed by Armstrong et al 1994).
In addition ICAM-1 can be induced on the surface of melanocytes, thus promoting
cell-cell interactions.
3





















Taken from Streilein J.W. (1989) Skin-associated lymphoid tissues (SALT):






Mast cells are bone marrow derived cells which in skin are located in close
proximity to blood vessels but are rarely found in the epidermis. These myeloid
cells store preformed enzymes, glycosaminoglycans, mediators of inflammation
such as histamine and express the high affinity IgE receptor on their cell surface.
The pattern of cytokines synthesised by mast cells is similar to a T helper type 2
(Th2) response, favouring IgE dependent immunological processes. Mast cells can
also synthesise IL-1, 3, 4, 5, 6, 8, TNF-oc, TGF-a and GM-CSF and can be found in
increased numbers in chronic inflammatory diseases of the skin (reviewed by Moller
etal 1994).
1.2 Human papillomavirus structure
HPV are icosahedral particles containing a single 8 Kb double stranded circular
DNA genome (Figure 1.2) which exists in a chromatin-like complex with cellular
histones. A proteinaceous coat, known as the capsid, protects the viral genome and
contains determinants which promote adherence of virus particles to receptors on
host cells.
Figure 1.2 HPV particle structure
55 nm
I 1
/ w viral DNA
HPV virion Capsid
Taken from Lowry et al (1991)
1.2.1 Structural proteins
The capsid of each infectious virion is composed of 72 capsomeres comprising the
virally encoded major and minor capsid proteins named LI and L2 respectively
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(reviewed by Pfister et al 1994). Each capsomere is a pentameric structure, formed
predominantly from LI, which has a highly conserved amino acid sequence amongst
different HPV types. The amino acid (aa) sequence of L2 is less well conserved
between different HPV types and is thought to be type specific.
Studies on the functions of capsid proteins have been facilitated by the discovery
that HPV-16 LI and L2 proteins, when expressed as recombinants in vaccinia virus,
self-assemble to form empty virus-like particles (VLPs) (Zhou et al 1991 and
reviewed by Schiller et al 1995). As judged by cryoelectron microscopy HPV-1
VLPs are indistinguishable from whole HPV-1 particles (Hagensee et al 1994). LI
protein has been shown to self-assemble into VLPs in all papillomavirus types tested
(Schiller et al 1995) and self-assembly is an intrinsic property of the LI protein.
The functions of L2 are less clear, since L2 alone cannot self-assemble (Hagensee et
al 1993) and VLPs containing only LI appear to be identical to capsids with both LI
and L2 (Hagensee et al 1994). However, the presence of L2 increases the efficiency
of assembly of LI (Hagensee et al 1993). Interestingly, the amino terminus of L2
can bind non-specifically to DNA, which suggests a role for L2 in virion assembly
(Zhou et al 1994).
7.2.2 Genomic structure and, organisation
The double stranded circular HPV DNA genome is represented in Figure 1.3.
Nomenclature of the genes is based upon the time when they are expressed in the
viral replication cycle (early or late). In infectious HPV particles the genomic DNA
is covalently closed, allowing super helical twists, but when viral DNA is
replicating, relaxed or open circular DNA predominates. HPV proteins are
expressed from open reading frames (ORFs) located on one DNA strand. The
second DNA strand is non-coding, but may have a regulatory role. The upstream
regulatory region (URR) contains the promoter elements and varies in size from 500
to 1000 bp depending on HPV type. Transcription factors such as NF-1, AP-1 and




Taken from Giri et al 1986. Thick lines show the HPV-la open reading frames (ORFs). The HPV
genome can be divided into 3 domains: early gene products, late gene products and upstream
regulatory region (URR) containing binding motifs for regulators of transcription and replication.
7
SP-1 bind to specific motifs which are repeated within the URR and regulate gene
expression. Response elements for HPV-E2, E6/E7 and the
glucocorticoid/progesterone receptors are also present within the URR.
1.3 HPV types.
Papillomaviruses (PV) are species specific and 77 different types which infect
humans have been identified to date. Originally a new HPV type was defined by
less than 50% cross hybridisation of the viral DNA to all known HPV types under
stringent conditions. Using sequence comparison, new types are now assigned if
there is < 90% homology in the DNA sequence of the LI, E6 and E7 ORFs to all
known types. Homology of >90% designates it a sub type of a known HPV (De
Villers, 1994). Figure 1.4 shows a phylogenetic tree of relatedness of different PV
types. PV have evolved relatively slowly and as these viruses rarely cross the
species barrier, the separation between 2 PV types may have occurred at the same
time as the separation between the 2 host species (reviewed by Bernard et al 1994).
Interestingly HPV-1, 41 and 63 are more closely related to cottontail rabbit PV
(CRPV) and canine oral PV (COPV) than to other human PV and pigmy
chimpanzee PV (PCPV) shares the greatest sequence homology to HPV-13.
Individual HPV types are associated with infection of either cutaneous or mucosal
epithelia (shown in Table 1.1). HPV-1, 2 and 4 are the main aetiological agents of
benign cutaneous papillomas (shown in Figure 1.5 and 1.6). However, some HPVs
infect both epithelial surfaces; for example, HPV-2a and HPV-57 which are closely
related types, infect both mucosal and cutaneous tissue, but HPV-57 preferentially
infects mucosal tissue and HPV-2a infects cutaneous tissue (Hirsch-Benham et al
1990).
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Figure 1.4 Phylogenetic tree of 54 types of papillomavirus
The phylogenetic tree (taken from Bernard et al 1994) is based on homology comparisons of two highly
conserved segments of the LI gene with a combined length of 420 bp. DPV = deer PV BPV = bovine PV,
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Table 1.1 Clinical associations of different HPV types







EV benign or malignant
Non-warty skin lesions
1,2, 4, 63
2, 4, 26, 27, 29, 57, 65
3, 10, 28, 49,
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2, 3, 10, 12, 15, 19, 36, 46, 47, 50




Non condylomatous lesions and/or
CIN
Carcinoma (cervix, penis, vulva)
6, 11,42-44
6, 11, 16, 18,30,31,33, 34, 35, 39, 40,
42, 43, 51, 52, 55, 56, 57-59, 61, 62,
64










2, 6, 11, 16, 18,30
Taken from (Cossart et al 1995). EV = epidermodysplasia verruciformis, CIN = cervical
intraepithelial neoplasia.
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Figure 1.5 Common hand warts on an immunocompetent
individual
Reproduced with kind permission of Dr. E.C. Benton, Department of Dermatology, Royal Infirmary,
Edinburgh.
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Figure 1.6 Extensive mosaic plantar warts in an
immunosuppressed renal allograft recipient
Reproduced with kind permission of Dr. E.C. Benton, Department of Dermatology, Royal Infirmary,
Edinburgh.
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1.4 Non-structural open reading frame proteins
1.4.1 Papillomavirus El
El protein plays a role in regulating viral DNA replication and is the largest of the
early genes expressed in HPV infection (reviewed by Storey, 1994 and Lambert,
1991). Experiments with BPV-1 have shown that a complex of the El protein and
the E2 protein bind specifically to the origin of replication (Mohr et al 1990). Full
length El and E2 proteins are required for optimal viral replication and may be
involved in both positive and negative regulation of this process (reviewed by
Cossart et al 1995). Although less is known about the HPV El, the HPV-la El
protein alone is sufficient for low levels of DNA replication. The domain of El that
modulates replication has been mapped to the 5' end of the El gene and is termed
E1M.
1.4.2 Papillomavirus E2
The E2 ORF codes for the main transcriptional regulatory protein of the virus which
also plays a role in DNA replication (Lambert, 1991). The full length E2 protein can
trans-activate or repress HPV promoters through binding to E2 responsive enhancer
elements which are repeated many times in the URR. Alternative splicing of E2
produces 2 truncated forms of E2 protein that have negative regulatory effects on
viral transcription (reviewed by Storey, 1994). E2 proteins consisting
predominantly of the carboxyl half (E2C) repress the activity of the full length E2 by
competitive binding to the DNA motif, or by forming complexes with E2, thus
inhibiting its activity (Lambert, 1991). The activity of E6/E7 promoters in HPV-11,
16, and 18 are inhibited by binding of the transactivating E2 protein. Distance from
the DNA bound by the E2 and the transcriptional start may determine whether
transcription is stimulated or repressed (reviewed by Cossart et al 1995). El from
HPV-11 in combination with E2 from either HPV-6, 16, or 18 support the
replication of HPV-11 genome, indicating that El and E2 proteins have shared
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functions between different HPV types (Del Vecchio et al 1992). E2 also increases
the efficiency of binding of the El protein and thus influences DNA replication
(Gopalakrishnan et al 1995). An E1MAE2C transcript detected in C127 cells
containing HPV-11 codes for an E2 binding site specific transcriptional repressor
(Chaing et al 1991).
1.4.3 Papillomavirus E4
E4 is highly expressed in palmar and plantar warts induced by HPV-1 infection, and
is also found in HPV-2, 4, 11 and 16 infections. Although E4 was originally defined
as an early gene it is expressed late in the viral life cycle. E4 is localised in the
cytoplasm and does not have any transforming functions. At the amino acid level
there is little homology between E4 products from different HPV types. However,
E4 proteins are more closely related in HPVs which infect similar epithelial
surfaces, suggesting a role for the protein in the epitheliotropism of HPV. Alternate
forms of E4 are found in HPV infection, and are differentially expressed during KC
differentiation. The primary product of HPV-1 E4 ORF is a 17 kD E1AE4 spliced
mRNA which has 5 amino acids from El (Chow et al 1987). In cells expressing E4,
the cytokeratins associated with differentiation (K1 and K10) are absent. This led to
the proposal that E4 may replace cytokeratins and is involved in virus release
(Doorbar et al 1988). Furthermore, E4 interacts with filaggrin, a known cytokeratin
binding protein. In papillomas there is a correlation between the amount of virus
and E4 expression. For example HPV-1 induced warts have a high viral content and
the highest level of E4 protein (reviewed by Doorbar, 1991).
1.4.4 Papillomavirus E5
The E5 ORF is the least conserved region of the HPV genome and can be absent or
truncated in many HPV. When present, its expression is localised to the cytoplasmic
membrane (reviewed by Storey, 1994). Papillomavirus E5 was initially not thought
to play a role in cellular transformation since it is lost from many cervical tumours.
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However, BPV-1 E5 efficiently transforms cells when transfected in vitro and HPV-
16 E5 stimulates the growth of rodent fibroblasts. HPV-16 E5 acts in association
with the epidermal growth factor (EGF) receptor to increase the expression of
cellular fos gene (Leechanachai et al 1992). Since, the URR has many fos/jun
responsive AP-1 sites the E5 protein may indirectly induce viral gene transcription.
In cutaneous warts infected with HPV-1, E5 protein is localised to the perinuclear
halos of koilocytes (Figure 1.8), but its exact function in papillomas remains
undetermined (reviewed by Storey, 1994).
1.4.5 Papillotnavirus E6
The E6 ORF is an HPV oncogene which is expressed in cell lines derived from
cervical carcinoma even when other HPV genes have been lost. Therefore the
continued presence of E6 is required for the maintenance of the transformed
phenotype of these cells. HPV-16 and 18 E6 proteins interact with the p53 tumour
suppressor gene product and lead to its degradation, thus eliminating the suppressive
effects of p53 on cell division. Mutations in p53 are found in many tumours and
cause altered cell cycle regulation. E6 protein binds to E6-associated protein, a
member of the ubiquitin degradation pathway, necessary for the degradation of p53
(reviewed by Androphy, 1994). Thus, E6 mediated degradation of wild type p53 is
functionally analogous to the mutation of wild type p53. HPV-6 and 11 E6 proteins,
associated with benign mucosal lesions, "weakly" interact with wild type p53 and
fail to promote its degradation in vitro. Interestingly, although HPV-1 E6 gene
products do not complex with p53 and therefore do not promote its degradation the
HPV-1 E6 protein can inhibit the transcriptional regulatory activity of p53 (Kiyono
et al 1994). However other cutaneous HPV types associated with EV (5, 8, or 47)
do not show a similar inhibition of p53 function.
1.4.6 Papillomavirus E7
The E7 ORF is the most widely studied papillomavirus oncogene. In common with
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E6, E7 is continually expressed in cervical tumours and cell lines immortalised in
vitro, and can maintain the transformed phenotype of the cells. E7 protein binds to
the retinoblastoma tumour suppresser gene product (Rb) and the related pl07
protein, both of which are involved in cell cycle regulation. In G1 of the cell cycle,
Rb or pi07 are complexed with E2F, a transcription factor. When cells move into S
phase, the Rb/pl07 is phosphorylated and the Rb-E2F (or pl07 /E2F) complex #
dissociates. E2F is then released and is involved in transactivation of many cellular
genes involved in cell division (reviewed by Androphy, 1994). E7 prevents Rb from
complexing with E2F and induces cellular proliferation. In an in vitro organotypic
culture E7 is also capable of reactivating cellular DNA replication in suprabasal KC
(Cheng et al 1995). Different domains of E7 protein determine trans-activation and
transformation. "High risk" HPV-types (HPV-16 and 18) bind Rb or pl07 more
efficiently than "low risk" (HPV-6 and 11), which may explain the differences
between these HPV types in the progression to carcinomas. Cervical tumours
lacking HPV sequences often carry mutations in the p53 and Rb genes. In contrast,
cervical tumours containing HPV DNA possess wild type Rb and p53 sequences.
Cutaneous infections in immunocompetent individuals do not usually progress to
carcinomas (Benton et al 1992), and the genomes of these cutaneous HPV types do
not cause transformation in vitro. It remains unknown whether E6 and E7 from
cutaneous HPV types have a role in self-limiting hyperproliferation, characteristic of
benign papillomas.
1.5 Natural infection with HPV
Productive HPV infection is restricted to stratified squamous epithelium and the
viral replication is intimately linked to the differentiation of host KC represented
diagramatically in Figure 1.7. HPV infection of basal KC is thought to occur via an
abrasion or breach into the deeper layers of the epidermis. The virus adsorbs to the
plasma membrane of the host cell to gain entry, probably through an interaction of
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capsid components with specific receptors on the KC membrane. Although it
remains undefined which determinants are involved in the binding of HPV to host
cells, studies using VLPs demonstrated the importance of LI in this process.
Capsids containing only LI were as efficient at binding and penetrating host cells as
VLPs containing LI and L2 (Muller et al 1995). Animal and human PVs enter host
cells via a similar cell surface receptor (Muller et al 1995). Therefore species and
epithelial specificity may reside in cellular events later in the infectious cycle. In an
in vitro system, BPV-1 particles can adsorb to C127 cells in 30 minutes at 37°C and
are completely taken up by 90 minutes. Since virus particles were not observed in
the nucleus of infected cells uncoating of virions was presumed to occur in the
cytoplasm (Zhou et al 1995). Indeed other studies provided evidence that following
adsorption, the virus penetrates the cytoplasm of the KC by receptor mediated
endocytosis (Muller etal 1995).
Once inside the cell the virus is disassociated through the separation of the capsid
and viral DNA. In benign cutaneous warts and low grade cervical intraepithelial
neoplasia, episomal HPV DNA is found in the nucleus of basal cells, where it
replicates but remains at low copy number (20 -100 copies / cell). Capsid proteins
or whole virus particles are not found in this basal KC layer.
The differentiation of the host cell induces extensive HPV DNA replication (1000s
of copies / cell), in addition to the expression of early and late proteins. HPV
particles are assembled in the stratum granulosum and many whole virions can be
detected in the cornified layers of the wart. HPV virions are released when KC
slough off from the highly keratinised stratum corneum. HPV infections which
progress to high grade carcinomas, usually contain HPV-DNA integrated into the
cellular genome without the production of virions.
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Studies of HPV-11 infection in nude mice, demonstrate transcription of early genes
4 weeks after initial infection (Stoler et al 1990). Viral replication and transcription
of early and late ORFs occurs maximally at 6-8 weeks, and after 10 weeks
condylomata are formed. However, in natural HPV infection, viral DNA may
persist in the basal cell layer, thus remaining latent before DNA replication and a
productive infection takes place.
Normal epidermis has an ordered keratin expression pattern from basal to terminally
differentiated KC that becomes disordered in HPV infection. The cytopathic effect
of HPV infection in skin is shown by the presence of koilocytes (large KC with
small pyknotic nuclei surrounded by a clear cytoplasm), parakeratosis (where
nuclear remnants persist in the superficial keratin layers), hyperkeratosis, (increase
in the horny layer), perinuclear vacuolisation, acanthosis (thickening) and
papillomatosis (folding) (Bunney et al 1992b) and are illustrated in Figure 1.8.
1.6 Prevalence of cutaneous HPV infection
The prevalence of cutaneous warts in the immunocompetent population is difficult
to determine accurately since diagnostic methods to detect previous infection are not
routine. Commonly used tests to detect HPV DNA in biopsy material are low-
stringency Southern blot, PCR with consensus LI primers, dot blot and hybrid
capture. Early studies based on serological tests have estimated the prevalence to be
between 7 and 13 % of the population (reviewed by Bunney et al 1992a). However,
more recent estimations of exposure to HPV using ELISA have shown that 85% of
individuals without current cutaneous warts have HPV-1 specific serum antibodies
(Steele et al 1990).
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Figure 1.8 The cytopathic effect of HPV in cutaneous warts
Photomicrographs of cutaneous viral wart sections stained with haematoxylin and eosin are shown.
Magnifications are : 12 X (panel A) and 100 X (panel B). Panel A: parakeratosis = PK, acanthosis =
C, papillomatosis = P, epidermis = E, dermis = D. The arrow indicates a prominent granular layer
with vacuolated cells. Panel B : the arrow indicates koilocytes in the upper epidermis of a palmar
wart.
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Where HPV prevalence is defined as the presence of viral DNA, Bauer et al (1991)
found a prevalence of 30-40% in normal cervical specimens of sexually active
women. However, more recent studies found approximately 8-27% of normal
cervical samples contained HPV DNA (reviewed by Shiffman 1994) which may
more accurately reflect the levels of HPV infection in the general population.
Thirty percent of cutaneous warts spontaneously resolve within 6 months, but
persistent HPV infection which is resistant to treatment occurs in a minority of
immunocompetent individuals. HPV infections are particularly persistent in
clinically immunosuppressed renal allograft recipients (RAR) (shown in Figure 1.6)
where the prevalence of HPV infection in this group of patients ranged from 42%-
55% in different studies (reviewed by Benton et al 1992). Patients receiving
immunosuppressive therapy for long duration have a greater likelihood of
developing warts. For example, a 20% prevalence of viral warts was found in a
group of RAR who had a graft survival of less than 5 years but a 77% prevalence in
those patients whose graft survival was between 5-22 years (Barr et al 1989). In a
study of RAR whose mean graft survival time was 4.5 years, the prevalence of
cutaneous warts was 26%. However, RAR with high exposure to sunlight had a
58% prevalence of viral warts (Boyle et al 1984). This suggests that UV exposure
plays a role in promoting the development of HPV infection. Infection with "low
risk" cutaneous HPVs is rarely associated with malignant progression. However,
HPV infection may be a co-factor which in combination with immunosuppressive
therapy and UV exposure, can lead to the transformation of common warts into
squamous cell carcinomas (Noel et al 1994). Indeed Stark et <2/(1994) detected
HPV-1 or 2 in 10% squamous cell carcinomas from RAR.
Epidermodysplasia verruciformis (EV) is a rare autosomal recessive disease which
predisposes individuals to infection with HPV types which are not pathogenic in
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immunocompetent individuals (reviewed by Majewski et al 1995). HPV-5 and 8
are often associated with this disease but many other HPV types have been detected
in these lesions. EV associated HPVs share DNA sequence homology and are
shown as a separate branch of the phylogenetic tree (Figure 1.4). Multiple
squamous cell carcinomas develop in approximately 33% of EV patients,
particularly on UV exposed sites. HPV-5 and 8 are present in 90% of these
squamous cell carcinomas and are thought to play a role in malignant transformation
of host cells. HPV infection which is clinically and histologically typical of EV, is
also found in RAR and high UVB exposure in RAR also increases the prevalence of
malignant conversion of warts infected with EV and other HPV types.
1.7 Models ofHPV infection and propagation
1.7.1 Mouse xenografts
The study of HPV life cycle and virus-host cell interactions have progressed slowly
due to lack of culture systems for the propagation of HPV in vitro. Kreider et al
(1985) were the first to demonstrate productive infection of HPV when normal
human cervical tissue infected with condylomata acuminata extracts were implanted
into the renal capsule of nude mice. HPV-11 DNA was detected in these infected
xenografts and they displayed histological features typical of condylomata.
Productive replication of HPV-11 was also observed in experiments using neonatal
foreskin epithelium xenografted into the renal capsule of nude mice. Virions
isolated from these grafts were capable of infecting foreskin epithelium (Kreider et
al 1987). However, HPV-1 is the only other HPV type which can be propagated in
this system (Kreider et al 1990).
Successful production of HPV-1 and 11 in xenografts, depends on the initial
isolation of virions from clinical samples. HPV-16 and 18 have not been produced
in this system since virus particles cannot be isolated from infections with these
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HPY types. However, productive infection of HPV-16 has been demonstrated by
grafting a low grade human cervical intraepithelial neoplasia derived cell line
containing episomal HPV-16 DNA onto prepared granulation beds in nude mice
(Sterling et al 1990). The grafted cells formed a stratified differentiating epithelium
and exhibited features of low grade cervical intraepithelial carcinoma. This
experimental system can support the complete HPV life cycle since HPV particles
can be found in the terminally differentiated KC. However, it is not known whether
the particles produced are infective virions. Nevertheless, the technique has been
useful in localising expression of the LI and E4 proteins within the differentiating
epithelium (Sterling et al 1993).
1.7.2 Raft Cultures
The organotypic culture system or raft culture is a model experimental system which
mimics the stratified epithelium in skin and therefore can allow productive infection
of HPV. Epithelial cells are placed on a dermal equivalent such as a synthetic
collagen matrix or de-epidermised dermis, and cultured at the air-liquid interface.
Initial studies have shown the production of infective virions from explants of HPV -
11 infected xenografts cultured on rafts (Dollard et al 1992). HPV production was
also demonstrated in a carcinoma cell line, containing episomal HPV-31 DNA,
when grown on a raft culture and treated with phorbol ester (Meyers et al 1992).
1.7.3 Non-productive HPV infection in vitro
Inoculation of KC with HPV in vitro does not lead to a productive HPV infection,
but may still provide insight into the early stages of HPV infection and DNA
replication. Infection of cultured human KC with HPV-1 virions from plantar warts
results in transient HPV DNA replication and viral DNA persists in KC for up to 4
months after infection before it is lost (La Porta et al 1982). Subsequent studies
have shown viral transcripts in HPV-1 infected human transformed KC (Burnett et
al 1983), primary human KC (Chow etal 1987) and bronchial cell lines (Christian et
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al 1987). Human KC infected with HPV-1 particles contained HPV-1 specific
mRNAs which represent a sub-set of those found in plantar warts and had identical
splice patterns (Chow et al 1987). The E1AE4 transcript is the most abundant viral
mRNA in HPV-1 infected KC (Chow et al 1987) and is also found in HPV-11
infected foreskin explants up to 4 weeks after infection (Smith et al 1993). Passage
of KC outgrown from these explants also had E1AE4 transcripts for up to 42 days in
culture.
In a study of virus-host interactions, monocytes infected with BPV produced
bioactive IL-1 3 days after infection and virai DNA was present in these monocyte
cultures up to 28 days after infection (Bonnez et al 1991). After infection of KC
with HPV-1 viral DNA could be detected up to 13 days, and was not replicated
under these conditions (Bossens et al 1992). Studies of HPV infection using HPV-
11 VLPs, demonstrated that VLPs bound and were taken up into a variety of cells in
different mammalian species (Muller et al 1995). This process could be partially
blocked in the presence of a neutralising antibody or by pre-trypsinisation of host
cells. When VLPs linked to a (3-galactosidase (P-gal) reporter plasmid were
inoculated into HeLa cell cultures, P-gal expression was detected up to 48 hours
after infection but only in 1% of cells. When cultures were co-infected with
replication-deficient adenovirus and VLP-P-gal, expression of (3-gal increased by
10- 20 fold. This indicates that release of VLP-fl-gal from lysosomes occurred at
low levels without the presence of adenovirus which is known to lyse lysosomal
membranes (Muller et al 1995)
1.7.4 Transfection in vitro
Much of the knowledge of HPV replication comes from in vitro transfection studies.
Oncogenic HPVs such as HPV-16, 18 and 33, when transfected into cells, integrate
into cellular genomes and cause transformation (Durst et al 1987; Gilles et al 1993).
In contrast non-oncogenic HPVs, such as HPV-11, generally do not integrate but
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replicate transiently when transfected into human KC (Mungal et al 1992) and
squamous cell carcinoma cell lines (Del Vecchio etal 1992).
1.8 Immunity to HPV
Persistent HPV infection is observed in patients with clinical immunosuppression
due to Hodgkin's disease, human immunodeficiency virus infection, inherited
disorders such as Wiskott Aldrich syndrome and therapeutically immunosuppressed
RAR (reviewed by Benton et al 1992). Patients with diseases consisting of
deficiencies in humoral immunity do not show such susceptibility to infection with
HPV (Frazer et al 1992). This observation suggests CMI plays a more central role
in controlling the course, duration and regression of HPV infection. However,
rabbits and dogs vaccinated with CRPV and COPV VLPs respectively, are protected
against experimental infection with PV (Breitburd et al 1995; Suzich et al 1995).
Passive transfer experiments indicated protection from infection was mediated by L1
specific antibodies. However, the role of humoral responses in HPV infection is less
clear.
Since HPV does not productively infect monolayers of cells in vitro, conventional
virus titre assays and isolations cannot be performed. Thus the identification of
infected individuals is not possible using conventional methods. The study of HPV-
specific immune responses has proved difficult largely due to a lack of suitable
HPV-antigens for use in both antibody and cellular assays, although the production
of VLPs has now provided an abundance of antigen to use in serological assays of
some HPV types. Since there is no reliable non-invasive specific test to determine
past or present HPV infection, information provided by patients has to be relied on
for infection history. Indeed normal tissue may harbour HPV DNA (Young et al
1989; Ferenczy et al 1985) suggesting either latent infection which may later
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generated which identified four LI epitopes. Altman et al (1992) generated CD4+
Tncell lines specific for HPV-16 E7 peptides which recognised three HPV-16 E7
epitopes using overlapping peptides.
Cytotoxic T cell (CTL) epitopes of HPV-16 E6, E7 and LI have been identified in
mice (Stauss et al 1992) and more recently human CTL specific for HPV-11 E7
peptides were demonstrated which were HLA-A2 restricted (Tarpey et al 1994).
Interestingly, some CD4+ Th cell lines generated towards HPV-16 E7 peptides
exhibited CTL activity in vitro (Altman et al 1992).
Natural killer (NK) cell activity from PBMC has been demonstrated towards KC
which contain HPV-16 genomes, and decreased NK lysis was shown in PBMC from
patients infected with HPV (Malejczyk et al 1989). Other studies could not
demonstrate NK mediated lysis of HPV-16 infected KC, although pretreatment of
freshly isolated PBMC with IL-2 generated lysis of these targets, which increased
when target cells were pre treated with y-IFN (Wu et al 1994).
1.8.2 Local cell mediated immunity
The study of cells within warts which play a role in skin immunity provide insight
into the way in which HPV infection alters local immunity. Immunohistochemical
studies of normal human epidermis have detected low numbers of T cells, with CD8
: CD4 T cell ratios of 3:2 (Foster et al 1990), while normal human mucosal
epithelium had equal ratios of these T cell subsets (Tay et al 1987). No
predominance of either T cell subset was found in the dermis of cutaneous or
mucosal warts using semi-quantitative analysis (Viae et al 1992a; Viae et al 1992b;
Chardonnet et al 1986; Tay et al 1987). Other studies found either a predominance
of CD4+ (Bishop et al 1990) or CD8+ T cells (Viae et al 1992b) in the stroma of
anal and laryngeal warts, while a predominance of CD8+ T cells were found in the
epithelium of cervical warts (Tay etal 1987). During regression of plane warts there
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is an increase in the numbers of T cells infiltrating the epidermis, with a
predominance of CD8 + cells (Iwatsuki et al 1986), thus suggesting a role for CD8+
T cells in wart regression. However, other studies observed a mononuclear cell
infiltrate in the epidermis of regressing plane and genital warts comprising
monocytes and equal numbers of CD8 + : CD4+ T cells (Aiba et al 1986; Fierlbeck
et al 1989). NK cells were not observed in either regressing plane (Aiba et al 1986)
or genital warts (Fierlbeck et al 1989), suggesting that NK cells do not have an
important role in the regression of warts.
In an animal model of HPV infection, syngeneic HPV-16 E7 expressing KC are
grafted onto mice therefore presenting HPV-16 E7 to the immune system in a
similar way to natural HPV infection (McLean et al 1993). Challenge of the grafted
mice with HPV-16 E7 vaccinia recombinants results in a delayed type
hypersensitivity response (DTH) which was mediated by CD4+ T cells (McLean et
al 1993). Immunohistochemical analysis of ears from grafted mice subsequently
challenged with vaccinia E7 recombinants showed infiltration of predominantly
activated CD4+ T cells and macrophages (Chambers et al 1994). A threshold dose
of grafted sensitising cells was observed below which a DTH response could not be
induced upon challenge. When a subthreshold dose of E7 expressing cells were
grafted, an unresponsive state was induced and mice could not be further sensitised
with high doses of E7 to induce a DTH response (Chambers et al 1994). This
suggests that low levels of HPV antigen presented to the immune system in a natural
infection may cause tolerance or an anergic state representing an evasion strategy by
the virus and may explain the persistent nature of HPV infections. Chen et al (1991)
implicated CD8+ T cells in the rejection of HPV-16 E7 expressing tumour cells in
mice vaccinated with HPV-16 E7 expressing cells.
Another possible strategy for HPV to evade the immune system may be effected
through the reduced numbers of LC observed in HPV infection. Whether this
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reduction is a cause or consequence of HPV infection is not known. Further
discussion of LC is found in Chapter 3. HPV may also alter local immune responses
by modulating ICAM-1, VCAM-1 and E-selectin expression on the surface of
vascular endothelial cells which regulate the entry of leucocytes into the skin
(discussed further in chapter 3). The presence of activated leucocytes within the
skin contribute to the local cytokine production by LC, KC, melanocytes, dendritic
cells, fibroblasts and mast cells, and alterations of this cytokine network can
determine the outcome of a cutaneous infection. Acute viral infections often
stimulate a ThI cytokine response thus promoting CMI whereas chronic infections
fail to stimulate this response, but generate a Th2 mediated response. This immune
reaction drives a humoral response which may not be appropriate for clearing a
chronic intracellular infection (Sher et al 1992). HPV often causes a chronic
infection of the epithelia but the cytokines produced by the host in response to this
infection are unknown. The effect of HPV on cutaneous cytokine responses are
discussed further in chapter 4.
1.9 Aims
The aims of the following study were to:
1) Generate HPV-specific Th cell clones and to further characterise the specificity
and function of these cells.
2) Quantify numbers of CD3+ and CD45RO+ T cells in the dermis and epidermis of
cutaneous warts. Determine the density of LC in the epidermis, and ICAM-1 and E-
selectin expression, in the dermis of cutaneous warts.
3) Undertake an adherence assay of activated T cells to sections of cutaneous warts
and compare this adhesion with that seen in normal skin and inflammatory skin
disease.
29
4) Determine the cytokine mRNA profile in cutaneous warts and compare this with
cytokine expression in normal skin.
5) Establish an in vitro system to model the early stages of HPV infection, and
determine whether HPV directly modulates cytokine expression in KC.
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Chapter 2
T cell proliferation to purified HPV
2.1 Aim
To evaluate the role of cellular immunity in HPV infection, Th proliferative
responses to purified HPV antigen were investigated in vitro. In addition the
generation of T cell clones to HPV was attempted in order to determine the role of
CMI in vivo .
2.2 Introduction
The immunology of cutaneous warts is not fully understood and it is uncertain what
factors lead to clinical infection, affect the duration of the disease, and trigger wart
regression. Evidence for CMI playing a greater role in immunity towards HPV than
humoral responses arise from the observations that RAR have an increased incidence
of cutaneous warts (Rudlinger et al 1986; Barr et al 1989). Patients with a defect in
the humoral arm of the immune system do not show a similar increase (Frazer et al
1992). T cells are key regulators of CMI and the in vitro proliferative response of
Th cells to specific antigen is thought to reflect both the memory and the size of the
systemic CMI response. T cell proliferative responses to purified HPV in vitro was
either weak or absent in individuals with either progressing or regressing cutaneous
warts (Charleson et al 1992). Clonal T lymphocytes may be generated from PBMC
which show an HPV specific response in vitro. Indeed, by isolating and expanding a
clone of T cells, any negative influence which could affect its proliferative capacity
in culture would be removed and increased proliferation may result.
The generation of HPV-specific clones of T cells in vitro can provide information
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about which antigen specific lymphocytes may be involved in immune responses
towards HPV. This may further the understanding of the pathogenesis of this virus
and aid the design of effective vaccines and therapies. The specificity and function
of T cell clones generated from patients infected with HPV is a part of the immune
response which can be dissected and studied in vitro. The MHC restriction of T cell
clones may also be examined therefore identifying HLA haplotypes which can
potentially restrict HPV-specific Th responses.
As discussed in chapter 1 it is difficult to obtain an accurate clinical history of a
patient with regard to cutaneous HPV infection. Eighty five percent of individuals
without current cutaneous warts have HPV-1 specific serum antibodies (Steele et al
1990), indicating previous exposure to HPV-1. However, antibody response is not
correlated with lymphoproliferation to purified HPV-1 or 2. In addition, another
study found no correlation with either the HPV-specific antibody response or CMI
and the presence of koilocytes (Cubie et al 1988). Therefore in this study, PBMC
from individuals either with or without current HPV infection were screened for
lymphoproliferative responses to the virus in vitro before proceeding with cloning.
The strategy taken to obtain HPV-specific T cell clones was to culture PBMC
together with purified HPV and then expand the numbers of T cells from this initial
stimulation. Cultures were then screened for responses to HPV and positive cultures
were cloned by limiting dilution. Alternatively, PBMC were stimulated initially
with HPV and then cloned directly from this cell population without additional
expansion.
Currently there are no in vitro culture systems able to produce HPV particles in
sufficient quantity to use as antigen for lymphoproliferation assays or T cell cloning,
therefore, HPV was purified from clinical samples. Autologous APC were also not
available in large numbers. The number of responding T cells were increased by
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stimulation with anti-CD3 antibody coated tissue culture plates. This procedure has
been reported to maintain the antigen specificity of the response (Garbrecht et al
1988). In general, lymphoproliferative responses to HPV in vitro are low (Cubie et
al 1988), possibly due to a suppressive effect of HPV on PBMC (Chopra et al 1991).
In a previous study, M.leprae specific T cell clones could only be generated using
allogeneic APC (Modlin et al 1986). Therefore the absence of autologous APC
during culture on antibody coated plates may be advantageous. The strategy of
increasing cell numbers non-specifically before cloning and the use of anti-CD3
antibody coated plates in the maintenance and expansion of cell lines has been
described previously (Ferrarini et al 1990; Yanelli et al 1990).
Immunity to viral infections requires CMI, namely CD8+ MHC class I restricted
CTL. However, it is the CD4+ Th cell which is an important initiator of this
response and provides help to CTL. Therefore expansion of the CD4+ T cell subset
is required to generate a Th clone. Previous studies, where anti-CD3 antibody was
used to stimulate T cells in vitro for long periods, showed a gradual decrease in the
antigen specific response, and an enrichment of CD8+ T cells (Crossland et al 1991).
However, signalling via the TCR alone is not sufficient for optimal interleukin-2
(IL-2) production, and proliferation of CD4+ T cells. Furthermore, stimulation of
the CD3-TCR complex in the absence of co-stimulation (usually provided by APC)
can lead to an anergic state (Allison, 1994). Indeed, stimulation using only anti-CD3
antibody coated plates, induced the death of TH1 clones (Liu et al 1991). Therefore,
additional antibodies were coated on plates together with anti-CD3 to avoid these
problems.
CD28 is a major co-stimulatory molecule on T cells which prevents clonal anergy
when bound by its natural B7 ligands present on APC (Allison, 1994). Clonal
anergy is also prevented when anti-CD28 antibodies are added in solution to cultures
of T cells stimulated by anti-CD3 antibodies (Harding et al 1992). Furthermore,
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Riddell et al (1990) used soluble anti-CD3 antibody and anti-CD28 antibody, with
APC to cross link the antibodies, as a strategy for cloning and expanding human T
cells in vitro.
Anti-CD4 antibodies have also been shown to synergise with anti-CD3 to induce
proliferation of CD4+ T cells when immobilised on tissue culture plates (Emmerich
et al 1987). Therefore, it was investigated whether the addition of anti-CD28 or
anti-CD4 to anti-CD3 coated tissue culture plates generated proliferation of CD4+ T
cells in vitro. The optimum coating procedure was then used to expand T cell
numbers before cloning.
2.3 Materials and methods
2.3.1 Isolation ofperipheral blood mononuclear cells
Ethical permission for this study was granted following review by a local ethics
committee, and was carried out in accordance with standards laid down in the 1964
declaration of Helsinki. Following informed consent, heparinised blood from
patients with current HPV infection attending the Department of Dermatology,
Royal Infirmary of Edinburgh or from normal healthy volunteers with no evidence
of current HPV infection, was separated by centrifugation of undiluted blood over an
equal volume of lymphoprep ™ (Nycomed UK, Sheldon, Birmingham, UK) at 800 g
for 30 minutes at room temperature. The interface containing the PBMC was
removed and washed three times in sterile phosphate buffered saline (PBS). The
isolated PBMC were resuspended in RPMI-1640 (Gibco-BRL, Paisley, Scotland,
UK) containing 10% autologous plasma, 100 IU / ml penicillin, 100 |ig / ml
streptomycin (Sigma, Poole, UK), and 2 mM L-glutamine (Gibco) (autologous GM).
2.3.2 Purification ofHPV
HPV was purified using a modification of a previously described method (Gissmann
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et al 1976). Briefly, tissue parings from cutaneous warts were removed as part of
normal treatment and stored in PBS with 100 IU / ml penicillin and 100 pig / ml
streptomycin at -20°C. Parings from 20 individuals were cut into small pieces and
homogenised in a small volume blender. The supernatant was aspirated and kept on
ice after gross debris was allowed to settle. The remaining pieces from the blender
were ground up in a mortar and pestle with sea sand, removing the supernatant
during the process, until no large pieces remained. The supernatant was cenlrifuged
at 1000 g for 15 min to remove any gross debris followed by ultra-centrifugation at
80,000 g for 75 min at 4°C to pellet virus. The pellet containing virus was then
resuspended in 40% caesium chloride in PBS (refractive index 1.367) and adjusted
to a refractive index of 1.365 with either PBS or caesium chloride. This virus
suspension was then centrifuged at 110,000 g for 20-24 hrs at 18°C. The opaque
band of virus particles was visualised under an inverted light microscope and the
band corresponding to 1.34 g / ml density containing the virus was aspirated using a
glass pasteur. CsCl was removed by dialysis against PBS overnight at 4°C,
followed by inactivation with 1000 J / m2 UVB radiation for further handling. The
preparation was then filter sterilised by passing the preparation through a 0.2 qm
filter. The presence of virus was confirmed in each preparation by negative staining
with 2% phosphotungstic acid for 2 min and visualised by transmission electron
microscopy. The quantity of protein in each virus preparation was estimated by
Biorad assay according to the manufacturers instructions (Biorad, Hemel
Hempstead, UK) which was performed on individual batches of HPV. However,
many batches of virus were below the detection limit of this assay, therefore titration
in lymphoproliferation assays was the preferred method of quantification. A limited
number of batches were analysed by denaturing sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) followed by Silver staining
(Biorad), and in some cases Western blotting onto nitrocellulose membranes
(Amersham, Bucks, UK). These were then probed with a monoclonal antibody to
HPV-1 LI (Seralab, Crawley Down, UK). Primary antibody was detected with a
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rabbit anti-mouse horseradish peroxidase conjugated antibody (DAKO, High
Wycombe, UK) an developed with diaminobenzidine (Sigma) as described in
chapter 3.
2.3.3 Lymphoproliferative responses to HPVparticles
Triplicate 200 p.1 cultures were established with 2 x 10 5 PBMC per well with
autologous GM in 96 well U-bottomed plates (Nunc, Roskylde, Denmark). Cultures
with various concentrations of HPV particles or controls without antigen were
incubated at 37°C in 95% air / 5% CO2 for seven days. Wells were pulsed with 0.75
pCi 3H methyl thymidine (Amersham) on day 6 of culture and harvested 16-24 hrs
later. Cells were harvested onto glass fibre filters using an Automash 2000 cell
harvester (Dynatech, UK), and the activity incorporated was measured by liquid
scintillation counting. One ml hydro luma scintillant (Lumac, Belgium) was
dispensed per vial before counting on a 1900CA tri carb liquid scintillation analyser
(Canberra Packard, UK). Proliferation is shown either as counts per minute (cpm) or
as stimulation index (SI) which was calculated as the cpm of cultures with HPV
divided by the cpm of cultures with medium only.
2.3.4 Initial stimulation ofcultures
Five to ten cultures were established in wells of a 96 U-bottomed plate in parallel to
the thymidine incorporation assay for a primary in vitro stimulation with purified
HPV as antigen. Recombinant human IL-2 (20 IU / ml), (Genzyme, Cambridge,
MA, USA) was added on days 5 and 8 of culture before harvesting on day 9. Cell
viabilities, as determined by trypan blue exclusion, were always > 80% and
frequently > 95%. Harvested cells were cultured at 1 x 106 / well of 24 well plates
coated with the following antibodies: 1) anti-CD3, 2) anti-CD3 and anti-CD4 and 3)
anti-CD3 and anti-CD28. Cells were cultured in RPMI-1640 supplemented with the
same additives as autologous GM except 10% heat inactivated pooled human plasma
was added (pooled human GM). Twenty IU / ml IL-2 was also added to this GM.
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After expansion of T cells for 1-4 weeks, the proliferative response to HPV particles
was assessed as outlined in section 2.3.3. When proliferative responses were
observed, these cell lines were cloned by limiting dilution. In some experiments
cloning was performed directly after the primary stimulation with HPV.
2.3.5 Coating plates with monoclonal antibodies
Flat bottomed 96 well plates (Falcon, USA) were coated with 50 pi of a 10 pg / ml
goat anti-mouse polyclonal antibody (Sigma) by incubation overnight in Tris buffer
pH 9.4 at 4°C. Plates were washed 3 X with 200 pi PBS / well before coating with
the monoclonal antibodies in 1% bovine serum albumin (BSA) in PBS for 2 hrs at
37°C. Sequential coating of plates was performed with 50 pi mouse anti-human
CD3, and monoclonal antibodies to either CD4 or CD28 (DAKO). Finally unbound
antibody was removed by washing the plates 3 X in PBS. Plates were stored at 4°C
for up to 1 week. To determine the optimum concentration for coating, the
antibodies were titrated in a checker board style, and the proliferation of PBMC
measured after 4 days.
2.3.6 Expansion and maintenance of cells on coated plates
Cells from the primary stimulation were cultured in pooled human GM containing
20 IU / ml IL-2 at 1 x 10 6 / ml in each well of a 24 well antibody coated plate. Cells
were transferred to fresh wells before they became overcrowded and transferred
weekly onto new plates, with fresh GM and IL-2 every 3 days. The phenotype of the
enriched cell population was determined by immunofluorescent staining as follows:
Mouse anti-human monoclonal antibodies to CD4, CD8 and CD25 were incubated
with 1 x 10 6 cells (harvested from coated tissue culture plates at various time points)
for 1 hr at 4°C, washed once in 1% BSA / PBS containing 0.01% sodium azide
(wash solution) and incubated for 60 min with fluorescein isothiocyanate (FITC)
conjugated sheep anti-mouse IgG (Sigma) before washing twice in the wash
solution. Flow cytometric analysis was performed using a Coulter XL (Coulter,
Hiyaleah, FL, USA) and the data analysed using XL 1.5 software.
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2.3.7 Screening cultured cells for lymphoproliferative responses to HPVparticles
Cells cultured in antibody coated wells were harvested at least 6 days after the last
stimulation and washed once in PBS and the viability determined as before. Cells
were cultured in 96 well U-bottomed plates with various numbers of gamma-
irradiated PBMC and purified HPV antigen. Cultures were incubated at 37 °C in 5%
CO2. In general, 5 x 10 4 T cells and 1 x 10 5 APC / well were used. Cultures were
harvested after 72 hr, although other times were also studied. APC were either
freshly isolated PBMC or recovered from frozen stocks kept under liquid nitrogen.
Proliferation of either autologous or allogeneic APC was inhibited by y-irradiation
(5000 RADS).
2.3.8 T cell cloning
Cells were harvested from primary cultures stimulated with purified HPV or from
secondary or tertiary stimulations on antibody coated tissue culture plates. In some
experiments T cell blasts were purified by separation on either Lymphoprep™ or a
discontinuous percoll (Sigma) gradient. Frozen autologous PBMC were recovered
into autologous GM, washed once and irradiated (5000 RADS) before use as APC.
T cell blasts were plated out at 30, 3 and 0.3 cells per well in 20 (il autologous GM
into Terazaki wells (Sterilin, UK) with 1 x 10 4 APC, 20 -200 U / ml IL-2 and
purified HPV at the optimum concentration. Between 60 - 300 wells were plated out
as the cell yield permitted. Alternatively, PBMC were stimulated for 7 days before
harvesting on lymphoprep™. These cells were then plated out in 96 well U-
bottomed plates at 10 T cell blasts per well with 1 x 10 5 autologous APC. Cultures
contained IL-2 (20 IU / ml) and HPV particles in 200 p.1 autologous GM. Plates
were screened by light microscopy for proliferating cultures for up to 14 days after
initiation. Any cultures containing proliferating cells were transferred to a fresh well





Since large quantities of HPV cannot be obtained in vitro virus particles were
purified from patients' tissue parings, as described in section 2.3.2. HPV do not
productively infect monolayer cultures of KC in vitro . Therefore it was not possible
to obtain an accurate virus titre for each batch of purified HPV. Four methods were
used to characterise and standardise the different preparations of virus. Firstly, in
order to confirm the presence of virus, transmission electron microscopy was
performed after negative staining with 2% phosphotungstic acid. Figure 2.1 shows
an electron micrograph of one batch of virus particles at a magnification of 75000 x.
This was the only effective method of determining if HPV was present and it is
estimated that 1 x 108 particles / ml are required to allow visualisation.
In the second method total protein was quantified using the Biorad assay. This
method was only useful for preparations with a high titre of virus. Many batches of
virus were below the sensitivity of the assay, although other batches contained as
much as 100 pg / ml. The three batches (1,2 and 4) described here contained 80, 25
and < 7 |ig / ml.
The third method of characterising batches of virus was by separation on SDS-
PAGE followed by silverstaining, or Western blotting with HPV-1 LI specific
antibody. The results obtained with batches 1, 2 and 4 are shown in Figures 2.2 and
2.3.
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Figure 2.1 Electronmicrograph of purified HPV (75000 X)
Bar = 100 nm. All HPV were complete with visible capsomeres (as indicated). No empty particles
were observed.
Figure 2.2 SDS-PAGE of purified HPV
Each batch of purified HPV was boiled for 5 min with 5 % 2-mercaptoethanol and 2% SDS and
resolved by 8% SDS-PAGE followed by silver staining. Lanes 1, 2 and 3 show 0.45 pg batch 2, 0.75
pg batch 1 and 2.4 pg batch 4 of purified HPV respectively. Batches 1, 2 and 4 were derived from
tissue parings which were clinically diagnosed as HPV-2, HPV-1 or undiagnosed cutaneous viral
warts respectively.
The main structural proteins of HPV are LI, the major capsid protein and L2 , the
minor capsid protein. LI has a molecular weight of 55 kD and L2 is 76 kD in size
(Pfister et al 1994). Both structural proteins can be observed as major bands on the
gel (Figure 2.2). However, the predominant protein in the three preparations has a
molecular weight of 66 kD. This band could either be another species of L2, or a
degradation product of L2 which is 65 kD (Doorbar et al 1987), or contaminating
keratins from host cells.
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Figure 2.3 Western blot of three different purified HPV
batches
Batches 1 (0.75 jag), 2 (0.45 jag), and 4 (2.4 jag) of purified HPV were separated by SDS-PAGE,
blotted onto nitrocellulose and probed with a monoclonal mouse anti-HPV-l LI primary antibody as
described in section 2.3.2. Lanes 1, 2 and 3 show batches 2, 1 and 4 (respectively ).
The 55 kD HPV-1 LI protein can be clearly identified in all 3 HPV batches in Figure
2.3. Although Batch 2 (Lane 1) had the least amount of protein loaded on the gel it
had the greatest abundance of HPV-1 LI. This indicated that most of the pairings
used to generate this batch were infected with HPV-1. Lane 2 (batch 4) contained
HPV purified from wart pairings diagnosed as HPV-2. This indicates contamination
of HPV-1 in this batch. Batch 1 (Lane 3) contained HPV-1 as expected.
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A fourth method of standardising preparations of HPV was to titrate the amount of
virus used to generate optimum proliferation in vitro. Figure 2.4 shows the
proliferation generated from PBMC of 2 different donors to 2 different HPV batches.
Figure 2.4 Determination of the optimal amount of purified
HPV for lymphoproliferation in vitro
Concentration of virus (pig / ml protein)
• = Donor 15 (stimulated with batch 4), A = Donor 5 (stimulated with batch 1). standard error of
the mean (SEM) of triplicates was calculated and was < 14% mean. The concentration of purified
HPV producing optimal proliferation of PBMC was determined by a 7 day thymidine incorporation
assay described in section 2.3.3.
Increasing the protein concentration of virus in the culture increased proliferation,
with the maximum at a concentration of 2 |ig / ml. This was repeated 6 times, and
all individuals with or without HPV infection produced an optimum proliferation in
the range of 1 - 2.5 (ig / ml. Two |ig / ml of batches 1 and 4 was used in all
subsequent assays to screen other PBMC or for cloning.
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2.4.2 Screening patients
In order to generate T cell clones from either asymptomatic individuals or patients
with current HPV infection, lymphoproliferative responses from each donor were
assessed to determine which donors had previous HPV exposure and could mount T
cell responses in vitro. PBMC from each individual selected was screened as
described in section 2.3.3









plantar wartscommon I plane
mosaic
PBMC were tested from the following groups of patients : no current HPV infection, common warts,
plane warts, plantar warts and mosaic warts. I = HPV , □ = PHA (1 |ig / ml). * = warts which were
regressing at the time blood was taken. Results are shown as stimulation indices (SI). Proliferation
of PBMC (medium only) = 3656 cpm ± 535 SEM.
Proliferative responses obtained were variable within each patient group and no
marked difference in amplitude of responses was observed from PBMC of patients
with current cutaneous warts or individuals without current HPV infection. An SI >
3 was taken as a positive response, and by this criteria 29% (10/34) of all patients
with current HPV infection showed a lymphoproliferative response to HPV. In
contrast only 8% (1/12) of individuals without current HPV infection responded to
HPV although this difference was not significant (Fishers exact test). When patients
were grouped by wart type as shown in Figure 2.5, 75% (3/4) plane, 27% (6/22)
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plantar, 14% (1/7) common and 0/1 mosaic warts responded with an SI > 3. A
significantly greater proportion of patients with plane warts responded to purified
HPV than individuals without current HPV infection (p = 0.02). The responses of
these four individuals to the mitogen PHA were significantly greater (p < 0.05) than
the PHA responses from either normal individuals or the other patient groups (data
not shown). For further analysis individuals were also divided into groups of
subjects whose warts showed no sign of regression and subjects whose warts were
regressing at the time blood was taken (including individuals whose warts had
resolved). Positive lymphoproliferative responses were observed in 20% (5/24)
patients who had non-regressing warts. Forty percent (4/10) patients whose warts
were resolving or had resolved showed proliferative responses towards HPV. This
difference in proliferative response was not significantly different between these 2
groups, although the patient who gave the highest SI (36) had plantar mosaic warts
which had completely resolved within 1 month of the assay.
2.4.3 Maintenance and expansion ofcell lines
PBMC from donors which generated proliferative responses were then either cloned
directly from freshly isolated PBMC, or stimulated initially with antigen and
maintained on antibody coated plates. Firstly, it was determined which antibody
combination and concentration were optimal. Figures 2.6, 2.7 and 2.8 illustrate the
results obtained in proliferation assays with these plates coated with anti-CD3 in
combination with either anti-CD4 or anti-CD28.
2.4.4 Titration ofanti-CD4 antibody
In order to maintain cell lines on antibody coated tissue culture plates, it was
investigated whether a combination of anti-CD3 and anti-CD4 antibodies
immobilised on tissue culture plates induced greater proliferation than anti-CD3
antibody alone.
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Figure 2.6 Determination of optimal anti-CD3 and anti-CD4
antibody concentrations
anti-CD4 concentration (ng / ml)
□ = 10, A = 50, • = 100, ■ = 500 (ng / ml of anti-CD3 antibody). PBMC previously cultured
with soluble anti-CD3 (50 ng / ml) for 5 days were plated out in flat bottomed plates coated with
dilutions of anti-CD3 and anti-CD4. 1 x 10 5 cells were plated out per 200 pi well in pooled human
GM and a four day thymidine incorporation assay was performed, the results of which are shown
above. Responses were: medium = 7,620 cpm; anti-CD3 (500 ng /ml) = 12,9281cpm; anti-CD4 (500
ng / ml) = 554 cpm. SEM < 30% mean of triplicates.
The anti-CD4 antibody when used alone had an inhibitory effect on proliferation
compared with the medium only control. Inhibition of proliferation was also
observed using the lowest concentration of anti-CD3 antibody (10 ng / ml) with the
highest concentration of anti-CD4 antibody (500 ng / ml). All other anti-CD4
antibody concentration combinations had an inhibitory effect on the proliferation to
anti-CD3 (500 ng / ml) alone. Increasing anti-CD4 antibody concentrations
decreased proliferation. Since the anti-CD4 antibody inhibited the proliferative
response of PBMC to anti-CD3 antibody, anti-CD4 antibody was not used in
conjunction with anti-CD3 antibody to expand T cell lines.
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2.4.5 Titration ofanti-CD28 antibody.
It was investigated whether antibodies to the co-stimulatory molecule CD28, when
used in conjunction with anti-CD3 antibody increased the proliferative response
compared with proliferation induced by anti-CD3 antibody alone (Figure 2.7).
Figure 2.7 Determination of optimal anti-CD28 and anti-CD3
antibody concentration
Concentration of anti-CD28 (ng / ml)
■ = 0, A = 50, • = 100, □ = 500 and 0= 1000 ng / ml anti-CD3. PBMC previously stimulated
with 50 ng / ml anti- CD3 were plated out at 1 x 10 ^ cells / well in 96 well plates. Triplicate cultures
in 200 pi pooled GM were established for a 4 day thymidine incorporation assay. Figure 2.7 shows
the cpm obtained from PBMC exposed to various concentrations of anti-CD28 on plates coated with
0 -250 ng /ml anti-CD3. SEM <11% mean of triplicates.
The addition of anti-CD28 antibody to the anti-CD3 antibody coated plates resulted
in enhanced proliferation compared with plates coated with anti-CD3 alone. A dose
of 12.5 ng / ml anti-CD28 antibody gave the greatest proliferation, at all anti-CD3
antibody concentrations. However, the end point had not been reached since anti-
CD28 antibody gave greater proliferation and the results are shown in Figure 2.8.
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Anti-CD28 antibody was further diluted in combination with a sub maximal dose of anti-CD3
antibody (100 ng / ml). The same assay conditions were used as in Figure 2.7. SEM < 17% mean of
triplicates.
Figure 2.8 shows that optimum proliferation was achieved with 0.25 ng / ml anti-
CD28 antibody in combination with 100 ng / ml anti-CD3 antibody. These
concentrations of antibody were chosen for the expansion and maintenance of T cell
lines without the use of feeder cells.
2.4.6 Phenotype ofcells grown on antibody coated plates.
Long-term culture of T cells on anti-CD3 antibody coated plates promotes the
expansion of CD8+ T cells. Since the objective was to isolate CD4+clones, the
preferential expansion of CD8+ T cells was undesirable. Therefore it was necessary
to determine whether there was selective expansion of CD8+ cells when T cells were
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cultured on anti-CD28 and anti-CD3 antibody coated plates. Figure 2.9 shows the
long term effect on phenotype of T cells maintained on antibody coated plates.
Figure 2.9 Phenotype of T cells after long-term culture
on antibody coated plates
■ = CD4+, □ = CD8+, A = CD25+. The phenotype of PBMC from 2 patients cultured for 40 days
(as described in section 2.3.6) on anti-CD3 and anti-CD28 antibody coated plates is shown. Samples
of cells were removed at various time points and analysed for the expression of CD4, CD8 and CD25
on the cell surface by flow cytometry described in section 2.3.6.
The results shown in Figure 2.9 show that PBMC from patient A initially had 30 %
CD4+, 23 % CD8+ and 1% CD25+ cells. Similarly patient B had 40% CD4+, 25 %
CD8+ and 5 % CD25+ cells. A rapid expansion in the percentage of the CD4+
population occurred within the first few days of culture. Patient A's CD4+ T cells
were 52% of the total population by day 15, and patients B's CD4+ cells were 68 %.
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Similarly, CD25+ cells increased to 81% (patient A) and 84% (patent B) during the
first 15 days of culture. It is likely that many of the CD4+ T cells were also CD25+.
The numbers of CD4+ T cells were maximal between day 10 and 15 of culture,
although after this time the percentage decreased markedly. By day 20 the
percentage of CD4+ T cells within the culture had fallen to less than 10% of the total
population, (shown in both subjects). The CD8+ T cells showed a less rapid
expansion, peaking to 70% of the total cell population (patient A), and 71% (patient
B) by day 34 of culture. The viability of the cells remained > 80% for both patients.
However, at the last two time points the viability had fallen to 66% and 88% for
patient A, and 55% and 60% for patient B.
2.4.7 HPV-specific T cell responses from an oligo clonal cell line
Freshly isolated PBMC from 46 individuals were screened for their
lymphoproliferative responses to HPV, as shown earlier in Figure 2.6. Many of
these PBMC were also expanded on anti-CD28 : anti-CD3 antibody coated plates
before screening for responses to HPV. As APC were not present in the T cell
cultures either autologous or allogeneic APC were added to these assays. A total of
14 cell lines from different individuals were screened for proliferative responses to
HPV. Only one cell line showed a response to antigen and this was from a patient
with current HPV-2 infection. Lymphoproliferative responses of freshly isolated
PBMC from donor 15 are shown in Figure 2.10 in comparison with the response
from a cell line at different passage number established from donor 15.
Figure 2.10 shows an increased cpm in response to HPV after one round of
stimulation on coated plates compared with freshly isolated PBMC. Although due to
a higher background cpm after culture, the SI was reduced from 9.8 in freshly
isolated PBMC to 7.3 after 1 round of stimulation. After seven rounds of stimulation
the response to HPV was reduced from a high response (SI = 7.3) to no response (SI
= 0.7).
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□ = medium only, | = HPV-1 , ^ = HPV-2. The PBMC from patient 15 were cultured on anti-
CD3 and anti-CD28 antibody coated tissue culture plates. The response of the oligo clonal cell line to
HPV-1 and 2 was screened after several rounds of stimulation and compared to freshly isolated
PBMC. One round of stimulation was equivalent to 7 days stimulation on a fresh antibody coated
plate in the presence of 20 IU / ml IL-2. SEM < 29% mean of triplicates.
2.4.8 Cloning experiments.
After screening a range of donors, several of these were chosen to proceed with
cloning. Table 2.1 shows results from seven cloning experiments using 6 separate
donors. PBMC from 2 different donors (donors 19 and 37) gave positively
proliferating cultures when visualised by inverted light microscopy. However, all of
these positive cultures failed to further expand in vitro in the presence of APC,
antigen and IL-2.
Fresh 1 3 6 7
Rounds of stimulation








































































0/60 0/300 0/300 4/100 4/100
0/60 0/300 0/300 1 /100 1 / 100
successful
expansion none none none none none none none
Table 2.1 Fresh = PBMC which were freshly isolated prior to stimulation with HPV for 9 days and
then cloned from this population. Cell lines = PBMC which were stimulated with HPV for 9 days
and then expanded on anti-CD3 anti-CD28 antibody coated tissue culture plates before cloning. The
duration of culture before cloning is indicated. T cell blasts which had been isolated by percol,
lymphoprep™ or not separated but counted (ND), were seeded at 30, 3 or 0.3 cells per well in
Terazaki plates with APC, antigen and IL-2. In some cloning experiments (donors 37 and 38) 10
blasts per well were seeded in 200 pi wells. During the following 14 day period the cultures were
scored visually as positive or negative relative to proliferation for each cell density. The frequency of
responding cultures is shown in each box.
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2.5 Discussion
Infection with HPV is chronic in nature and can persist even in an
immunocompetent host, suggesting an effective evasion strategy of the virus or a
defect in the elicitation of an effective immune response. Thirty percent of warts
regress within 6 months (Bunney et al 1992) and it is likely that these patients
generated effective T cell responses towards the virus at that time. In order to design
effective vaccines and therapies it is critical that the nature of this CMI response
towards HPV is understood. Investigations into CMI towards HPV have mainly
concentrated on infections with the mucocutaneous types of HPV, the oncogenic
types of which can lead to carcinoma (frequently HPV-16 and 18). Many of these
studies have been undertaken in mice and fewer studies have investigated CMI to
cutaneous HPV types in humans. The following discussion will cover possible
reasons for poor lymphoproliferative responses obtained to purified HPV in vitro,
and will then discuss findings from other studies on responses to other HPV ORFs in
humans and mice.
2.5.1 Clinical history ofHPV infection
Previous studies on T cell responses from HPV infected individuals have suggested
that the degree of in vitro T cell proliferation to HPV is related to the clinical status
of the patient (i.e. individuals with resolving warts or those who are asymptomatic,
have higher responses than people with warts of several years duration) (Steele et al
1993). However, not all studies reached the same conclusion (Charleson et al 1992).
This hypothesis is difficult to investigate, because the true clinical status of an
individual with regard to cutaneous HPV infection cannot be accurately determined,
due to the lack of a pre-clinical diagnostic test. The majority of people have had
cutaneous warts, indeed 85% of normal laboratory donors have antibodies to HPV-1
(Steele et al 1990). If a Th cell response is generated in vivo during regression of
warts these individuals will have circulating HPV-specific memory T cells.
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Individuals without current HPV infection (for use as controls) may be
asymptomatic but are unlikely to be naive with respect to HPV infection. These
individuals may have been infected with HPV which could remain latent before the
infection shows clinical signs and the consequent change in epidermal morphology.
Alternatively, HPV DNA may remain latent after the resolution of a wart. Patients
with HPV infection in this study had their warts for at least 1 year and most were
non-regressing at the time they volunteered the blood. PBMC were also isolated
from patients whose warts had completely resolved or were in the process of
resolving.
2.5.2 Purified HPV as an antigen
Antigen is required in large amounts to clone and maintain antigen specific T cells.
Due to the lack of a viable culture system to obtain sufficient purified virus, HPV
was obtained from clinical material for this study. The fact that HPV cannot be
propagated in conventional virus titre assays in vitro prevents the accurate
quantification of the number of particles present in each preparation. Four methods
were used to standardise batches of HPV, and to characterise the antigen.
Transmission electron microscopy was essential to confirm the presence of virus
particles and showed qualitative differences in amount of virus in different batches.
The Biorad protein estimation was quantitative but a high virus titre was required to
be within the range of the assay. SDS-PAGE was used to characterise the purified
HPV and silver staining of 3 different batches indicated many protein species present
in all three preparations. The main bands visible were 78 kD, 66 kD and 55 kD in
size. The 78 and 66 kD bands may be the L2 structural protein, while Western blot
confirmed that the 55 kD was the LI (Doorbar et al 1987), although the presence of
contaminating host cell keratins cannot be ruled out. The three batches were
prepared from samples clinically diagnosed as either HPV-1, HPV-2 or undiagnosed
cutaneous viral warts. However, HPV-1 LI was detected in all three batches to
different extents. This indicates that determining the HPV type based on
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batches to different extents. This indicates that determining the HPV type based on
clinical observations is inaccurate In order to standardise the different batches of
purified HPV, the virus was used as antigen at a range of concentrations in
lymphoproliferation assays. The concentration of virus generating optimal
proliferation of PBMC was determined by Biorad protein estimation to be 2 (ig / ml.
2.5.3 Status ofHPV infection andproliferative response
In order to generate T cell clones to purified HPV, many individuals with or without
current HPV infection were screened for lymphoproliferative responses to purified
antigen. Great variation existed in lymphoproliferative responses to purified HPV
within a given group of individuals. In general, lymphoproliferation in response to
purified HPV was low (SI< 5) although PHA responses were high (data not shown).
Similarly Cubie et al (1988) measured low lymphoproliferative responses to purified
virus from patients attending colposcopy clinic, where the majority of SI were < 2.
Although 29 % of patients with current warts responded with an SI >3, only 8%
individuals with no current warts responded to the virus. However, no significant
difference was found between the percentage of responders with or without current
cutaneous warts. These findings do not support the hypothesis that asymptomatic
individuals have greater proliferative responses than those with current HPV
infection. This in part may be due to the low number of individuals without current
HPV infection tested in this study. Asymptomatic individuals as a group may also
include people with warts which have recently regressed, with warts unknown to
them or with a subclinical infection. Thus the division between these two groups is
not very distinct. PBMC from individuals with plane warts did show a significantly
greater (p = 0.02) proliferation than individuals without current HPV infection. It is
possible that infection with HPV types associated with plane warts (HPV-3 and 10)
induce T cell responses to a greater extent than infection with other cutaneous types.
However, since only 4 subjects with plane warts were analysed, more subjects need
to be screened before conclusions regarding this can be made. PBMC from donors
55
whose warts were regressing at the time blood was taken showed no difference in
proliferation when compared with PBMC from individuals whose warts showed no
change in status. However, one individual whose wart had regressed within 1 month
of the analysis responded with an SI of 36. This finding supports the evidence that
in vivo proliferative responses towards HPV may only be transient. Kadish et al
(1994) followed the PBMC response of one patient whose warts underwent
spontaneous regression. During regression a proliferative response was observed,
but when assayed 3 months later, the same response could not be demonstrated.
The lymphoproliferative responses to purified HPV reported in this study are greater
than described previously (Charleson et al 1992). Charleson et al (1992) observed
32 % patients and no controls with a proliferative response of SI > 2 to purified
HPV-1 and 2. In the present study a greater amplitude of response was observed in
many patients with the highest SI of 36, and many SI between 2-5. If the same
criteria were used as Charleson et al (1992), 41% of patients either with or without
current HPV infection would have positive proliferative responses in this study. The
present study showed a similar range of SI (0 -11) as seen previously, although
Steele et al (1993) found a greater percentage of asymptomatic individuals were
found to respond with an SI > 3 (52%). Cubie et al (1988) observed that 25%
colposcopy patients responded to purified HPV-1 and 2 (which are types not
associated with genital HPV infection). In addition there was no correlation with the
degree of dysplasia.
2.5.4 HPV type andproliferative response
In this study, no correlation could be made between type of wart and proliferative
response. Since HPV DNA typing was not available, patients were divided into
groups having either common, plantar or plane warts on clinical and
histopathological observations. Although plantar warts are often caused by HPV-1,
common warts by HPV-2 and plane warts by HPV-3, other types of HPV are found
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in these cutaneous lesions. DNA typing is essential to reach a definitive conclusion
regarding correlation between HPV type and proliferative response.
Since immune responses to HPV may be type specific the possibility of using the
incorrect HPV type as antigen cannot be ruled out, and may explain the lack of
response in some individuals. Indeed one study observed that regression of HPV-3
plane warts does not cause simultaneous regression of common warts in the same
patient (Tagami et al 1980). Cubie et al (1988) found positive responses of PBMC
from patients attending a colposcopy clinic to purified HPV-1 and HPV-2 virus
(usually cutaneous types). This response correlated with the patient history of skin
warts and not the grade of dysplasia due to HPV-16 infection. However, Strang et al
(1990) generated T cell clones reactive against five determinants from HPV-16 LI.
T cell clones specific for three of these determinants were cross reactive with
peptides corresponding to the LI peptides from other HPV types. Kadish et al
(1994) identified T cell responses to HPV-16 E7 peptides which appear to be HPV-
16 group specific, since 64% of patients with HPV-16 (or the closely related HPVs
31 and 33) responded to the peptides whereas only 16% of patients with other HPV
infections responded. This suggests that a type specific (or closely related type)
response may occur in vivo. Taken together the present evidence indicates that some
cross reactivity exists in immunity to HPV types and is more likely to occur between
similar HPV types.
2.5.5 HPV could be immunosuppressive in vitro
Whole HPV could exert a suppressive effect within the culture: HPV itself may
interfere with T cell proliferation in vitro. This is the case with Herpes Simplex
virus which may prevent monocytes from providing necessary co-stimulation for T
cell proliferation (Hayward et al 1993). Alternatively it is possible that HPV may
induce soluble suppressive factors in vitro (Chopra et al 1991) and suppression
caused by HPV could reflect an evasion strategy in vivo.
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2.5.6 Antigens not present in purified HPV
Proteins present in the whole inactivated HPV may not be the appropriate antigens to
elicit an immune response. Peptides provided by purified virus e.g. structural
proteins of the virus such as LI and L2, may not be antigenic in vivo, therefore little
response would be seen upon secondary stimulation in vitro. Other proteins encoded
by the virus which do not form a structural part of the virion itself (e.g. E4, E6, E7)
may be the antigens inducing the immune response in vivo.
2.5.7 Epithelial sequestration ofantigen
HPV is exclusively an intraepithelial pathogen which replicates in KC of the
differentiated upper layers of the epidermis and is released when they slough off the
top of the epidermis. LC present in the epidermis migrate to the draining lymph
node after stimulation by antigen or insult such as UV light or contact sensitisers
(Moodycliffe etal 1992; Macatonia el al 1986; Moll etal 1993). In HPV infection,
antigens may not be released by KC into the epidermis, thus viral antigen may be
sequestered away from the main APC of the skin. Therefore, if T cells are not
presented with HPV antigen in vivo, a secondary response will not be observed in
vitro, resulting in the poor responses seen in this study.
2.5.8 Local response versus systemic response
If a local HPV-specific immune response is generated, then venous blood may be an
inappropriate source to screen for responses. Primed T cells may occur at such low
frequency in peripheral blood that an in vitro response cannot be measured. HPV-
specific T cells may home back to the site of infection where greater numbers
accumulate.
2.5.9 Reduction ofantigen presentation by Langerhans cells
LC are found in reduced density in the majority of cutaneous warts (Chapter 3 and
Hughes et al 1988; Viae etal 1992a; Chardonnet et al 1986; Chardonnet etal 1983).
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It is not clear whether LC initially migrate from the epidermis during HPV infection
and are not replaced with LC from progenitors in the blood, or if HPV infection
occurs as a result of reduced LC density in the epidermis. If the latter occurred, the
reduced density of epidermal LC at the site of infection could lead to T cells not
being exposed to antigen. However, it has been observed that some chronic warts
have no reduction in epidermal LC (Chapter 3), which may suggest that a reduced
LC density alone cannot explain persistence of HPV infection. It is possible that
warts which do not have a reduced density of LC were about to regress, since an
infiltration of dendritic cells is observed in regressing plane and genital warts
(Fierlbeck et al 1989).
2.5.10 Lack ofMHC class II expression on keratinocytes
Resident KC in the epidermis do not express MHC class II (Viae et al 1993) but can
be induced to express these molecules (Coleman et al 1994a). The up-regulation of
MHC class II on KC by y-IFN implies that KC can serve as APC for T cells.
Presentation of herpes Simplex virus by MHC class II + KC to T cells in vitro has
been demonstrated (Cunningham et al 1989). However, MHC class II expression on
KC is not seen in the epidermis of cutaneous warts (Viae et al 1993) although it has
been detected at low levels in benign laryngeal papillomas and low grade genital
lesions (Viae et al 1993; Viae et al 1992b; Norton et al 1991). Lack of MHC class II
on KC may be partly responsible for poor lymphoproliferative responses observed in
vitro to HPV antigens. Regression is associated with the expression of MHC class II
on epidermal KC in genital (Coleman et al 1994a; Fierlbeck et al 1989) and plane
(Aiba et al 1986) warts. MHC class II induction on KC may be necessary for an
HPV-specific immune response to occur. MHC class II is frequently found in high
grade cervical intraepithelial neoplasia (Coleman et al 1994b; Glew et al 1992).
However, Glew et al (1992) found no correlation between MHC class II expression
and the presence of HPV-16 DNA in cervical squamous cell carcinomas.
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2.5.11 MHC Class I modulation
MHC class I molecules are expressed constitutively on most somatic cell types and
are responsible for the presentation of peptide fragments of viral proteins to CD8+ T
cells. A reduction in the expression of MHC class I is frequently observed in
cervical carcinoma (Connor et al 1990), but this decrease does not occur in all HPV
induced carcinomas, indicating no direct effect of HPV on MHC class I expression.
MHC class I reductions are most prominent in invasive cervical carcinomas, whereas
no evidence of class I modulation is observed in benign HPV associated disease, low
grade cervical intraepithelial neoplasia or cutaneous warts (Viae et al 1990).
Modulation of class I MHC may enable HPV induced carcinomas to evade the
immune system although it is not a strategy utilised in benign HPV infections.
2.5.12 Clonal anergy
Induction of MHC Class II expression on KC allows these cells to function as APC.
Presentation of Herpes Simplex virus (Cunningham et al 1989), bacterial derived
superantigens, PHA, anti-CD3 (Nickoloff etal 1993), and M. leprae antigens (Mutis
et al 1993) by class II + KC to CD4+ T cells has been observed in vitro. However,
the presentation of alloantigen (Nickoloff et al 1993), influenza virus peptides (Bal
et al 1990), and contact allergens (Gaspari etal 1988) by MHC class II+ KC in vitro
and in vivo (Gaspari et al 1991) have been shown to induce a non-responsive or
anergic state. Anergy occurs when peptide and MHC II are presented to T cells
without co-stimulation by APC. Important receptors involved in costimulation are
the B7 group (B7.1, B7.2, B7.3) which interact with CD28 or CTLA-4 on T cells
(Nickoloff et al 1994). KC express B7.3 which binds to CD28 but does not provide
co-stimulatory signals (Nickoloff et al 1994). Non-regressing warts have been
shown to lack MHC class II on KC (Viae et al 1993), therefore KC are not able to
present antigen to CD4+ T cells. However, if expression of MHC class II on KC is
required for regression to occur, then the lack of co-stimulatory molecules such as
B7.1 or B7.2 to stimulate CD28 on the surface of the T cell could induce anergy.
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MHC class II is induced in regressing genital HPV lesions (Coleman et al 1994a),
but it is unknown whether this is a necessary requirement for wart regression. It is
also unknown if co-stimulatory molecules are also upregulated on the KC of
regressing warts. Transfection of B7 into tumourigenic cell lines which already
possess HPV-16 E7 leads to regression of the tumours when these cell lines are
inoculated into immunocompetent mice (Chen et al 1992).
Other molecules which may be involved in cutaneous co-stimulation are ICAM-1,
LFA-3, heat stable antigen (Chen et al 1993) and the invariant chain (Ii-CS) which
associates with MHC class II and is thought to enhance T cell responses via the
CD44 molecule (Naujokas etal 1993).
Low levels of HPV antigen presented to the immune system may also be a cause of
anergy. This has been demonstrated in a mouse model where high levels of antigen
presented to the immune system induce an immune response while low levels induce
an anergic state (Chambers et al 1994).
2.5.13 Decreased general cell mediated immunity
Although lymphoproliferation was generally poor in response to whole virus, the
PBMC did proliferate to mitogens such as PHA (data not shown). This indicates
that PBMC from individuals tested were still able to mount T cell responses which is
in agreement with some studies (Vardy et al 1990; Androphy et al 1984) but not
others (Carson etal 1986; Obalek etal 1980).
2.5.14 Cloning experiments
In this study, individuals who showed initial responses to purified HPV were used
for cloning experiments. Cloning was attempted either from freshly isolated PBMC
which had undergone stimulation with purified HPV for 9 days, or PBMC which had
undergone initial stimulation with purified HPV and then subsequent growth on
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tissue culture plates coated with antibodies. The advantage of culturing T cells in
vitro before cloning are that T cells are selectively enriched on anti-CD3 coated
plates, and after the first round of stimulation, are not under any negative influence
which may be present in a culture of whole PBMC (e.g. APC, HPV or other T cells).
Culture of lymphocytes without APC may increase the success of subsequent
cloning by either removing negative influences or by increasing the frequency of
antigen specific precursors. Indeed, one investigation isolated melanoma-specific
CTL clones from cultured PBMC but could not elicit CTL from fresh PBMC from
the same patient (Mukherji et al 1989).
2.5.15 Growth ofT cells on antibody coated plates.
Anti-CD3 and anti-CD4 antibody coated plates were used to investigate the potential
of CD3 and CD4 as co-stimulatory ligands for expansion and maintenance of T cells
prior to cloning. Co-stimulation via CD4 molecule did not augment T cell
proliferation by anti-CD3 alone and was not used further. Anti-CD28 antibodies
were used in conjunction with anti-CD3 antibodies as they generated increased
proliferation compared with anti-CD3 alone. These antibody coated plates
maintained CD4+ cells over short periods of time (15 days). Lymphoproliferation
towards HPV was increased after one round of stimulation on coated plates, but after
seven rounds of stimulation the response had diminished markedly. These results
suggest that the coated plates are of use in the maintenance of these cell lines but
only in the short term (< 2 rounds). Long term culture on these plates (30 - 40 days)
preferentially selected CD8+ cells. Fourteen cell lines derived from donors with
different clinical history were expanded on anti-CD3 and anti-CD28 antibody coated
plates before being screened for responses to whole HPV using autologous APC. A
mixed pool of 3 allogeneic donors were also used to increase the chance of
presentation by an APC of matched HLA type. Only a very small proportion of
these donors responded to purified HPV (1/14), indicating that the strategy of
expanding T cells on coated plates was not augmenting the HPV specific response.
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Cloning by limiting dilution was attempted from either these expanded cell lines or
from fresh PBMC. The PBMC from one donor produced positive cultures, but these
positive cultures failed to expand when they were transferred to larger wells with
APC, antigen and IL-2. The failure to obtain T cell clones could be due to several
reasons:- 1) there were no antigen specific T cells responding and colonies picked as
positives by eye were not genuine proliferating cultures, 2) the method was
inappropriate for selecting low frequency precursor T cells, 3) expansion of clones
was not optimal. 4) antigen was inappropriate and 5) APC were inappropriate.
There may be ways of improving the success rate of cloning. After initial culture
with antigen other cytokines such as IL-12, or IL-4 could be added to the culture to
stimulate either ThI or Th2 T cell clones respectively. Alternatively antibodies
towards these cytokines may promote clonal growth of T cell subsets. PBMC from a
panel of HLA typed donors to use as APC would remove the limitations of obtaining
sufficient APC from one particular donor. Other HPV antigens may be more
appropriate to generate recall responses in vitro.
2.5.16 Human T cell responses to HPVE4
In order to identify epitopes involved in immune responses to HPV, researchers have
generated overlapping peptides derived from HPVs and identified sequences which
produce T cell responses in vitro. In addition, peptides which can potentially induce
immune responses have been determined by screening their binding to MHC
molecules. Alternatively, predictions have been based on elution of peptides from
MHC antigens or by using motifs of known T cell epitopes (Rothbard et al 1988; De
Lisi et al 1985).
Steele et al (1993) screened individuals for HPV specific lymphoproliferative
responses and generated T cell clones from one donor whose PBMC responded to
both HPV-1 and native HPV-1 E4. However, in these studies it was not clear if
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cloning was attempted for whole virus. Using HPV-1 E4-specific T cell clones,
Steele et al (1993) determined which part of E4 was recognised by screening
responses to 15-mer overlapping peptides derived from the E1AE4 protein. The
minimal epitope recognised by one clone was a 13 mer peptide (aa 38 - 50) and did
not fit predictions from De Lisi et al (1985) or Rothbard et al (1988). Blocking
studies suggested that this peptide was restricted by an identified HLA-DQ antigen.
Although responses to native E4 protein were detected (Steele et al 1993), responses
to HPV-1 E4 p-gal fusion protein were obscured by proliferation towards (3-gal
alone (Charleson et al 1992). Cubie et al (1989) also found little evidence of HPV-
specific T cell responses to P-gal-HPV-16 E4 fusion proteins in a 6-7 day
proliferation assay. However, (3-gal fusions with other antigens have been successful
in generating antigen specific T cell responses (Shepherd et al 1994).
The lymphoproliferative response towards HPV E4 observed by Steele et al (1993)
suggests previous immune recognition of E4. However, without analysis of memory
and naive populations this remains speculative since Plasmodium falciparum
specific T cell responses have been demonstrated from non-exposed individuals.
The responses from non-exposed individuals may be due to either cross reactive
memory T cells (Currier et al 1992), or in some cases to naive T cells (Fern et al
1992). The Th response to HPV-E4 may be important in immunity against HPV-1
infections such as deep plantar warts where this antigen is highly abundant.
2.5.17 Humans T cell responses to HPV E7
E7 is the most abundant viral protein in HPV-16 associated genital cancer and has
been shown to have transforming activity in vitro. As a result, many studies have
investigated HPV-16 E7 specific T cell responses and attempted to map the epitopes
involved in recognition. One approach has been to generate overlapping 17-26 mer
(Kadish et al 1994) and 14 mer (Altman et al 1992) peptides which span the E7
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region and use these to identify epitopes involved in generating T cell responses.
Altraan et al (1992) generated CD4+ T cell lines from asymptomatic seropositive
individuals, which responded to HPV-16 E7 peptides. Three determinants of E7
were recognised in association with two MHC class II types and some of these
CD4+ clones had cytolytic activity. One E7 peptide (amino acids (aa) 17-39)
containing a Th epitope identified by Altman et al (1992), was also identified by
Kadish et al (1994). Kadish et al (1994) did not observe proliferative responses to
HPV-16 E7 peptides after 7 days, but by 21 days in bulk culture with the addition of
IL-2 responses were evident. Twenty eight percent of patients attending a
colposcopy clinic and 23% of controls responded to at least one of these peptides. It
may be the case that the precursor frequency for these antigens is low in vivo and
extended culture causes expansion of precursors. Alternatively, T cells may have
been primed in vitro to E7 peptides during the extended initial culture. If T cells
were primed in vitro, then the proliferative responses would not reflect in vivo
responses. This seems unlikely as the T cell responses to one peptide were related to
current cervical infection with HPV-16 and the closely related HPV-31 and HPV-33
types.
2.5.18 Human T cells responses to other HPVproteins
Shepherd et al (1994) identified immunodominant regions of the HPV-16 LI ORF
using T cell lines derived from colposcopy patients. Fusion proteins of (3-gal HPV-
16 LI were used to generate Ll-specific T cell lines by culture for 14 days. These
were then screened for responses to LI peptides. Although poor responses were
found to peptides, 3 immunodominant regions of the LI were identified. Strang et al
(1990) demonstrated four Th determinants in LI and generated human TH cell clones
specific for HPV-16 LI peptides predicted from algorithms of MHC class II binding
T cell epitopes (Rothbard et al 1988). One Th determinant was found in HPV-16 E6
which generated in vitro proliferative responses (Strang et al 1990), and Cubie et al
(1989) found proliferative responses to HPV-16 or 18 E6-(3-gal fusion proteins from
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29% patients with cervical intraepithelial neoplasia, but the majority of SI were < 3.
Although HPV-specific CTL have been demonstrated in mice (Stauss et al 1992;
Sadovnikova et al 1994), Tarpey et al (1994) were the first to demonstrate human
HLA-A2 restricted CTL specific for HPV-11 E7 peptides. However, this may not
reflect the presence of HPV specific CTL in vivo since it is possible that the CTLs
were primed in vitro.
2.5.19 MHC restriction
The T cell response to a protein is limited to a few epitopes which in turn is
restricted by the HLA type of the host. Individuals that express HLA types which do
not bind immunogenic epitopes of HPV are presumably more susceptible to long
term infection with HPV. Indeed, an association of HLA-DQw3 and cervical
carcinoma has been identified in HPV-16 infections (Wank et al 1991). The MHC
class II of the host has also been shown to be important in the regression of warts
caused by cottontail rabbit papillomavirus (CRPV), where the rejection of warts was
related to DR and DQ genotypes (Han etal 1992).
In humans HLA-B7 genotype is also associated with poorer clinical outcome for
cervical carcinoma patients (Keating et al 1995). This is partly mediated by loss of
HLA-B7 expression which correlates with metastasis or cervical neoplasia. In HLA-
B7 individuals a variation in HPV-16 E6 was demonstrated (Ellis et al 1995). This
E6 variant was observed in an epitope which was shown to bind MHC class I in
vitro. Thus an escape mechanism from immunosurveillance by HPV-16 E6 specific
CTL occurs in individuals with HLA-B7 haplotype. In this respect the modulation
of class I expression also has an effect such that 73% of cervical carcinomas had a
reduction in expression at HLA-A or B alleles. Thirty eight percent of these also
had a decrease in the transporter associated with antigen presentation -1 (TAP-1)
(Keating et al 1996), indicating that TAP-1 expression may
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be partly responsible for the observed reduction in HLA-A or B expression.
Polymorphisms in the TAP genes also influence the spectrum of peptides presented
by MHC class I (Powis et al 1992), which may contribute to genetic susceptibility or
protection.
2.5.20Murine 7# epitopes
Although papillomavirus is species specific and HPV does not infect mice under
natural conditions, the antigenicity of HPV proteins has been determined in murine
models. Tindle et al (1991) demonstrated a murine Th epitope of HPV-16 E7
(contained within aa 48-57) in 5 mice strains with differing class II MHC and was
not predicted using the predictions of Rothbard et al (1988) or De Lisi et al (1985).
This region has been confirmed as containing a Th epitope both in humans (Kadish
et al 1994) and mice of differing H-2 haplotypes (Comerford et al 1991; Shepherd et
al 1992).
Three other murine T cell epitopes were found in HPV-16 E7. Amino acids 20-29,
69-80 and 85-90 were identified as containing Th epitopes (Comerford et al 1991;
Shepherd et al 1992; Ressing et al 1995) and CTL epitopes in mice (Sadovnikova et
al 1994; Bauer et al 1995). In addition, amino acids 69-80 and 85-90 were
confirmed as Th epitopes in humans (Kadish et al 1994; Altman et al 1992).
HPV-16 E7 specific responses were also demonstrated in a mouse model in which
E7 was presented to the immune system at the epidermis by grafting an HPVE7
expressing cell line onto syngeneic mice. In vitro lymphoproliferation towards E7
was found in recipient mice challenged with a vaccinia recombinant expressing E7
(Chambers et al 1994). These experiments emphasise the importance of E7 in
infections with HPV-16 where it is expressed in abundance. Although two H-2k
restricted TH epitopes were found in HPV-18 E7 (Fernando et al 1995), a public
epitope of E7 similar to the HPV-16 E7 (aa 49-57) was not found in HPV-18 E7.
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2.5.21 Murine CTL epitopes
The HPV-16 E7 peptide aa 49-57 shown to contain a TH determinant also contained
a murine CTL epitope restricted by H-2Db and Kb (Sadovnikova et al 1994; Bauer et
al 1995). In addition Db mice immunised with a peptide containing this determinant
were protected against challenge with HPV-16 transformed tumourigenic lines
(Feltkamp et al 1994). Stauss et al (1992) demonstrated murine CTL responses to
15/20 peptides derived from HPV-16 E7, E6 or LI which bound to class I MHC.
Not all of these sequences were predicted by known motifs of naturally processed
peptides. Sadovnikova et al (1994) also used murine MHC class I binding to predict
E7 peptides containing CTL epitopes, and compared these predicted epitopes to
naturally processed peptides eluted from E7 expressing cells. Not all peptides found
to be naturally processed were predicted epitopes, and some CTL generated from
predicted epitopes did not recognise E7 expressing cells. This suggests that natural
peptide epitope mapping is more appropriate than synthetic peptide epitope mapping
using predictions and HLA binding assays. This approach is not possible in all
studies since eluting peptides from infected cells requires large numbers of cells and
the sequence of the antigen must be known. However, Falk et al (1991) provide
evidence that epitopes from natural peptides are identical to those from synthetic
peptides, indicating that both methods are appropriate for epitope mapping.
2.5.22 Conclusion
The data presented in this chapter demonstrate that some donors have
lymphoproliferative responses to purified HPV in vitro., but these responses were
not related to status of the infection of the donor. The proliferative response of these
individuals may reflect immunity to HPV in vivo at that time. However, HPV-
specific T cell clones could not be generated from these donors.
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Chapter 3
Local immune responses in cutaneous
warts
3.1 Introduction
The previous chapter examined systemic T cell responses towards purified HPV in
lymphoproliferation assays. HPV specific T cell clones could not be generated and
80 % of patients who had current HPV infection with no signs of regression did not
show proliferation towards HPV. One explanation for poor T cell responses to HPV
discussed in chapter 2 is that modulation of immune functions by HPV may occur
within the wart rather than in peripheral blood, therefore, this chapter demonstrates
investigation of local immunity in cutaneous warts.
3.1.1 Lymphocyte trafficking
Leucocyte adhesion and trafficking have been excellently reviewed by Springer
(1994) and Hogg (1993). Lymphocytes constantly recirculate from the blood into
the tissues and back into the lymph and blood, in a process which is part of the
normal surveillance for foreign pathogens. The migration of leucocytes into tissues
can be dramatically increased in an inflammatory reaction. Immune effector cells
enter tissues at postcapillary vascular sites where the specialised endothelial cell
walls have similarities to high endothelial venules associated with migration into
lymphoid organs. Adhesion molecules on endothelial cells mediate trans-
endothelial migration and their differential expression determine which subsets of
leucocytes cross the endothelium. Cytokines within the local environment influence
the expression of vascular adhesion molecules, thus the nature of the inflammatory
stimulus will dictate the type of cells entering the tissues. The movement of
leucocytes through the vessel walls into the tissues occurs in four overlapping steps
shown in Figure 3.1.
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First, leucocytes loosely attach to the vessel wall via selectins and begin rolling in
the direction of the blood flow (Figure 3.1 A). Selectins are a family of
carbohydrate binding molecules; L-selectin is expressed on the majority of
circulating leucocytes which bind to ligands on inflamed endothelium, while P-
selectin and E-selectin are induced on activated endothelial cells which bind to
ligands on passing leucocytes. The sialyated form of the Lewis X antigen has been
shown to be an important determinant in the binding of the selectins (Vestweber,
1993). Rolling of leucocytes along the endothelium has been attributed to rapid
rates of binding and dissociation of selectins (Lawrence et al 1991) although the
rapid shedding of L-selectin after binding may contribute to this effect. In addition
to the selectins, the oc4 integrins expressed on leucocytes can initiate rolling on
mucosal addressin (MadCAM-1) and VCAM-1 expressed on endothelium (Berlin et
al 1995; Jones etal 1994).
In the second phase, activation of integrins on these loosely attached rolling
leucocytes (Figure 3 B). Integrins are hetero-dimers of an a subunit non-covalently
linked to a P subunit. At least 14 different oc, and 8 different P subunits have been
identified, thus forming at least 20 different integrin hetero-dimers which are
differentially expressed on leucocytes. T cells express LFA-1 (oci P2 or CDlla,
CD18) and very late activation antigen-4 (VLA-4) ((X4P1 or CD49d, CD29).
Neutrophils express LFA-1 and MAC-1 (aMp2 or CDllb, CD18), monocytes
express LFA-1 and all leucocytes express pl50,95 (aXp2 or CDllc, CD18). Many
integrins including LFA-1 require activation before binding to their ligand can occur
(Dustin et al 1989). Chemokines may provide the activation signal for integrins
since IL-8 and macrophage inflammatory protein-1 P (MIP-1P) can transiently
trigger the activation of integrins such as LFA-1 by "so called" inside out signalling
(reviewed by Lub et al 1995). Activation may also cluster integrins on the cell
surface and increase the avidity of binding. CD44 may play a role in binding MIP-
ip, thus immobilising it for presentation to receptors on leucocytes (Tanaka et al
71
1993). E-selectin may also perform the dual function of tethering and activation of
leucocytes (reviewed by Hogg, 1993).
Arrest of rolling then occurs by adhesion of the now functional integrins to the
endothelium, via adhesion molecules of the immunoglobulin superfamily (Figure 3
C). ICAM-1 and 2 and VCAM-1 are the 3 major cutaneous endothelial ligands for
integrins. Interaction of LFA-1 or MAC-1 to ICAM-1, VLA-4 and VCAM-1 or
LFA-1 and ICAM-2 promotes strong attachment of leucocytes to the vessel wall.
ICAM-1 and 2 are expressed constitutivelv at low levels on vascular endothelial
cells. VCAM-1, E-selectin, ICAM-1 and ICAM-2 can be up-regulated by TNF-oc
and IL-1; whereas IL-4 induces V-CAM-1 but not ICAM-1 or E-selectin (Schleimer
et al). Histamine and thrombin can also modulate adhesion molecule expression on
endothelial cells (reviewed by Hogg, 1993).
The final stage is transendothelial migration from the blood vessels through the
endothelial cell wall, surrounding pericytes and basement membrane and into the
tissues (Figure 3 D). Once in the tissues, leucocytes move towards an increasing
concentration of chemoattractant (chemotaxis). Alternatively haptotaxis may occur,
where cells migrate towards the highest density of adhesive ligands (although this
has only been demonstrated in vitro) (reviewed by Springer, 1994). The secretion of
cytokines such as IL-1 IL-8, MCP-1, RANTES and IL-6 play a role in migration of
leucocytes from blood.
3.1.2 Cutaneous trafficking
Components of the skin and its associated lymphoid system is shown in Chapter 1
section 1.1. KC are the most abundant cells in the epidermis and together with
melanocytes comprise the majority of resident epidermal cells. Most other cell types
found in the epidermis migrate from the blood into the skin, many remain in the
dermis but some penetrate the basement membrane and enter the epidermis. LC
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migrate into the epidermis from the blood where they remain until they are induced
to migrate to the draining lymph node, to present antigen to naive T cells. The
epidermis is then repopulated with LC derived from progenitors in the blood,
although it is not known what regulates this process. Other APC such as
macrophages migrate into the skin along with granulocytes but do not recirculate,
whereas skin homing T cells migrate from the blood vessels into the skin and
recirculate back into the blood via the afferent lymphatic and draining lymph node.
The endothelium of the post capillary venules can be induced by cytokines to
express selectins and cell adhesion molecules thus promoting trans-endothelial
migration (described in section 3.1.1). In resting skin, small numbers of
lymphocytes can be observed around dermal blood vessels and in the basal layer of
the epidermis (Foster et al 1990), suggesting that movement of cells into the skin is
part of the normal immunosurveillance. In normal skin ICAM-1 is constitutively
expressed on vascular endothelial cells, presumably facilitating movement of
leucocytes into the dermis. There is evidence for preferential trafficking of
leucocyte subsets to particular sites since priming of T cells by a specific antigen in
a particular environment induces surface receptors that enables preferential
recirculation to the site where antigen was first encountered (Mackay, 1992).
ICAM-1 is upregulated on endothelial cells and induced on epidermal KC in
psoriasis and other cutaneous inflammatory reactions (Dustin et al 1988; Singer et al
1989; McGregor et al 1992; Barker, 1991). E-selectin is not constitutively
expressed in resting skin but is induced on the surface of activated endothelial cells
in inflammation (Bevilacqua et al 1987). E-selectin was initially found to bind to a
ligand on neutrophils (Bevilacqua et al 1989) and was later shown to bind a subset
of memory T cells in vitro (Picker et al 1991). These cells are CD4+ CD45Ra~
CD45RO + CD58 hish and express cutaneous lymphocyte associated antigen (CLA).
CLA+ T cells are found in greater numbers in the skin than other non-lymphoid
tissues and it is thought that the CLA-E-selectin interaction is a skin specific homing
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pathway (Picker et al 1991; Berg et al 1991). CLA expression is dependent on
TGF-P and is induced by IL-12 (Leung et al 1995).
The adhesion of L-selectin to the peripheral lymph node addressin (PNad) forms a
homing pathway to the peripheral lymph node, since expression of PNad is restricted
to high endothelial cells or similar endothelium. Endothelium in resting skin does
not express this L-selectin ligand, but some inflammatory cutaneous lesions express
vascular PNad when there is an extensive mononuclear cell infiltrate in the skin
(Michie et al 1993). This suggests that the L-selectin-PNad mediated homing
pathway is induced in skin, only after the initial influx of lymphocytes. The
pathway may act only with intense or persistent stimuli to augment cellular
recruitment by E-selectin and ICAM-1.
3.1.3 Trafficking towards the epidermis
ICAM-1+ KC bind LFA-1+ T cells in vitro and is a proposed mechanism for the
epidermotropism of T cells in vivo (Dustin et al 1988; Nickoloff et al 1989). This
finding is supported by the observation that intra-epidermal T cells are often
localised adjacent to ICAM-1 + KC (Morelli et al 1994). In vivo studies show a high
correlation of LFA-1 expression on leucocytes with an ability to migrate to the
epidermis in mice (Shiohara et al 1989). Anti-LFA-1 antibodies also inhibit the
migration of T cells to the epidermis (Shiohara et al 1989) and the development of a
DTH response in mice (Kondo et al 1994). Viae et al (1992b) provide evidence for
an important role of ICAM-1 in the movement of T cells into the epithelium of HPV
infections at mucosal sites.
3.1.4 Local changes in HPV infection
A decrease in the density of epidermal LC has been reported in non-regressing
cutaneous (Viae et al 1992a; Chardonnet et al 1986; Chardonnet et al 1983) and
mucosal warts (Viae et al 1992a; Hughes et al 1988; Tay et al 1987a). This
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decrease of LC may contribute to the lack of an immune response and wart
persistence in these patients to HPV since LC are the major antigen presenting cell
of the skin. This idea is supported by the observation that warts which were
regressing did not have a reduction in the epidermal LC density (Chardonnet et al
1986; Fierlbeck etal 1989).
Semi-quantitative studies of mononuclear cells in cutaneous warts have shown some
dermal T cell infiltrate with no predominance of either T cell subset (Viae et al
1992a; Viae et al 1992b; Chardonnet et al 1983). When plane warts regress the
mononuclear cell infiltrate in the epidermis is found adjacent to damaged KC
(Iwatsuki et al 1986), thus supporting the role of CMI in clearing HPV infection. A
T cell infiltrate has been observed in genital warts with the predominance of CD8+
T cells in the epithelium (Tay etal 1987b) or in the whole lesion (Viae et al 1992b).
This infiltrate may be due to changes in adhesion molecule expression within the
HPV lesion, which could alter the trafficking of mononuclear cells to the wart.
ICAM-1 has been observed in the vascular endothelium of laryngeal and cutaneous
warts. However, epidermal expression was not observed in cutaneous warts (Viae et
al 1992b).
3.2 Aim
The aim of this chapter is to investigate whether HPV infection modulates cutaneous
immunity. First the numbers of infiltrating T cells (CD3) and memory T cell
phenotype (CD45RO) in the dermis and epidermis, and number of LC in the
epidermis of these lesions were quantified in cutaneous warts. In addition the areas
of ICAM-1 and E-selectin expression were quantified in these lesions. The second
approach was to investigate whether HPV modulates the function of adhesion
molecule expression within the skin. A frozen section adhesion assay of activated T
cells was undertaken as an in vitro model of lymphocyte homing (Stamper et al
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1976). In view of the potential importance of the ICAM-1 and LFA-1 interaction,
both for the movement of lymphocytes into the dermis from the blood vessels and
from the dermis to the epidermis, adhesion was blocked using monoclonal
antibodies to ICAM-1 and LFA-1. Comparisons were made throughout between
sections of skin from normal subjects and involved skin of patients with chronic
plaque psoriasis, a disorder in which the influx of T cells into the epidermis has been
attributed to ICAM-1 and LFA-1 interaction (Barker etal 1992).
3.3 Materials and methods
3.3.1 Immunohistochemistry
3.3.1.1 Patients
Viral warts were obtained from 8 patients aged 17-55 years. Five were common
facial warts which had been present for less than 1 year (numbers 1-5). The
remaining three were a plantar wart (number 6) and two hand warts (numbers 7 and
8) all of which had persisted for at least two years. None of the warts had been
treated prior to their removal by curettage. All specimens were bisected, half being
formalin-fixed for routine histological examination, the remainder being snap frozen
in liquid nitrogen and stored at -70°C. Control specimens consisted of 6 mm punch
biopsies from normal forearm skin of six volunteers (age 20-57 years) and from
involved skin of four psoriatic patients (age 21-46 years).
3.3.1.2 Immunoperoxidase staining of sections
Five |im cryostat sections were cut and air dried overnight before fixing in acetone
for 20 min at room temperature. Slides were air dried and stored at -20 °C until
used. Indirect immunoperoxidase staining was performed using the mouse anti-
human monoclonal antibodies listed in Table 3.1.
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Table 3.1 Primary antibodies used in immunohistochemistry
Antibody Source Product Dilution
Code
anti-CD3 DAKO M 835 1/20
anti-CD la DAKO M 721 1/20
anti-CD45R0 DAKO M 742 1/200
anti-ICAM-1 R and D systems BBA 3 1/200
anti-E-selectin R and D systems BBA 1 1 / 100
R and D systems (Abingdon, UK). DAKO (High Wycombe, UK)
Sections were immersed in tris-buffered saline (TBS) pH 7.6, and endogenous
peroxidase inactivated with 0.6% hydrogen peroxide in ethanol for 5 min followed
by blocking in 20% rabbit serum in TBS for 20 min. Sections were washed 3 X in
TBS after each step. Primary antibodies diluted as shown in Table 3.1 in 10%
human serum in TBS, were added to the slides and they were incubated in a humid
chamber at 4°C overnight. The human serum used throughout was from the same
pooled batch which had been heat inactivated. Ten % human serum in TBS was
used as a control and additional controls contained irrelevant monoclonal antibodies
of the same isotypes as those used in Table 3.1. The slides were washed in TBS and
goat anti-mouse horseradish peroxidase conjugated antibody (DAKO), diluted 1/100
in 10% human serum in TBS, was layered on top of the slides which were incubated
for 30 min at room temperature. The developing substrate was one 10 mg
diaminobenzidine tetrahydrochloride tablet (Sigma) dissolved in 15 ml TBS
containing 12 (il 30% hydrogen peroxide solution filtered through a 0.2 |am filter.
Slides were lightly counterstained with haematoxylin to enable visualisation of the
dermis and epidermis before dehydrating the slides through 30%, 70% and 100%
ethanol and finally immersing in xylene and mounting in DPX.
3.3.1.3 Quantification of cell numbers and area ofadhesion molecule expression
The stained areas were quantified using image analysis of sections and a semi-
automated quantification method using the TPL software version 5 on the Seescan
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image analysis system (Seescan Pic, Cambridge, UK). Areas of dermis and
epidermis were traced on the video screen and numbers of positively stained cells
and area of positive staining was calculated per (im2 (or mm2) dermis or epidermis,
based on at least three fields of view at x 10 magnification (mean of three separate
measurements) depending on the size of the section. Expression of adhesion
molecules was calculated as area stained per area measured, since positively stained
endothelial cell numbers were difficult to determine. CD3+ and CD45RO+ T cells
were expressed as numbers of cells stained per mm2 of dermis and epidermis
measured. CDla+ LC were expressed as number of cells stained per mm2 epidermis
measured.
3.3.2 Adhesion assay
3.3.2.1 Activation of lymphocytes
Although resting T cells express LFA-1 they lack the NK1-L16 epitope essential for
in vitro aggregation and spontaneous adhesion; indeed no adherence above basal
levels with unstimulated lymphocytes is found (Barker et al 1992). Stimulation with
phorbol myristate acetate (PMA), activation with phytohaemagglutinin (PHA) via
the T cell receptor and addition of interleukin 2 (IL-2) increase levels of NK1-L16
and change the status of LFA-1 from an inactive to an active form (Figdor et al
1990). In this study, the experiments without blocking were done following the
method of Barker et al (1992). Heparinised blood from normal donors was diluted
1:1 in RPMI-1640 (Gibco) containing 10 % foetal calf serum (FCS) and separated
on lymphoprep™ (Nycomed). The purified PBMC were washed X 3 in RPMI-1640
/10% FCS with 200 mM L-glutamine (Gibco) and were dispensed into 24 well
plates at 1 x 106 / ml in medium containing 50 ng / ml PMA (Sigma) and incubated
for 30 min at 37°C in 95% air / 5 % C02. To facilitate the measurement of any
inhibition caused by the blocking antibodies, the adhesion of cells to the skin
sections was increased by activating the PBMC in medium containing 50 ng/ml
PMA and 1 |ag / ml PHA (Sigma) for six days. The medium was replaced and
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supplemented with recombinant human IL-2 (Genzyme), 20 units / ml, on days three
and five of culture.
3.3.2.2 Phenotyping ofactivated lymphocytes
The phenotype of the stimulated PBMC cell population for the adhesion assay was
performed using the following mouse anti-human monoclonal antibodies (DAKO).
CD3 (T cell receptor), CD 14 (monocyte marker), CD 18 (LFA-1 (3 chain), CD25 (IL-
2 R a chain) and CD56 (NK cell marker). A fluorescein isothiocyanate (FITC)
conjugated sheep anti-mouse IgG F(ab')2 fragment was used as a secondary antibody
(Sigma), and the samples were analysed by flow cytometry on a Coulter XL using
XL software version 1.5 (Coulter).
3.3.2.3 Patients
Persistent viral cutaneous warts were curetted from 6 patients (aged 18-57 years)
who had received no treatment several weeks prior to curettage. Three were plantar
mosaic warts, 2 were common hand warts, and one was from the supra-pubic region.
All specimens were bisected, half being formalin fixed for histological confirmation
of the diagnosis. The remainder was snap frozen in liquid nitrogen and stored at
-70°C. Control specimens consisted of 6 mm punch biopsies from normal forearm
skin of six volunteers (aged 20 -57 years) and from involved skin of six patients with
psoriasis (aged 18-75 years). Two specimens were from the trunk, two from the leg
and two from the forearm. Cryostat sections of the biopsies (8 qm) were cut on to
uncoated slides and air dried at room temperature before storing at -20 °C. On the
day of the assay, sections were thawed and fixed in 2% glutaraldehyde in PBS for 5
min followed by washing in RPMI (2 X 10 min).
3.3.2.4 Blocking sections with anti-ICAM-1
Fixed tissue sections were incubated for 15 min with 20% rabbit serum in TBS.
Incubation for 1 hr at room temperature in 1/50 dilution of anti-ICAM-1 monoclonal
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antibody (BBA-3, 1 mg / ml, R + D systems) in 20% rabbit serum in 0.1 M TBS pH
7.6 in a humid chamber. Control sections were incubated with diluent only. This
dilution of antibody was shown to be at a saturating concentration for functional
blocking by use of a range of dilutions in a preliminary study. Excess fluid was
removed from the slides. The monoclonal antibody that remained was present
throughout the subsequent adhesion assay.
3.3.2.5 Blocking PBMC with anti-LFA-1 antibody
Activated PBMC described in section 3.3.2.1 were blocked in TBS containing a 1/50
dilution of anti-CD 18, the (3 2 chain of LFA-1 (MHM 23, DAKO, 206 jig / ml) at
room temperature for 1 hr. The cells were then used without washing so that some
antibody was present throughout the adhesion period. Since adhesion mediated by
integrins or selectins is an energy dependent process which requires divalent cations
(Figdor et al 1990; Hogg, 1993), additional sections were blocked with adhesion
buffer containing 5 mM EDTA or 0.01% sodium azide to determine if the adhesion
was integrin / selectin mediated. The experiment with EDTA and sodium azide was
performed on psoriasis sections only.
3.3.2.6Adhesion
The adhesion method has been described previously (Nickoloff et al 1989; Barker et
al 1992). Briefly, activated PBMC as prepared in section 3.3.2.1 were harvested and
resuspended at 1.5 x 106/ ml in adhesion buffer. Adhesion buffer was minimum
essential medium (MEM) (Gibco) containing 40 mM tricine buffer pH 7.4 (Sigma)
and 1 mg/ml bovine serum albumin. 400 |il of blocked or untreated activated PBMC
was layered carefully on top of the tissue sections and incubated for 45 min at 37°C
with gentle agitation. Slides were then dipped X 5 in adhesion buffer to remove any
non-adherent PBMC from the sections. Washed tissue sections were fixed in
acetone for 20 min at room temperature, followed by blocking in 20% rabbit serum
in TBS for 20 min. CD3+ and CD 18+ leucocytes were stained using
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immunoperoxidase as described in section 3.3.1.2 using 1/20 dilutions of mouse
anti-human CD3 (DAKO) or anti-human CD 18 (DAKO).
3.3.2.7 Quantification ofadherent cells
CD3+ or CD 18+ adherent T cells could be easily distinguished from endogenous T
cells as they were above the plane of the tissue section. Numbers of adherent cells
were counted per mm2 of normal skin (N), warts (W), and psoriasis skin (P) using
image analysis described in section 3.3.1.3. Each experiment consisted of the
lymphocytes from one individual used to adhere to sections of at least 2 W, 2 N and
2 P (from a total of 6 for each skin type), and different blood donors were used in
each experiment. The adhesion was expressed as means of number of adherent cells
/ mm2 of dermis and epidermis or as a percent inhibition of binding. The error bars
are the standard error of the means between experiments. Percentage inhibition was
calculated by :
100 - ( number of cells bound / mm^-tissue with antibody present x 100 )
number of cells bound / mm2 tissue
3.3.3 Statistical analysis
Standard deviation from the means was calculated in all cases and statistical analysis




Wart, normal skin and psoriasis sections were stained with the panel of monoclonal
antibodies (Table 3.1) or isotype matched controls. Photomicrographs of
representative tissue sections are illustrated, and the quantification of the positively
staining cells and areas of staining are shown. Non-specific staining was not
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observed in any of the controls which were incubated with either diluent or isotype
matched controls.
3.4.1.1 Langerhans' cells
CD la staining of LC in 1 normal skin sample and 2 cutaneous wart specimens are
shown below.
Photomicrograph of normal skin stained with CDla antibody. D = dermis, E = epidermis.
Magnification = X 50. The arrow indicates a LC with typical dendritic morphology.
Figure 3.2 CD1a+ LC in normal skin
D
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Figure 3.4 CD1a+ LC (low) in a cutaneous wart
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. *.
Photomicrographs of high numbers ofCDla + LC in a wart (Figure 3.3) and low numbers of CD la +
LC in a wart (Figure 3.4). Magnification = X 50. D = dermis, E = epidermis. The arrow on Figure
3.3 indicates LC throughout the depth of the epidermis The arrow on Figure 3.4 indicates CDla+
LC in the basal layers of the epidermis only.
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CDla+ cells with dendritic morphology typical of LC were strongly expressed in the
epidermis of normal skin (Figure 3.2). Figure 3.5 shows quantification of LC
density in the epidermis, of the 3 skin types.















Density of CDla+ LC expressed as numbers of cells stained per total area of epidermis measured
(mm2) in the 6 normal subjects, 8 with warts and 4 with psoriasis. Wart patients 1-5 had papuliferous
lesions, patient 6 had plantar warts and 7 + 8 had common hand warts. Bars depict standard deviation
from the mean. Numbers of CDla+ LC were significantly greater in the epidermis of normal skin
compared with wart epidermis or with psoriatic skin (p < 0.05 in both cases). No significant
difference was observed between the numbers of LC in die psoriatic epidermis and wart epidermis.
Intensely stained LC were observed throughout the depth of the epidermis in normal
skin. The number of positive cells ranged from 314 ± 8 to 981 ± 318 per mm2
epidermis. In contrast the warts had variable numbers of CDla+ LC. Warts 1 and 4
showed CD la expression with a wide distribution throughout the epidermis (Figure
3.4). Staining was also observed in the papillary dermis although these cells had a
123456 12345678 1234
Normal Skin Warts Psoriasis
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rounded morphology, and some CDla+ cells with dendritic morphology were seen
around the blood vessels in the dermis. Warts 3 and 5 had a reduced density of
CD la + LC, although they were still evenly distributed throughout the epidermis
(Figure 3.4). The other four warts had a few LC in the epidermis with CD la
expression only in the basal and mid-epidermis, and none in the dermis. The LC
density in the epidermis of all 8 warts was significantly less than LC density in the
epidermis of normal skin (p < 0.05). CD la expression in the epidermis of psoriatic
lesions was also significantly decreased in comparison with normal epidermis (p =
0.05) (Figure 3.5). No significant difference was observed between the CD la
expression in the epidermis of patients with warts and with psoriasis.
3.4.1.2 Adhesion molecule expression
ICAM-1 and E-selectin showed a similar vascular pattern of expression. The
expression of E-selectin in normal skin, a cutaneous wart and ICAM-1 in a
cutaneous wart are shown in Figures 3.6-3.8.
Figure 3.7 and 3.8 demonstrates that there are increased areas of ICAM-1 and E-
selectin expression in the dermis of warts compared with normal skin. Patterns of
expression were similar for these adhesion molecules in all sections. No epidermal
ICAM-1 was observed. The areas of ICAM-1 and E-selectin expression in the
dermis of normal skin, warts and psoriasis were quantified and is shown in Figure
3.9.
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Figure 3.6 E-selectin expression in normal skin
Photomicrograph of normal skin stained with anti-E-selectin. D = dermis, E = epidermis.
Magnification = X 50. Arrow indicates longitudinal section of vascular endothelial cells positively
stained for E-selectin.
Figure 3.7 E-selectin expression in a cutaneous wart
Figure 3.8 ICAM-1 expression in a cutaneous wart
Photomicrographs of stained sections at a magnification of X 50 show E-selectin expression and
ICAM-1 expression in the same wart specimen (number 1). D = dermis, E = epidermis. The arrows
in Figure 3.7 and 3.8 indicate E-selectin and ICAM-1 expression respectively, on vascular
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Expression of adhesion molecules in the dermis of 6 normal subjects, 6 with warts and 4 with
psoriasis. Positive staining is expressed as area stained per total area measured (pm2 and bars depict
standard deviation from the mean. I = ICAM-1, □ = E-selectin. The area of ICAM-1 and E-
selectin staining in the dermis was significantly increased (p < 0.005 in both cases) in wart dermis
compared with the expression in the dermis of normal skin. The ICAM-1 and E-selectin staining was
also significantly greater in the dermis of psoriatic skin compared with normal dermis (p < 0.05 in
both cases). No significant difference was observed in the expression of these adhesion molecules in
the dermis of warts and psoriatic skin.
Normal skin had weakly stained areas of ICAM-1 and E-selectin on vascular
endothelial cells (Figure 3.6) which was not observed elsewhere (with a range of 2
± 1 |im2 to 4 ± 1 (im2 for ICAM-1 and 0 to 3 ± 0 pm2 for E-selectin). In contrast,
warts showed a significant increase in the areas of ICAM-1 and E-selectin stained
(Figure 3.7 and 3.8). The areas stained ranged from 13 ± 4 |im 2 to 48 ± 17 |im2 for
ICAM-1 and 12 ± 8 p.m2 to 35 ± 17 pm2 for E-selectin. Positive staining for both
ICAM-1 and E-selectin was in longitudinal or circular strands typical of vascular
endothelium in the dermis. The warts were more highly vascularized than the
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normal skin, and a high proportion of the vascular endothelial cells were positive in
the warts. The dermis of psoriatic lesions also expressed ICAM-1 and E-selectin on
the vascular endothelium as previously reported (Singer et al 1989; McGregor et al
1992; Barker, 1991; Scheynius et al 1992). Areas of adhesion molecule expression
were significantly greater in the dermis of warts than in normal skin. No difference
was seen between the expression of adhesion molecules in the wart dermis and
psoriatic dermis. ICAM-1 positive KC were not detected in the epidermis of any
sections tested in this study although ICAM-1 positive KC were detected in the
epidermis of one patient with eczema (not shown).
3.4.1.3 T cells
The pan T cell marker (CD3) and the memory T cell marker (CD45RO) showed
similar staining patterns, therefore only CD3+ T cells are shown in normal skin,
warts and psoriasis skin. Figure 3.10 -3.12 show CD3+ T cells in the dermis and
epidermis in warts, normal skin and psoriatic skin (respectively) and the
quantification of these numbers are shown in Figure 3.13.
Normal skin had little or no mononuclear cell infiltrate into the dermis or epidermis.
CD3+ T cells in the dermis were in the range 26 ± 6 to 140 ± 88 per mm2 and were
not significantly different from the numbers found in the epidermis (0 to 166 ± 95
per mm2). Cells of CD45RO phenotype were present at similar frequencies to the
CD3+ T cells in both the dermis and the epidermis, suggesting that most of the T
cells present were of the memory phenotype (Figure 3.13). Both cell phenotypes
were observed in the perivascular area of the dermis. The CD3+ infiltrate varied in
the wart patients from a mild (53 ± 36 cells / mm2) to a strong dermal infiltrate (654
± 242 cells / mm2).
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Figure 3.10 CD3 + T cells in normal skin
Photomicrograph of CD3+ T cells in normal skin, magnification = X 50. D = dermis, E = epidermis.
The arrow indicates positive T cells in the dermis of the normal skin.
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Figure 3.11 CD3 + T cells in cutaneous warts
Photomicrograph of CD3+ T cells in 2 cutaneous warts magnification = X 50. D = dermis, E
epidermis. The arrow indicates T cells in the dermis .
Figure 3.12 CD3+ T cells in psoriasis.
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Photomicrograph of CD3+ T cells in psoriasis, magnification = X 50. D = dermis, E = epidermis.
The arrow indicates positive T cells in the epidermis.
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Figure 3.13 Quantification of CD3+ and CD45 RO+ T cells
1 2 3 4 5 6
Normal Skin
1 2 3 4 5 6
Warts
1 2 3 4 5 6
Normal Skin






Numbers of T cells in the dermis and epidermis were quantified in 6 normal subjects, 6 with warts
and 4 with psoriasis. CD3+ = I and CD45RO+ = E3 . Significantly greater numbers of T cells
(CD45RO+ and CD3 + cells) were seen in the dermis of warts compared widi normal dermis (p <
0.05 in both cases). No significant difference in the numbers of T cells was seen in the epidermis of
warts and normal skin. T cell numbers were significantly greater in psoriatic epidermis as compared
with wart epidermis (p < 0.05 for both CD3+ and CD45 RO + cells).
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Many of the infiltrating T cells were CD45 RO positive (Figure 3.14). Interestingly,
the numbers of CD3+ and CD45RO+ T cells decreased significantly in the
epidermis of wart patients compared with the dermis (p < 0.005). Psoriatic lesions
had comparable numbers of T cells infiltrating the dermis as the warts but more T
cells in the epidermis. The wart epidermis was more comparable to normal
epidermis in terms of intraepithelial T cell numbers.
3.4.2 Adhesion assay
3.4.2.1 Adherence ofactivated T cells to tissue sections
In studies without blocking, whole PBMC were stimulated for 30 min with PMA,
and prior to their use in the adherence assay. This population of cells was 62%
CD3+ and 67% CD 18+(Table 3.2).
Table 3.2 Phenotype of the activated PBMC used












CD3 62 (+/_ 8) 71 (+/- 8)
CD14 13 (+/-4) 4 (+/-1)
CD 18 67 (+/_ 4) 95 (+/_ 1)
CD25 5 (+/-2) 86 (+/-3)
CD56 7 (+/. 2) 8 (+/- 3)
Values are mean percentages of positive cells from 5 individuals used in experiments without
blocking and from three individuals used in experiments with blocking +/- standard error of tire mean.
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Adherence of CD3+T cells and CD18+ cells to the epidermis and dermis of
cutaneous warts, normal skin and psoriatic skin are shown in Figure 3.14 and 3.15.
The adhesion of both these cell types to wart dermis and epidermis was significantly
lower than the adhesion to the psoriasis dermis and epidermis (p < 0.05).






The adhesion of CD3+ T cells to skin sections of normal skin (N), warts (W), and psoriasis skin (P).
■ = epidermis, □ = dermis. * = significantly different as determined by the Mann-Whitney U test (p
< 0.05). SEM are from the means of 12 experiments each using 2 W, 2 P and 2 N sections.
The adherence of CD3+ T cells to wart dermis and epidermis was 16 and 26 cells /
mm2 respectively, these numbers were similar to the adhesion of CD3+ T cells to
normal skin (16 cells / mm2 for the dermis and 22 cells / mm2 for the epidermis).
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The adhesion of CD18+ cells to sections of normal skin (N), warts (W), and psoriasis skin (P). ■ =
epidermis, □ = dermis. * = significantly different as determined by the Mann-Whitney U test (p <
0.05). SEM are from the means of 3 experiments each using 2 W, 2 P and 2 N sections.
Adhesion of CD 18+ cells to tissue sections (Figure 3.15) showed a similar pattern of
adhesion as CD3+ T cells. In both adherence assays there was no significant
difference in numbers of cells adhering to normal skin dermis and epidermis
compared with wart dermis and epidermis. The adhesion of CD3+ T cells to
psoriatic dermis and epidermis was significantly increased compared with normal
and wart dermis and epidermis, and confirms the work of (Barker et al 1992). There
was also significantly greater adhesion of CD 18+ cells to psoriasis skin compared
with either normal skin or warts.
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3.4.2.2 Blocking studies
For the blocking studies, the PBMC were activated for 1 week with PHA, PMA and
recombinant human IL-2. The majority of these were CD3+ (71%), while the
percentage of CD18+ cells in this population was 95% (Table 3.14).








Blocking the adhesion of CD3+ T cells with anti-ICAM-1 monoclonal antibody to sections of
normal skin (N), warts (W), and psoriasis skin (P). I = epidermis, □ = dermis. SEM are from the
means of 7 experiments.
Adhesion of CD3+ T cells to normal skin, wart and psoriatic dermis and epidermis
was partially blocked by anti-ICAM-1 monoclonal antibody, but total blocking was
not achieved (Figure 3.16). Adherence to psoriasis skin was blocked to the greatest
extent with a mean percentage inhibition of 44% and 48% for the epidermis and
dermis respectively. The binding of CD3+ T cells to wart dermis and epidermis was
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inhibited by 34% and 22% respectively and the binding to normal skin epidermis
and dermis was inhibited by 36% 18% respectively.
Figure 3.17 Blocking CD3+ adhesion with anti-LFA-1
antibody
100-i
The percentage inhibition of binding of CD3+ T cells to normal skin (N), warts (W), and psoriasis
skin (P) after using MHM23 LFA-1 monoclonal antibody. I = epidermis, 0 = dermis. EDTA and
AZIDE show the % inhibition of binding to psoriasis skin with 5 mM EDTA and 0.01% sodium azide
added during the adhesion. No error bars are shown as the means from 2 experiments are shown.
Figures 3.17 shows the means of percentage inhibition when stimulated PBMC were
blocked with MHM23 anti-LFA-1 monoclonal antibody prior to the adhesion assay.
As with ICAM-1 blocking, only partial inhibition of binding of CD3+ T cells to all
three tissue types was achieved using MHM23. In addition the adhesion of activated
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T cells to all 3 skin types was inhibited partially by the LFA-1 a chain antibody
(WAC70, kindly supplied by Dr. J. Ross. Dept surgery, Royal Infirmary, Edinburgh)
although this inhibition was never above 50%. Adhesion of activated T cells to
psoriasis skin was inhibited by EDTA and sodium azide (Figure 3.17), indicating
that the adhesion in this assay was dependent on divalent cations and was an energy
dependent process. The percentage inhibition of binding in the presence of EDTA
was 77% and 55% for the epidermis and dermis respectively. Sodium azide
inhibited the adhesion to the epidermis and dermis by 90 and 82% respectively.
3.5 Discussion
3.5.1 Immunohistochemistry
3.5.1.1 Adhesion molecules and T cells
The increase in expression of ICAM-1 and E-selectin found in the dermis of warts
can be partly accounted for by the increase in vascularization of these lesions.
Although the intensity of staining was not included as part of the quantitative
analysis, there was a greater intensity of ICAM-1 and E-selectin expression on
endothelium in warts and psoriasis skin compared with normal skin.
It has been suggested that E-selectin plays a role in initiating the adhesion of resting
T cells and neutrophils to activated endothelium. The CLA marker on T cells has
been proposed as the ligand for E-selectin (Picker et al 1991), and this interaction
may represent a skin-specific homing mechanism, for the movement of memory T
cells to cutaneous sites. The results presented in this study suggest that E-selectin
may be important in the trafficking of memory T lymphocytes through vascular
endothelium to the wart dermis.
99
Upregulation of integrins on the T cell surface promotes strong adhesion to the
endothelium via VLA-4-VCAM-1, LFA-l-ICAM-2 and LFA-l-ICAM-1
interactions, and leads to extravasation into surrounding tissues. Only the expression
of ICAM-1 has been considered here although ICAM-2 was expressed on the
vascular endothelium of wart dermis (data not shown). The expression of ICAM-1
at high levels in the dermis of warts demonstrates that this adhesion molecule also
has a role in the homing of T cells into these lesions. E-selectin and ICAM-1 were
both expressed at low levels in the dermis of normal skin, which may indicate that
they play a role in the normal surveillance of cutaneous sites.
Studies on cervical intraepithelial neoplasia have also shown the vascular expression
of ICAM-1, E-selectin and VCAM-1 (Coleman et al 1994). Increasing areas and
intensity of adhesion molecule expression were found in samples exhibiting more
severe grades of dysplasia.
ICAM-1 expression was not detected in epidermal KC in cutaneous warts, in
agreement with results of other studies (Viae et al 1992a). ICAM-1+ KC have been
seen in some vulval condylomata (Morelli et al 1994), high grade cervical
intraepithelial neoplasia and genital warts (Coleman et al 1994). ICAM-1 is also
induced on the epidermal KC of regressing genital warts (Coleman et al 1994).
Weak and scattered foci of epithelial ICAM-1 staining were found in HPV lesions
which were low grade or without dysplasia. These findings may suggest a different
host response at cutaneous sites compared with mucosal sites of HPV infection.
Alternatively, changes in ICAM-1 expression on KC may be associated with the
transformation of the cell rather than HPV infection alone. Indeed, Coleman et al
(1993) observed constitutive ICAM-1 expression only in fully transformed
tumourigenic cell lines which contained HPV, in vitro. In contrast, an HPV-16
infected cell line which retained episomal DNA copies did not constitutively express
ICAM-1.
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Studies on regressing genital warts have shown intense ICAM-1 and MHC class II
KC expression, together with a significantly increased epithelial infiltrate of CD4+,
CD8+ and CD25+ T cells (Coleman et al 1994). In the epithelium, the number of
CD4+ T cells was greater than CD8+ cells in regressing lesions, whereas CD8+ cells
were predominant in non-regressing warts.
ICAM-1 has been detected in the KC of laryngeal HPV-induced lesions only when
intensely infiltrated with mononuclear cells (Viae et al 1992b). This could provide
an explanation of why there are low numbers of T cells in the epidermis of warts,
since interaction between ICAM-1 + KC and LFA-1+ T cells may have a role in the
epidermotropism of T cells. However, epidermal KC in psoriatic lesions were also
negative for ICAM-1 in this study, despite the presence of many intraepithelial T
cells. Thus an ICAM-1 independent mechanism for this movement into the
epidermis may be operating. ICAM-1 has been demonstrated on the KC of psoriatic
lesions (Singer et al 1989; McGregor et al 1992; Barker, 1991) although Scheynius
et al (1992) found expression on only 45% of involved psoriatic lesions. This
suggests that ICAM-1 may not be the sole pathway of epidermal movement, and
may only be induced after an intense infiltrate has entered the epidermis.
It has been postulated that LC may have a role in epidermotropism of T cells in mice
(Shiohara et al 1988), however this was based on the observation that increased
numbers of LC in the epidermis correlated with an influx of T cells. Indeed, in one
study, normal skin was found to contain epidermal T cells which were not localised
next to ICAM-1+ KC (Konter et al 1989). Treatment of KC with y-IFN induces the
expression of ICAM-1 (Dustin et al 1988; Barker et al 1989) and therefore
infiltrating TH1 cells may be the inducer of epidermal ICAM-1 expression.
However, studies in mice showed that intradermal injection of epidermotropic T
cells caused intense epidermal ICAM-1 expression before the T cells had entered the
epidermis (Shiohara et al 1989). High levels of ICAM-1 expression on KC is
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observed in drug induced cutaneous vasculitis, where the infiltrating cells remain
perivascularly. This may indicate that activated T cells in the epidermis are not
necessary for ICAM-1 induction on KC, but activated T cells in the dermis may be
sufficient to induce this adhesion molecule. In addition there is some evidence that
contact allergens may induce ICAM-1 directly (Villada et al 1992; Griffiths et al
1989).
3.5.1.2 Langerhans' cells
The present study showed variable numbers of LC in the epidermis of HPV-induced
warts which is in agreement with previous findings (Chardonnet et al 1986;
Chardonnet et al 1983). Seventy five percent (6/8) of warts showed greatly reduced
LC numbers while the remainder showed numbers comparable with those seen in
the normal epidermis. LC in the warts with reduced numbers of CD la staining were
located towards the basal layer of the epidermis. This irregular distribution of LC is
also found in vulval condyloma (Morelli et al 1994). Since nothing is known about
the migration of LC to and from the epidermis into the draining lymph node during a
chronic infection such as with HPV this finding remains difficult to explain. There
was no clinical or histopathological evidence that the warts which showed no
reduction in LC density were regressing. The two warts without a reduction in LC
density were facial lesions, but other warts from the same clinical group also had
decreased LC numbers. An increase in LC numbers has been observed in regressing
cutaneous warts and it has been suggested that LC play a role in this regression
(Chardonnet et al 1983; Iwatsuki et al 1986; Thivolet et al 1982). However, a
significant increase in LC numbers was not observed in regressing genital warts
(Coleman et al 1994). Regressing plane warts have a high LC density in the dermis
and epidermis with T cells located adjacent to LC, and lymphocytes next to
damaged KC in the epidermis (Iwatsuki et al 1986) which suggests a specific cell
mediated immunity against viral infected KC.
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Some reports indicate that there is an increase in LC numbers in the epidermis of
non-viral skin tumours (Thivolet et al 1982), suggesting that HPV infection may
contribute to the observed reduction in LC density in warts. However, other studies
found a decrease in LC density in these tumours (Acalay et al 1989; Chen et al
1989). Chardonnet et al (1986), analysed a large number of cutaneous warts from
different anatomical sites and found a reduction in LC densities in most but not all
warts. There was some indication that the location of the wart could influence the
number of LC since 47% of plantar warts, 29% of hand warts and only 14% of
genital lesions had no epidermal LC (Chardonnet et al 1986). However, this may
not be due to HPV infection since one study found no differences in LC density at
different anatomical locations with the exception of the soles of the feet which had
significantly less LC in the epidermis (Berman et al 1983). It has been demonstrated
previously that the depletion of LC in the epidermis correlated with the presence of
HPV antigen (Chardonnet et al 1986). It remains to be shown whether HPV
interacts directly with LC resulting in their cytolysis. Alternatively cytokines
secreted by HPV-infected KC, such as TNF-a, may influence LC migration. It is
also possible that infection with different types of HPV may cause differences in
cytokine modulation. It should be noted that 6/8 warts analysed in this study were
facial lesions which are likely to be sun exposed. Irradiation with UVB light
decreases LC numbers in human skin, and also modulates normal cytokine and
adhesion molecule expression. It is unknown what effect UVB exposure over long
periods of time might have on HPV infection. However it has been noted that RAR
who are clinically immunosuppressed have increased incidence of HPV infections




3.5.2.1 Adhesion ofCD3+ and CD18+ Tcells to cutaneous warts
Recirculating memory T cells form an important part of the skin immune system and
are necessary to promote effective immunity against epidermal pathogens such as
HPV. There is evidence that their recruitment is not random (Picker, 1994). In skin,
CLA and its ligand, E-selectin, have been implicated in the movement of memory T
cells into cutaneous sites (Picker et al 1991; Berg et al 1991) and there is also
evidence that ICAM-1 plays a role in the epidermotropism of LFA-1+ cells (Viae et
al 1992b). In chronic inflammatory skin diseases such as psoriasis, the specific
recruitment may be overridden by a non-specific influx of cells into the tissue. The
significantly augmented adhesion of CD3+ and CD18+ cells to psoriatic dermis and
epidermis seen in this study and by others (Barker et al 1992) reflects the increased
trafficking into the involved site. Up regulation of vascular ICAM-1 and E-selectin
expression was found in cutaneous warts together with an increased dermal T cell
infiltrate compared with normal skin.
The present study investigated whether there is increased adhesion of CD3+ and
CD18 + cells to warts compared with normal skin. The results show that there was
not increased adhesion to either wart dermis or epidermis compared with adhesion to
normal skin. This could reflect the lack of increased trafficking in vivo into the HPV
lesion. However, the lack of an increase in adhesion to the dermis or epidermis of
warts contrasts with the immunohistological findings. The reduced adherence of
activated T cells to both the dermis and epidermis of cutaneous warts may reflect
reduced functional adhesion to ligands other than ICAM-1 or E-selectin. HPV
infection may modulate the expression of cytokines in the local environment and
thus may play a role in the observed decrease in functional adhesion. Indeed, many
viruses express cytokines (so called virokines) and cytokine receptors which have
the potential to modulate normal immune responses (Spriggs, 1994).
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3.5.2.2 Role of ICAM-1 in adhesion to cutaneous warts
The contradiction between the immunohistological results and functional adhesion
assay may indicate that the adhesion in this assay is not ICAM-1 dependent.
Adhesion of CD3+ T cells to tissue sections was partly blocked by monoclonal
antibodies to LFA-1 and ICAM-1 but the reduction was never greater than 50%.
This suggest that ICAM-1 and LFA-1 adhesion is not solely responsible for thfe
binding of CD3+ T cells to the skin sections in this assay and may reflect the
situation in vivo. Interestingly there was a lack of ICAM-1 expression on epidermal
KC of active psoriatic lesions and wart lesions despite expression in adjacent
vascular endothelium which is in apparent contrast with the functional studies. The
increased adhesion of CD3+ T cells to psoriasis epidermis, in conjunction with
increased numbers of endogenous T cells in the epidermis may indicate; 1) ICAM-1
is not solely responsible for the epidermotropism of T cells in this disorder, and 2)
ICAM-1 is not wholly responsible for the adhesion seen in this assay. Indeed Barker
et al (1992) also found that blocking antibodies to ICAM-1 and LFA-1 did not
entirely prevent adhesion to psoriasis sections.
Other adhesion molecules in skin, such as E-selectin, are induced on vascular
endothelial cells and play a role in the active movement of cells from the dermal
blood vessels into the dermis. LFA-1 also binds to ICAM-2, which could be
responsible in part for movement of LFA-1 positive cells from the blood vessels
into the dermis. Indeed ICAM-2 was expressed on the vascular endothelial cells in
warts in this study. The a4 integrin, VLA-4, and its ligand VCAM-1, although not
investigated in this study, is often absent from vascular endothelium in cutaneous
inflammation (Picker, 1994). This may suggest that this pathway is not the main
pathway for lymphocyte homing to the skin. Other molecules such as the a3(3l
integrin on lymphocytes and epiligrin in the basement membrane have been
implicated in movement of T cells towards the epidermis (Wayner et al 1993).
CD44 is also a potential candidate for mediating adhesion since it has a broad
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distribution and is the main cell surface receptor for hyaluronic acid, a component of
the extra cellular matrix and may be important in lymphocyte homing to inflamed
skin (Jalkanen et al 1990). Stimulation via CD44 also increases adhesion via the
LFA-1 -ICAM-1 pathway (Bruynzeel et al 1993). Cytokine expression at a local
level is also likely to play a role in movement of leucocytes into the epidermis.
There is evidence for the involvement of IL-1, IL-6, IL-8 and MCP-1 in leucocyte
trafficking (Bacon et al 1990; Westwick et al 1989; Gillitzer et al 1993).
3.6 Conclusion
Non-regressing cutaneous warts have a CD3+ memory T cell infiltrate in the dermis
but not the epidermis. This implies a defect in the epidermal trafficking of T cells,
some of which may be HPV-specific. Although epidermal ICAM-1 expression was
not observed, ICAM-1 expression on KC may not be necessary for this movement,
since it is sometimes not observed in conditions where there are many
intraepidermal T cells. The adhesion of activated T cells to wart sections was not
increased to levels above that seen for normal skin whereas adhesion to psoriasis
skin was increased. It is possible that inflammatory skin, such as psoriasis, may
exhibit increased expression of adhesive ligands other than ICAM-1, which are not
present in cutaneous warts. Increased vascular expression of ICAM-1 and E-selectin
may be responsible for the transendothelial migration, although the involvement of
molecules such as VCAM-lor ICAM-2 is also a possibility. It is not known whether
the decrease in LC numbers seen in cutaneous warts is a cause or a consequence of
prolonged HPV persistence. If the reduction in numbers of LC is a contribution to
HPV persistence, then it may be speculated that the 2/8 warts with high LC densities
were about to regress. Regressing mucocutaneous lesions have shown increased KC
ICAM-1, increased epidermal T cell infiltrate with CD4+ T cells predominating and
increased HLA-DR expression. All of these changes may be required for resolution
to occur, but it remains unknown what factors initiate the regression of warts.
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Chapter 4
Cytokine mRNA expression in
cutaneous warts
4.1 Introduction
Although the mechanisms underlying wart regression remain unclear, the resolution
of HPV-3 (or 10) associated plane warts is accompanied by a dense mononuclear
infiltrate into the epidermis (Tagami et al 1980), resembling features of a DTH
response (Berman et al 1977). Clinical observations on the regression of cutaneous
warts differ depending on morphological classification of the wart. For example,
during regression of plane warts, erythema and swelling of the warts occurs before
they rapidly disappear (Berman et al 1977). In contrast to this dramatic resolution of
plane warts, similar features have not been described for the regression of common
warts or deep plantar warts which frequently become painful and show signs of
haemorrhaging before complete resolution. This could suggest a unique regression
mechanism for plane warts. However, Coleman et al (1994) observed a significant
increase in numbers of infiltrating lymphocytes and macrophages in the epithelium
of regressing genital warts consistent with a DTH like response, indicating a similar
mechanism of cell-mediated regression to plane warts. Increased numbers of
infiltrating MHC class 11+cells were also seen in regressing Shope rabbit papillomas,
compared with progressing warts (Okabayashi et al 1991), which supports the
hypothesis that common mechanisms bring about regression in warts infected with
different papillomavirus types.
The cytokine network is central to the generation of an inflammatory response in the
skin and the recruitment of effector cells to the epidermis, thereby controlling skin
immunity. A defect in this cytokine network may explain the inability of
mononuclear cells to enter the epidermis of warts and thus clear the virus. Therefore
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the aim of this study was to determine if HPV can modulate cytokine mRNA
expression in long-term HPV infection, and therefore explain the persistence of
warts. Expression of cytokines with a role in induction and regulation of
inflammatory processes were examined in cutaneous warts.
4.1.1 Transforming growth factor-[5
Transforming growth factor-P (TGF-P) is a multifunctional molecule which can
regulate KC growth and the deposition and degradation of extracellular matrix. This
cytokine can have a pro-inflammatory role acting as a chemoattractant for
monocytes, neutrophils and T cells or can have a suppressive role in inflammation,
partly by inducing EL-1 receptor antagonist (IL-lra) and inhibiting IL-1 receptor (IL-
1R) expression (reviewed by Wahl 1994). TGF-P has been found to reduce HPV-16
or 18 early gene transcription in immortalised cell lines in vitro (Braun et al 1992;
Woodworth et al 1990). There is also evidence for a decrease in TGF-P mRNA in
HPV-induced condylomata (Arany et al 1993), and an increase in EV lesions
(Majewski et al 1991). However, no change in TGF-P mRNA expression in HPV-
16/18 immortalised cell lines was observed in vitro (Braun etal 1992).
4.1.2 Tumour necrosis factor- a
The pro-inflammatory cytokine TNF-a induces the secretion of IL-l(Kutsch et al
1993), IL-8, IL-6 and GM-CSF by KC. TNF-a also stimulates the expression of
MHC class II, IL-2 receptor and adhesion molecules ICAM-1 and E-selectin on
endothelial cells. As discussed in chapter 3, the expression of endothelial adhesion
molecules enables granulocytes, monocytes and lymphocytes to bind to the vessel
walls and subsequently migrate into the tissues. TNF-a is implicated in the
migration of LC from the epidermis (Cumberbatch etal 1992). Although expressed
at low levels in normal skin (Oxholm et al 1991) TNF-a mRNA is raised in EV
lesions (Majewski et al 1991), and HPV-16 containing tumourigenic cell lines
(Malejczyk et al 1992). This suggests that TNF-a is up-regulated in HPV infection.
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However, Woodworth et al (1993) found a reduced secretion of TNF-a in HPV-16
or 18 cell lines immortalised in vitro.
4.1.3 Granulocyte macrophage-colony stimulating factor
GM-CSF is produced by KC, T cells, macrophages, mast cells and endothelial cells
(Schrader, 1994). It enhances the viability and antigen presentation function of
dendritic cells (Witmer-Pack et al 1987), and stimulates the migration of leucocytes
into the skin with promotion of their survival and phagocytic activity. Although
GM-CSF has been shown to be secreted in reduced amounts in HPV-16 or 18
immortalised KC cell lines (Woodworth et al 1993), its expression has not been
studied in cutaneous warts.
4.1.4 lnterleukin-1
IL-1 is a pro-inflammatory cytokine secreted by many cell types with a pivotal role
in epidermal inflammation. It induces adhesion molecules on endothelial cells and
stimulates the secretion of secondary cytokines such as IL-6 (Partridge et al 1991),
IL-8 (Larsen et al 1989) and GM-CSF (Kupper et al 1988) from many cells,
including fibroblasts and KC. KC produce active IL-la and the inactive IL-ip
precursor. Unstimulated KC store large amounts of pre-formed IL-la (Sauder et al
1982) which is released upon damage to the epidermis. Since IL-la is a potent
initiator of inflammation in the epidermis several regulatory mechanisms occur. The
biological actions of KC-derived IL-1 relies upon the binding of IL-la to type 1 IL-1
(signalling) receptors, which are found in low numbers on KC, thus regulating the
autocrine actions of IL-la, and epidermal inflammation. Autocrine action of IL-la
on KC is antagonised by IL-lra which is thought to remain intracellular in KC since
it lacks the signal peptide of the secreted form seen in monocytes (Bigler et al 1992).
KC IL-lra binds preferentially to type 1 IL-1 receptors, and IL-la binds
preferentially to type 2 IL-1 receptors found in large numbers on the KC cell surface
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or shed into the extracellular environment (Groves et al 1995).
4.1.5 lnterleukin-8
IL-8 is a chemoattractant for neutrophils and T cells, produced by KC, PBMC,
dermal fibroblasts and endothelial cells (Matsushima et al 1989). This chemokine is
a secondary cytokine and its expression is induced by primary cytokines such as IL-
1 and TNF-a. Human KC produce IL-8, which plays a role in the movement of T
cells and neutrophils towards the epidermis (Barker et al 1991). Woodworth et al
(1993) observed decreased secretion of IL-8 in HPV-16 or 18 immortalised KC cell
lines. The expression of IL-8 has not been studied in cutaneous warts.
4.1.6 Interleukin-10
IL-10 or cytokine synthesis inhibitory factor is regarded as an inhibitory regulator of
the immune system. It regulates the inflammatory immune response by inhibiting
the synthesis of IL-la, TNF-a, GM-CSF, and colony stimulating factor (CSF) (de
Waal Malefyt et al 1991) and y-IFN production by T cells (Fiorentino et al 1991;
Enk, 1994). The latter may be partially mediated by the down regulation of IL-12
p40 by IL-10 (D'Andrea et al 1993). IL-10 steers the immune response towards a
Th2 type response by inhibiting TH1 function and augmenting Th2 cell growth
(Gajewski et al 1988). Increased expression of IL-10 therefore could play a role in
the persistence of HPV disease, by promoting an inappropriate Th2 response as
observed in infection with some retroviral and parasitic infections, (reviewed by
Sher et al 1992). In the skin IL-10 is induced in contact sensitivity responses in
mice (Enk et al 1992) and may have a role in limiting the inflammatory response
induced by this treatment. Exposure of murine KC in vitro to UVB induces IL-10
expression and thus suppresses DTH responses in mice (Rivas et al 1992).
However, the production of IL-10 in human KC in vitro remains controversial since
some investigators have identified IL-10 protein and mRNA in UVB exposed human
KC (Grewe et al 1995; Enk et al 1995), while others could not demonstrate the
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expression of the IL-10 gene (chapter 5 and Ried et al 1994; Teunissen etal 1995).
4.1.7 Interleukin-12
IL-12 is a hetero-dimer of p35 and p40 molecules; p35 is constitutively expressed in
many cell types, whereas the p40 is inducibly regulated. The IL-12 hetero-dimer
produced by monocytes, macrophages, neutrophils, KC, B-cells and LC is potent at
inducing the production of y-IFN from NK and T cells. The combination of y-IFN
and IL-12 shifts immune responses towards a cellular or ThI response (Trincheri,
1993). KC express p35 constitutively and IL-12 p40 can be induced upon contact
sensitisation (Muller et al 1994). IL-12 can also counteract the immune suppression
observed following UVB irradiation (Schmitt et al 1995).
4.1.8 y-Interferon
Memory CD4+ T cells can be divided into ThI or Th2 subsets in murine and human
systems depending on their cytokine secretion profile (Mosmann etal 1986;
Kapsenberg etal 1991). ThI subsets produce IL-2, y-IFN and IL-12 thus promoting
macrophage functions and inhibiting B cell help. Th2 secrete cytokines not
produced by ThI cells including IL-4 and IL-10, thus promoting B cell help and
inhibiting macrophage function. Therefore humoral and cell mediated immunity are
often mutually exclusive. Gamma interferon is also produced by NK cells and has
been detected in B cells (Dayton et al 1992), macrophages (Fultz et al 1993) and
fibroblasts (Rady et al 1995). Gamma IFN induces MHC class II on many cell types
(Barker etal 1989) and can induce ICAM-1 on KC and endothelial cells.
4.1.9 lnterleukin-4
The Th2 T cell subset produce IL-3, 4, 5, 6 and 10. IL-4 production is typical of a
Th2 type CD4+ T cell which stimulates immunoglobulin synthesis and drives a Th2
response. Detection of IL-4 in warts will indicate the presence of activated T cell
populations of the Th2 subset.
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4.1.10 Amphiregulin
Amphiregulin (AR) is a member of the EGF family which can have either growth
promoting or inhibitory effects on epithelial cells (Plowman et al 1990). As for EGF
and transforming growth factor-a , AR is synthesised as a transmembrane precursor,
with the secreted protein being released after proteolytic cleavage. AR is the main
autocrine growth factor for KC (Piepkorn et al 1994), acts via the EGF receptor and
is induced by insulin and insulin-like growth factor-1 in vitro (Vardy et al 1995).
AR mRNA is upregulated in psoriasis (Cook et al 1992), and immunostaining of AR
in vivo correlates with epidermal proliferative activity (Piepkorn et al 1995). AR has
been localised to the nucleus and is proposed to have DNA binding activity (Modrell
et al 1992), thus indicating a direct role for AR in controlling gene expression.
Significantly, Woodworth et al (1995), showed that IL-la induced AR which
mediated growth promotion in a cervical carcinoma derived HPV-16 containing cell
line.
The expression of cytokines in HPV infection in vitro and in vivo is variable and
may depend on HPV type, site of infection, or degree of malignancy. Cytokine
expression has not been previously studied in cutaneous warts and was therefore
investigated in this study. Preliminary non-quantitative RT-PCR experiments were
performed to determine whether TGF-(3, TNF-a, GM-CSF, IL-la, IL-1(3, IL-10 , IL-
8 and IL-12 p40 mRNA were expressed in cutaneous warts. Since there appeared to
be reproducible differences in the expression of some cytokines, semi-quantitative
RT-PCR mRNA expression of IL-la, intracellular IL-ra (icIL-lra), secretory IL-1 ra
(secIL-lra), IL-10 , IL-8, IL-12 p40 and AR was then investigated in non-regressing
cutaneous warts and compared with expression in normal skin. The house-keeping
gene glyceraldehyde-3-phosphate-dehydrogenase (G3PDH) was used throughout to





Non-regressing viral warts from 24 patients between the ages of 18 and 68 years
were removed by curettage as part of clinical management of these patients. Half of
each wart was formalin-fixed for routine histological examination, and the remainder
was snap frozen in liquid nitrogen and stored at -70°C. Eleven of the warts were
common hand warts, one a common wart in the nostril, 2 mosaic, 4 deep plantar, 1
plantar mosaic, 1 deep palmar wart, 1 plane wart, and 3 common warts from renal
allograft recipients. The duration of these warts varied from 2 months to 30 years,.
Samples of normal skin used in this study were taken from 4 breast reductions and 7
foreskins (taken from donors of up to 11 years old which were removed for non¬
medical reasons) and were snap frozen until processed. Ethical permission for this
study was granted following review by a local ethics committee, and was carried out
in accordance with standards laid down in the 1964 declaration of Helsinki.
4.2.2 RNA extraction and reverse transcription.
Frozen tissue specimens were ground into a fine powder in a mortar and pestle with
liquid nitrogen, before lysis in 4M guanidinium isothiocyanate. Total RNA was
extracted (Chomczynski et al 1987), quantitated spectrophotometrically and 1 |ig
total RNA was used as a template to generate cDNA. RNA was denatured at 65°C
for 5 min, before adding the reverse transcription (RT) cocktail consisting of: 5 mM
MgCl2; 1 X RT buffer (10 mM tris HC1, 50 mM KC1, 0.1% triton X-100); 1 mM
each dinucleotide triphosphate (dNTP); 2.5 units RNAse inhibitor; 15 units avian
myeloblastosis virus reverse transcriptase; 0.5 pig oligo dT (15) in a reaction volume
of 20 jil. After incubation for 1 hr at 42°C the reaction was terminated by heating to




Table 4.1 PCR primers pairs
Cytokine Primer sequence Product size
(bp)
H-lcx 5' =5' ATGGCCAAAGTTCCAGACATGTTT3' 816
3' = 5' GGTTTTCCAGTATCTGAAAGTCAG3'
IL-ip 5' =5'AAACAGATGAAGTGCTCCTTCCAG3' 388
3' =5'TGGAGAACACCACTTGTTGCTCCA
TNF-a 5' =5'ATGAGCACTGAAAGCATGATCCGG3' 695
3' = 5 'GCAATGATCCCAAAGTAGACCTGCCC3'
TGF-P 5' = 5'CGCCTTAG€GCCCACTGCTCCTGTGT3' 573
3' = 5 'GGGGCGGGACCTCAGCTGCACTTG3'
IL-4 5' = 5'ATGGGTCTCACCTCCCAACTGCT3' 456
3' = 5'CGAACACTTTGAATATTTCTCTCTCAT3'
y-IFN 5' = 5'GCATCGTTTTGGGTTCTCTTGGCTGTTACTGC3' 427
3' = 5'CTCCTTTTTCGCTTCCCTGTTTTAGCTGCTGG3'
GM-CSF 5' = 5'ATGTGGCTGCAGAGCCTGCTGC3' 424
3' =5 'CTGGCTCCCAGCAGTCAAAGGG3'
IL-8 5' = 5'ATGACTTCCAAGCTGGCCGTGGCT3289
3' = 5' TCTCAGCCCTCTTCAAAAACTTCTC3'




icIL-lra 5' = 5'CAGAAGACCTCCTGTCCTATGAGG3' 470
3' =5'TTGTCAGGCATATTGGTGAGGCTGAC3'
secIL-1 ra 5' = 5'TTCGTCAGGCATATTGGTGAGGCTGAC3' 492
3' = 5'ATGGAAATCTGCAGAGGCCTC3'
G3PDH 5' = 5'CATGTGGGCCATGAGGTCCACCAC 3' 983
3' = 5TGAAGGTCGGAGTCAACGGATTTGGT3
AR 5' = TCCTCGGGAGCCGACTATGAC 3' 329
3' = GGACTTTTCCCCACACCG 3'
Primer pairs spanned at least one intron to distinguish cDNA product from genomic DNA. IL-ip
(Krishnaswamy et al 1993), TNF-a (Krishnaswamy et al 1993), TGF-P (Van Zoelen et al 1993), IL-8
(Krishnaswamy et al 1993), IL-12p40 (Zhang et al 1994) and AR (Ebert et al 1994) were synthesised
by Oswell DNA (Southampton, UK), icIL-lra, (Chan et al 1992) secIL-lra (Chan et al 1992) and
GM-CSF (Lagoo-Deenadayalan et al 1993) were synthesised by Dalton Chemical labs (Ontario,
Canada), and IL-la, G3PDH, IL-10, IL-4, y-IFN were from Clontech (Palo Alto, CA, USA).
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4.2.4 Controls
Positive controls for cytokine expression were RNA from PBMC stimulated with
PHA (l|ig / ml) and PMA (50 ng / ml) (Sigma) for 24 hrs. For IL-10 and IL-12 p40,
4 hr stimulated PBMC and a bladder carcinoma cell line (SD) were used
respectively. MCF-7 cell line stimulated with 100 ng / ml PMA for 24 hrs provided
the positive control for AR (Plowman et al 1990). Negative controls were cDNA
synthesis reactions of RNA from positive controls minus reverse transcriptase
enzyme in order to rule out the possibility of amplifying genomic DNA. PCR
reactions with H2O instead of cDNA were also used to check for contamination of
PCR reagents.
4.2.5 PCR amplifications
PCR was performed using 1.5 fil RT reaction in a PCR cocktail containing 2.7 mM
MgCl2, 0.2 mM d NTPs (Promega), 5 units Thermus aquaticus (Taq) thermally
stable DNA polymerase (Promega) 1 X PCR buffer (10 mM Tris HC1, 50 mM KC1,
0.1% Triton X -100) and 0.16 pM of each primer in a reaction volume of 23 (ll. All
PCR reactions were hot started (D'aquila et al 1991) and run on a Techne PHC3 dri-
block cycler (Techne, Cambridge, UK) at 94°C for 45 sec, 60°C for 2 min, 72°C
for 3 min.
4.2.6 Non-quantitative PCR using Southern blots
4.2.6.1 Blotting.
Preliminary non-quantitative PCR was performed as above for 30 cycles to detect
mRNA for IL-la, IL-lp, IL-8, TNF-a, TGF-p, IL-10, IL-12 p40, y-IFN, IL-4 and
G3PDH. PCR products were resolved by agarose gel (1.5%) electrophoresis which
were denatured and neutralised as described previously (Sambrook et al 1989)
before blotting onto positively charged nylon membrane (Zeta probe GT, Biorad,
Hemel Hempstead, UK) by capillary action in 10 X sodium saline citrate (SSC)
buffer overnight. Blots were rinsed in 2 x SSC before fixing for 1 minute face down
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on a UV transilluminator, air dried and stored at room temperature.
4.2.6.2 Generation ofprobes
Digoxigenin-labelled riboprobes were generated by subcloning cytokine cDNA
fragments into the Bluescript SKII plasmid using standard methods (Sambrook et al
1989). Sense or anti-sense RNA run-off transcripts were generated from this
template in the presence of either T3 or T7 RNA polymerase (Promega). Plasmids
containing cDNAs for the cytokines investigated were provided by : Dr. A Singh,
Genentech CA, USA. (TGF-P and TNF-a), Dr. P. Lomedico, Hoffman -La Roche,
NJ. USA. (IL-la), Dr. S. Wolf, Genetics Institute Inc. MA, USA. (IL-12 p40), Dr.
G. Wong, Genetics Institute Inc. MA, USA (GM-CSF ), Dr. J. Oppenheim, National
Cancer Institute, MD, USA. (IL-8) and IL-10 cDNA was cloned and sequenced from
a PCR product using a TA cloning kit (Invitrogen Inc., The Netherlands). Bluescript
plasmids containing cytokine cDNA inserts were linearised by restriction digest,
using enzymes which did not leave 3' overhangs. Linearised plasmids were
subjected to agarose gel electrophoresis to confirm the completion of the reaction.
The linear plasmid was then phenol / chloroform extracted, precipitated to remove
enzyme and any other contaminating proteins and resuspended in H2O. One pg of
linearised plasmid DNA was then used as a template to generate a digoxigenin
labelled riboprobe in 1 x RNA labelling mix (1 mM ATP, 1 mM GTP, 1 mM CTP,
6.5 mM UTP, 3.5 mM DIG-UTP) (Boehringer Mannheim, Lewes, UK), 1 X
transcription buffer (Promega) (20 mM Tris pH 7.5, 3 mM MgCl2, 1 mM
spermidine, 5 mM NaCl), 20 units RNAse inhibitor (Promega), 40 units T3 or T7
RNA polymerase (Promega), 10 mM dithiothreitol (DTT) (Promega) in a reaction
volume of 20 pi Labelling reactions were incubated at 37°C for at least 1 hr before
stopping the reaction with 2.5 pi 200 mM EDTA, and precipitating at -70°C
overnight with 2.5 pi 4M LiCl, 100 pi 100% ethanol, before resuspending in 20 pi
H2O plus RNAse inhibitor.
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4.2.6.3 Confirmation ofprobe labelling
Under the conditions specified, 1 pg DNA linear template was estimated to generate
10 pg of labelled riboprobe (Boehringer Mannheim Ltd, 1993). The efficiency of the
digoxigenin labelling was confirmed by: 1) subjecting a sample of probe to agarose
gel electrophoresis, blotting the gel and detecting the digoxigenin as described
below, 2) dilutions of the probe from 10 ng / pi down to 0.1 pg / pi were made andT
pi dots were spotted on to membrane followed by digoxigenin detection (section
3.2.6.4). The limit of detection was 1 pg of probe.
4.2.6.4 Digoxigenin detection
Detection of digoxigenin was performed by incubating the membrane in 1%
blocking reagent (Boehringer), for 30 min, followed by 1/5000 anti-digoxigenin
alkaline phosphatase F(ab) fragments (Boehringer) diluted in blocking reagent for 30
min. Membranes were washed in Buffer 1 (100 mM Tris, 150 mM NaCl, pH 7.5) 2
x 15 min, and then developed without shaking in 10 ml colour solution (10 ml Buffer
3 (100 mM Tris, 100 mM NaCl, 50 mM MgCl2, pH 9.5), 45 pi nitro-blue
tetrazolium (Sigma), (100 mg/ml in 70% dimethylformamide), 35 pi 5-bromo-4-
chloro-3-indolylphosphate (Sigma), (50 mg / ml in dimethylformamide) in the dark
for up to 2 hrs. Membranes were finally rinsed in 10 mM Tris 1 mM EDTA and air
dried in the dark.
4.2.6.5 Hybridisation
Membranes were pre-hybridised at 55°C for at least 30 min in high SDS buffer (7%
SDS, 50 mM NaPCU pH 7.0, 50% formamide, 2% blocking reagent (Boehringer), 5
x SSC, 0.1% sarkosyl) using a Hybri-tube (Gibco-BRL), before hybridising in 100
ng / ml riboprobe in high SDS buffer overnight at 55°C. Stringency washes were as
follows:- 2x5 min at room temperature in 2 X SSC, 0.1 % SDS, followed by 2 x 15
min at 55°C in 0.2 X SSC, 0.1 % SDS. Membranes were rinsed in Buffer 1 before
developing as described above. One riboprobe was used for all hybridisations for
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each cytokine, and stored at -20°C between use. Each probe was confirmed as being
specific for each cytokine before use.
4.2.7Semi-quantitative PCR
4.2.7.1 Labelling primers
For semi-quantitative PCR, each primer was 32P-end labelled in a reaction mix
consisting of 5 (iM primer, 1 X polynucleotide kinase (PNK) buffer (70 mM Tris
HC1, 10 mM MgCh, 5 mM DTT) 0.5 units T4 PNK (New England Biolabs, Beverly,
MA, USA) and 0.05 pi 7000 Ci / mmol y [32P] -dATP (ICN Biochemicals, Thame,
UK) at 37°C for 1 hour before denaturing at 95 °C for 5 min.
4.2.7.2 Radiolabeled PCR
PCR was performed as described in section 3.2.5 except 1.5 pi radiolabelled primer
(5' and 3' mixed) were added last to 20 pi PCR cocktail containing 1.5 pi of RT
reaction mix at 85°C (hot start). Reactions were overlaid with 20 pi of mineral oil to
prevent evaporation. The optimum number of cycles were derived for each primer
pair by plotting product yield against cycle number following autoradiography. The
cycle number for further amplifications was chosen from a point within the linear
exponential portion of the plot.
4.2.7.3 SDS-PAGE and autoradiography
Radioactive 32P-labelled PCR products were subjected to 12 % SDS-PAGE at 150
volts for 1.5 hr. The gels were exposed to Kodak X Omat AR autoradiography film
'(Sigma). Autoradiographs were visualised on the Seescan system image analyser
(Seescan, Cambridge, UK) and integrated OD units were obtained using gel analysis
software vl.O ID (Seescan). The housekeeping gene G3PDH was used to control
for differences in abundance of cDNA in RT reactions (Tso et al 1985). The ratio of
integrated OD units for each cytokine : G3PDH, were used to compare relative
1
cytokine mRNA expression in warts compared with normal skin samples. All warts
and normal skins and controls were amplified within the same run, subjected to
SDS-PAGE and autoradiographed at the same time. All PCR reactions for each
tissue sample used cDNA from identical RT reactions. All PCR reactions were
performed at least twice.
4.2.8 Statistical Analysis
Ratios of cytokine : G3PDH integrated OD units derived from image analysis of
autoradiographs were subjected to statistical analysis. The Mann-Whitney U test for
unpaired samples was used on Systat version 5.2.1 for the Macintosh. P values of
less than 0.05 were considered significant.
4.3 Results
4.3.1 Preliminary Non Quantitative PCR
4.3.1.1 Confirmation ofprobe digoxigenin labelling and specificity
Before hybridisation of membranes, confirmation of digoxigenin labelling was
performed and the specificity of each riboprobe was confirmed. One-ten pg of
riboprobe could be detected for all the probes used in this study (Figure 4.1 A) and
were visualised on blotted agarose gels (Figure 4.1 B). To confirm the specificity of
each probe, hybridisations were performed with blots of a range of PCR product
targets. Figure 4.2 indicates that the riboprobe generated from the IL-loc cDNA
template was specific for IL-loc PCR product. Non-specific hybridisation was not
detected to PCR products from G3PDH, GM-CSF or IL-1 (3 primers. The specificity
of all probes were confirmed before use.
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Figure 4.1 Digoxigenin labelling of probes
(A) Sensitivity of probe detection
ng P9
i 1 i 1
100 10 1 100 10 1
T7— 7 • • • #
TNF-oc
T3— • • • •
(B) Agarose gel electrophoresis and blotting of probes
TNF-a TGF-B IL-8
I 1 l 1 I 1
T7 T3 T7 T3 T7 T3
To confirm that riboprobes had been labelled dilutions of T7 and T3 RNA polymerase generated
TNF-a riboprobes were dotted onto nylon membrane (A). In addition riboprobes (TNF-a, TGF-P
and IL-8 ) were run on 1% agarose gels, and blotted onto nylon membrane (B). Digoxigenin was
detected as described in section 4.2.6.4.
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Figure 4.2 Confirmation of specificity of riboprobes
Hybridisation with IL-1a probe
12 3 4
Southern blot of PCR products described in section 4.2.6.1 for IL-1 a (lane 1), IL-1 (3 (lane 2),
G3PDH (lane 3) and GM-CSF (lane 4) hybridised with the probe generated from the IL-1 a cDNA
template described in section 4.2.6.2
4.3.1.2 Non-quantitative cytokine expression in warts and normal skin
In preliminary experiments, expression of TNF -a, TGF-J3, GM-CSF, IL-10, IL-8,
IL-12 p40, y-IFN, IL-4, IL-1 P and IL-1a mRNA was investigated in cutaneous warts
(n=18) and normal skin (n=10) using RT- PCR. Electrophoresis of PCR products on
agarose gels and Southern blotting using specific digoxigenin-labelled riboprobes
was carried out as described in section 4.2.6. In the majority of cases cytokine PCR
products were only detectable after Southern blotting. An indication of the
abundance of a particular cytokine mRNA was obtained depending on whether the
product could be detected by ethidium bromide staining or only by more sensitive
Southern blotting.
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Soutliem blots of PCR products are shown for 6 warts and 6 normal skin samples, with positive and
negative controls (+ and -).
The housekeeping gene G3PDH was expressed in all tissue samples included in this
study, indicating that RNA was intact and that RT-PCR had been performed
successfully. The percentages of warts and normal skin samples which expressed
each cytokine were calculated and are shown in Table 4.2.
Preliminary studies indicated the following trends: 1) cutaneous warts may have
higher levels of IL-loc mRNA expression compared with normal skin, 2) IL-10
mRNA was constitutively expressed in normal skin as judged by Southern blotting,
whilst fewer numbers of warts expressed this cytokine (although 2/18 warts
expressed IL-10 at higher levels than normal skin), 3) Fewer numbers of warts
expressed IL-12 mRNA than normal skin. No marked differences were apparent in
the numbers of warts expressing GM-CSF, TGF-(3, TNF-a, or IL-lp mRNA
compared with normal skin.
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Table 4.2 Percentages of warts and normal skin samples










TNF-a 67% 89% 90% 100%
TGF-J3 89% 100% 100% 100%
IL-la 56% 83% 0% 90%
IL-lp 56% ND 50% ND i
IL-8 0% 72% 20% 50%
IL-10 11% 72% 0% 100%
IL-12 p40 33% 33% 50% 70%
GM-CSF 11% 61% 0% 70%
y-IFN 0% ND 0% ND
IL-4 0% ND 0% ND
The percentage of warts and normal skin samples containing detectable mRNA of each cytokine
following agarose gel electrophoresis and Southern blotting, (warts n = 18, normal skin n = 10)
ND = not done.
4.3.2 Semi-quantitative PCR
4.3.2.1 Optimum cycle number determination
In order to analyse cytokine mRNA expression semi-quantitatively, the optimum
cycle number for each PCR product was determined. A pool of cDNAs taken from
wart and normal skin RT reactions expressing high and low amounts of each
cytokine mRNA were used as target sequences.
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Figure 4.4 Determination of optimum cycle numbers
Cycle number
25 30 35 40 25 30 35 40 +
G3PDH m m
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35 40 45 50 35 40 45 50 +
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30 33 36 39 30 33 36 39 +
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30 33 36 39 30 33 36 39 +
IL-12 .4
Eight identical PCR reactions were established for each cytokine as described in section 4.3.2.1. The
PCR was performed, removing 2 reaction tubes at a determined cycle number. Products were
subjected to SDS-PAGE and autoradiographs of these gels are shown.
Figure 4.4 shows that a product for IL-la could only be detected after 40 PCR
cycles. A specific PCR product was not obtained beyond this cycle number,
therefore 40 cycles were routinely used to detect IL-la mRNA. PCR cycle
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numbers of 33-39 generated a smear when detecting IL-8 mRNA. Thirty nine cycles
were used to detect IL-8 mRNA in further experiments which generated a specific
product (Figure 4.6). SecIL-lra mRNA could not be detected in any wart or normal
skin sample (data not shown) using 40 cycles. Forty cycles was the maximum cycle
number used in this study since above this number the reaction is likely to plateau
due to exhaustion of Taq and PCR reagents. Integrated OD units of PCR products
from these cycle experiments were derived where possible and the linearity of PCR
product accumulation versus cycle number was determined (Figure 4.5).
Figure 4.5 Linearity of PCR product accumulation with
increasing cycle number
Densitometry of PCR product shown in Figure 4.4 was performed where possible and accumulation
of PCR product versus cycle number is shown.
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Optimum cycle numbers for detection of each cytokine mRNA determined from
Figures 4.4 and 4.5 were 40 cycles for IL-la, 36 cycles for IL-10, 39 cycles for IL-8,
36 cycles for IL-12 p40, 31 cycles for icIL-lra, 40 cycles for secIL-lra and 35 cycles
for G3PDH.
4.3.2.2 Semi-quantitative expression of cytokines in warts and normal skin
The expression of IL-la, icIL-lra, IL-8, IL-10 and IL-12 p40 mRNAs was analysed
in non-regressing cutaneous warts and compared with normal skin samples.
Autoradiographs of PCR products for these cytokines at the optimum cycle numbers
are shown in Figure 4.6.
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Autoradiographs of labelled cytokine PCR products for 11 normal skin and 24 warts were
subjected to SDS-PAGE and the results are shown above. Warts 1-3, 8 and 24 were plantar , 6, 7, 9,
10, 12- 14, 17-19 and 23 were common hand warts, while 15 and 16 were mosaic, 20-22 were
common warts taken from renal allograft recipients, 11 was a plane wart, 4 was a common wart from
the nostril and 5 was a deep palmar wart.
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IL-1 a mRNA in the normal skin samples and many warts was either absent or
present at low levels, whereas 33% warts expressed this cytokine at high levels. The
majority of warts which expressed IL-1a mRNA also expressed icIL-lra mRNA
whereas most normal skin samples expressed this mRNA. The secreted form of IL-
lra was not expressed in any of the normal skin samples or warts, but a PCR product
was obtained when mRNA was used from PBMC stimulated for 4 hr with PHA and
PMA (data not shown). Expression of mRNA for secreted IL-lra has previously
been shown in monocytes and fibroblasts but is not found in KC. IL-12 p40 mRNA
was expressed at varying levels in warts and normal skin but no marked difference in
expression was apparent between the two skin types. IL-10 mRNA was present at
low levels in all normal skins but was not detected in many warts, thus confirming
the findings of the preliminary experiments. IL-8 mRNA was detected in one
normal skin sample, while 5 warts expressed mRNA for this cytokine. However, 3
of these warts had a low abundance of IL-8 PCR product. Densitometry was
performed on the autoradiographs and ratios of integrated OD units for cytokine:
G3PDH are shown in Figure 4.7. Many warts have increased IL-la, icIL-lra and
IL-12 p40 mRNAs compared with normal skin (Figure 4.7). The expression of IL-
la mRNA was significantly greater in warts than normal skin (p = 0.003), while the
expression of IL-10 mRNA was significantly greater in normal skin than in
cutaneous warts (p = 0.002).
4.3.2.3 IL-1 a mRNA expression in common and plantar warts
Differences in IL-la mRNA levels could occur depending on anatomical site,
morphology and HPV type. Although molecular HPV typing of warts was not
available for this study, the anatomical site and clinical diagnosis was known. When
common and plantar warts were compared, only the expression of IL-la mRNA was
significantly different between these wart types (shown in Figure 4.8).
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Integrated OD units were obtained by image analysis of autoradiographs. Relative expression of each
cytokine is shown as a ratio of cytokine : G3PDH. Normal skin = O, warts = • , IL-la mRNA
expression was significantly greater in warts than normal skin. IL-10 mRNA was significantly
greater in normal skin (median = 0.200) compared with warts (median = 0.000).
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p = 0.019 •
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Normal Common Plantar
Ratios of IL-la : G3PDH mRNAs expression are compared for normal skin (n = 11) O , common
warts (n = 11) • , and plantar warts (n= 5) • , and are shown above.
Significantly greater IL-la mRNA expression was found in common hand warts
than in normal skin (p = 0.019). Plantar warts also had significantly greater IL-la
expression than common warts (p = 0.003). IL-la was the only cytokine which had
greater expression levels in warts than normal skin, and had differential expression
depending on wart type. Of the three warts taken from RAR, one expressed IL-la,
icIL-lra and IL-10 mRNAs, one expressed icIL-lra and IL-12 mRNAs while the
third did not express any of the cytokines studied. The one plane wart expressed IL-
12 and IL-10 mRNAs.
4.3.2.4 Correlation between IL-la and icIL-lra mRNA expression
The autoradiographs in Figure 4.6 indicate that warts which expressed IL-la mRNA
also expressed icIL-lra mRNA. The correlation between the expression of these
mRNAs is shown in Figure 4.9.
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Figure 4.9 Correlation between IL-1a and iclL-1ra mRNA
expression
IL-la / : G3PDH ratios were correlated with icIL-lra : G3PDH ratios Normal skin = □ , Common
warts = ■ , Plantar warts = #. Pearson correlation r values are 0.546 for common warts, - 0.180 for
normal skin and 0.831 for plantar warts which was the only significant correlation (p = 0.05).
There was no correlation between the expression of mRNA for IL-la and icIL-lra
in samples from normal skin. Indeed, icIL-lra mRNA was present in normal skin
samples but IL-la mRNA was absent or at low levels. There was a trend toward
correlation between IL-la and icIL-lra mRNA levels in common warts, but the
expression of these 2 mRNAs was not significantly correlated. In samples of plantar
warts the correlation between icIL-lra and IL-la mRNA expression was significant
(Pearson correlation r = 0.846, significant at p = 0.05).
4.3.2.5 Amphiregulin mRNA expression in cutaneous warts
Since IL-la mRNA was significantly up-regulated in cutaneous warts compared
with normal skin, the expression of AR mRNA in cutaneous warts was examined.
0 0.2 0.4 0.6 0.8
ic IL-1ra: G3PDH ratio
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Warts were divided into groups of high, medium and negative for IL-lot mRNA
expression based on levels found in semi-quantitative RT-PCR shown in Figure 4.7.
Warts in the negative category were also negative by Southern blot. Semi¬
quantitative RT-PCR analysis of AR expression was performed, the autoradiographs
are shown in Figure 4.10. Warts which expressed either medium or high levels of
IL-loc also expressed AR
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Autoradiographs of 32P-labelled amphiregulin PCR products separated by SDS-PAGE. IL-la high =
6 warts with the highest level of IL-la mRNA expression as shown in Figure 4.7. IL-la Med = all
other warts in which IL-la was detected. IL-la Neg = warts in which no IL-la was detected (either
with 32P labelled primers or by Southern blotting).
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mRNA, while warts negative for IL-la mRNA expression did not express AR
mRNA. The expression of AR mRNA was positively correlated with IL-la mRNA
expression in warts (Pearson correlation r = 0.590, p < 0.05), shown in Figure 4.11.
No such correlation was observed in normal skin.







IL-1 a : G3PDH
IL-la /: G3PDH ratios were correlated with AR : G3PDH ratios in nonnal skin and cutaneous warts.
A positive correlation (p < 0.05) was found between AR and IL-la expression in cutaneous warts.
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4.4 Discussion
The primary aim of this study was to investigate whether cytokine expression is
modulated in chronic cutaneous HPV infection. Preliminary non-quantitative
experiments found that more warts expressed IL-la and IL-8 than normal skin,
while fewer warts expressed IL-10 and IL-12. No marked differences were found
between the numbers of warts and normal skin samples expressing TNF-a, TGF-P,
IL-ip or GM-CSF. No IL-4 or y-IFN mRNAs were found at levels detectable by
RT-PCR and visualised by agarose gel electrophoresis in either warts or normal skin.
Semi-quantitative analysis found significantly higher IL-1 a mRNA expression in
warts than normal skin, whereas IL-10 mRNA was found at lower levels in warts
than normal skin.
4.4.1 HPV infection and TGF-(5
TGF-P mRNA was found abundant normal skin, as shown previously (Arany et al
1993; Majewski et al 1991). There was no change between the percentages of
normal skin samples and warts expressing TGF-p mRNA by non quantitative RT-
PCR analysis. TGF-P mRNA has been reported to be increased in HPV-5 or 8
associated EV lesions (Majewski et al 1991) and decreased in HPV-6 or 11
associated condylomas (Arany et al 1993). This discrepancy in TGF-P expression
could be due to different effects of the HPV types causing the infection or differing
host responses at cutaneous and mucosal epithelium. However, the induction of
TGF-P mRNA seen in EV lesions was greater in the samples showing signs of
malignancy suggesting an association between TGF-P mRNA induction and
progression towards carcinoma (Majewski et al 1991). Although expression of
TGF-P mRNA may indicate that bioactive TGF-P is potentially available in
cutaneous warts, since the gene is regulated at both transcriptional and post
translational level (reviewed by Wahl, (1994) the functional protein may not be
present. Furthermore,-since nascent secreted TGF-P is biologically inactive, due to
133
its interaction with a latency associated protein and activation of the latent TGF-(3
complex must occur before TGF-(3 is available to bind to cellular receptors,
(reviewed by Wahl 1994).
HPV immortalised KC in vitro have been shown in some studies to be resistant to
growth inhibition by TGF-(3 (Pietenpol et al 1990). However, not all HPV
containing cell lines are resistant to TGF-(3 (Braun et al 1992; Woodworth et al
1990). HPV containing cell lines derived from carcinomas or high passage number
cultures were resistant to TGF-|3 mediated growth inhibition (Braun et al 1992).
Taken together these findings indicate that increased TGF-f3 mRNA expression and
resistance to its growth inhibitory effects may play a role in progression towards
carcinogenesis rather than in the persistence of HPV infection. TGF-(3 could
mediate regression of pre-neoplastic HPV lesions in the early stages of infection, and
the subsequent loss of responsiveness to TGF-P may aid the progression to
carcinoma.
4.4.2 HPV infection and TNF-a
Similar numbers of normal skin samples and wart specimens expressed TNF-a
mRNA in this study. Although all normal skin samples and the majority of warts
expressed TNF-a mRNA, in agreement with previous data (Viae et al 1995), 2 warts
were found not to express TNF-a mRNA. It is postulated that TNF-a has a role in
the migration of LC from the epidermis (Cumberbatch et al 1992). Most cutaneous
warts show a reduced density of LC in the epidermis compared with normal skin, but
this reduction is not universal (Chapter 3). It has not been determined if the warts
lacking TNF-a mRNA expression in this study are those without a reduction of LC
in the epidermis. Many cell types secrete TNF-a including KC, T cells and
macrophages. It has been suggested that the TNF-a produced by infiltrating
mononuclear cells has a role in wart regression, rather than the TNF-a production by
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KC (Hagari et al 1995). The phenotype and location of TNF-a expressing cells was
not addressed in this study.
TNF-a mRNA is elevated in EV lesions (Majewski et al 1991) and HPV-16
containing KC cell lines (Malejczyk et al 1992), but reduced secretion was found in
other HPV-16 containing cell lines (Woodworth et al 1993). TNF-a inhibits growth
of normal human skin KC lines (Pillai et al 1989), KC derived from normal cervix
(Woodworth et al 1995) and HPV-16 transformed KC in vitro (Malejczyk et al
1992; Villa et al 1992). Nevertheless, resistance to growth inhibitory effects of
TNF-a has also been observed in HPV-16, 18 and 33 containing KC (Delvenne etal
1995; Villa et al 1992; Malejczyk et al 1994). In other cases TNF-a promoted the
growth of HPV-16/18 immortalised KC (Woodworth et al 1995). In common with
the loss of TGF-P growth inhibition outlined above, escape from TNF-a growth
inhibition is associated with increased tumourigenicity of the cell lines (Malejczyk et
al 1994).
A decrease in the TNF-a receptor has been observed in HPV-16 tumourigenic cell
lines and also increased secretion of soluble TNF-a receptor type 1 (Malejczyk et al
1994), which suggests antagonism of TNF-a in these cell lines. Although TNF-a,
similar to TGF-(3, may be involved in the progression to carcinoma of HPV-16
containing KC lines, the data presented in this study would suggest that this cytokine
is not modulated in chronic infection with cutaneous HPV types. However, TNF-a
may still have a role in the regression of cutaneous warts, as indicated in CRPV
warts (Hagari et al 1995), which may be due in part to its role in reducing HPV
transcription (Kyo et al 1994)
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4.4.3 HPV infection and GM-CSF
GM-CSF mRNA was expressed in 2/18 warts and 0/10 normal skin samples, when
PCR products were visualised on agarose gels. However, no marked difference in
the numbers of wart samples or normal skin samples expressing GM-CSF mRNA
was seen when Southern blotting was performed. GM-CSF is not constitutively
produced in normal skin, but upon stimulation, monocytes, endothelial cells,
fibroblasts and KC are able to express this cytokine. The low level of GM-CSF
transcripts detected here may represent untranslated cytokine in both normal skin
and warts. The only other report to date concerning GM-CSF and HPV infection is
the study by Woodworth et al (1993) which detected reduced secretion of GM-CSF
in HPV-16 and 18 immortalised KC cell lines, suggesting a down-regulation of GM-
CSF by HPV. The data from the present study do not support these findings.
4.4.4 HPV infection and IL-1
Preliminary studies showed a greater percentage of warts expressing IL-1 a mRNA
than the percentage of normal skin samples. No difference in the percentage of
warts or normal skin samples expressing IL-ipmRNA was observed. Semi¬
quantitative RT-PCR analysis confirmed these preliminary findings and indicated
that IL-1 a mRNA expression was significantly (p = 0.003) greater in warts
compared with normal skin. In addition, plantar warts expressed significantly more
IL-la mRNA than common hand warts.
Although RT-PCR is a very sensitive technique, enabling large numbers of samples
to be analysed, it does not yield information regarding phenotype of the cells
expressing cytokine mRNA in cutaneous warts. KC comprise the majority of cells
within the curetted specimens of warts and are the main producers of IL-la within
the epidermis. However, a small amount of dermis is included; therefore infiltrating
mononuclear cells, and dermal fibroblasts which also express IL-la could be a
source of IL-1 a mRNA.
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Protein expression or biological activity of IL-la needs to be analysed for a
definitive interpretation of these PCR results. Bioactive IL-la is stored pre-formed
in epidermal KC and is released upon damage or trauma which could include
infection with papillomavirus. Many of the warts in this study have been present for
a number of years, therefore continuous up-regulation of bioactive IL-la seems
unlikely since these lesions rarely shown signs of inflammation. Indeed, cutaneous
warts typically show few signs of being inflammatory lesions. Although ICAM-1
and E-selectin are up-regulated on vascular endothelium in cutaneous warts in
conjunction with a mononuclear infiltrate into the dermis (chapter 3).
IL-la is a potent initiator of inflammation, and a network regulating the actions of
IL-1 exists within the epidermis. KC and fibroblasts produce IL-lra (Chan et al
1992) which inhibits the action of IL-1 in vitro by binding to type 1 receptors (Bigler
et al 1992). The mRNA for the secreted form of this molecule found in monocytes
and fibroblasts was not detected in this study, but the mRNA for the intracellular
form found in KC was expressed in both normal skin and warts. Many IL-la
expressing warts also showed icIL-lra mRNA expression, therefore negative
regulation of IL-la is possible. Since IL-1 induces IL-8 expression in PBMC, KC,
dermal fibroblasts and endothelial cells (Matsushima et al 1989), the lack of IL-8
mRNA in many warts which express IL-la mRNA, may indicate regulation of
bioactive IL-la. The ratio of IL-lra to IL-la is an important indicator of bioactive
IL-la. A ratio of IL-lra : IL-la is approximately 100 to 1 is found in uninfected
normal skin (Hammerberg et al 1992).
Cutaneous warts which expressed IL-la mRNA also tended to express AR mRNA,
and a significant correlation was observed between the two. No correlation was
found between the expression of AR mRNA and IL-la mRNA in normal skin. IL-
la promotes the growth of HPV-16 or 18-transformed KC in vitro, mediated by AR
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(Woodworth et al 1995), but IL-la remains inhibitory to the growth of normal KC.
Although a causal relationship cannot be assumed from mRNA expression in
cutaneous warts, one speculation is that IL-la may induce the observed AR mRNA
expression in cutaneous warts and thus promote the growth of HPV-infected KC.
Woodworth et al (1995) showed that AR stimulated growth of HPV infected KC
through interaction with the EGF receptor. Interestingly the papillomavirus E5
protein associates with the EGF receptor (Pirn et al 1992) preventing its degradation
and increasing the sensitivity of the cell to EGF and therefore increasing cell
proliferation. This data indicates that KC in benign cutaneous HPV infections, may
have increased sensitivity to AR. In some cases, such as condylomata, this effect
may be augmented by increased EGF receptor expression (Viae et al 1990). The E5-
EGF receptor interaction may be a first step in the transition to viral mediated
transformation, although E6 and E7 later function to maintain this transformed
phenotype. A previous study has also shown nuclear localisation of AR and binding
to DNA, indicating a possible role in transcriptional regulation (Modrell et al 1992).
It is not clear whether the autocrine AR stimulation is associated with integration of
the genome of oncogenic types of HPV and immortalisation of the host cells.
Autocrine growth stimulation of KC in cutaneous warts could occur which may
explain the hyper-proliferative nature of epidermal KC in cutaneous warts. IL-la is
also an inducer of IL-6 which itself induces AR expression in HPV-immortalised KC
(Iglesias et al 1995). However, in other studies, IL-la had no effect on the growth
of carcinoma cells containing HPV-16 (Malejczyk et al 1992).
If IL-la is not released from KC, it could act in an intracellular autocrine fashion, by
binding receptors before they reach the cell surface. Intracellular autocrine action
has been described for GM-CSF, IL-6, IL-3 and platelet derived growth factor in
immortalised cell lines (Lang et al 1990). IL-la has also been shown to decrease
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early viral transcription of HPV-16 immortalised cells (Kyo et al 1994) suggesting a
role for pro-inflammatory cytokines in the defence against HPV.
4.4.5 HPV infection and IL-8
IL-8 mRNA was detected in more warts than normal skin samples by both Southern
blot and 32P-labelled detection of RT-PCR products. However, in semi-quantitative
analysis, the abundance of IL-8 mRNA was not significantly different in warts than
in normal skin when IL-8 : G3PDH ratios were subjected to statistical analysis. This
suggests that IL-8 is not modulated by HPV infection in cutaneous warts. The lack
of IL-8 expression in many warts may partly explain impaired trafficking of
mononuclear cells into the epidermis of warts, and thus viral persistence (chapter 3).
Interestingly, HPV-16 immortalised cell lines secrete less IL-8 than normal KC lines
(Woodworth et al 1993).
4.4.6 HPV infection and IL-10
By both the semi-quantitative RT-PCR and non-quantitative assays, all normal skin
samples with the exception of two samples had low level constitutive IL-10 mRNA
expression, as observed by others (Teunissen et al 1995). The majority of the warts
had no IL-10 mRNA but it was induced to high levels in 2 lesions. Normal skin
expressed more IL-10 mRNA than warts (p = 0.002). It has been suggested that up-
regulated IL-10 expression aids viral persistence (Sher et al 1992), however these
results do not support a similar hypothesis for HPV infection. It could be speculated
that IL-10 inhibits expression of cytokines in normal skin, thus its absence in the
majority of cutaneous warts might lead to increased expression of IL-la, IL-8, IL-12
cytokines and IL-lra. However, there is no evidence from other studies to suggest
that this is the case.
No data on localisation of IL-10 mRNA expression are presented in this study. It is
139
possible that KC are not the main source of IL-10 in human skin. Indeed infiltrating
monocytes have been proposed as the main epidermal source of IL-10 (Kang et al
1994). In human KC IL-10 mRNA could not be detected in some in vitro studies
(Ried et al 1994; Teunissen et al 1995). However, the present study found IL-10
mRNA without the detection of protein in human KC exposed to high doses of UVB
irradiation (200 J / m2) (Chapter 5). The role of KC derived IL-10 in human skin is
still unclear since other studies have found low levels of IL-10 mRNA in human KC
lines, and varying levels of protein (Grewe etal 1995; Enk et al 1995). Nickoloff et
al (1994) detected KC derived IL-10 protein in human skin in situ after tape
stripping and in poison ivy dermatitis.
4.3.7HPVinfection andIL-12
Many cell types are known to constitutively express IL-12 p35. However, the
expression of IL-12 p40 is restricted to certain cell types, including KC. These data
presented in this study, indicate that many warts and normal skin samples have
increased IL-12 p40 mRNA expression. A trend towards higher relative expression
of IL-12 p40 mRNA was observed in cutaneous warts compared with normal skin,
but these differences were not significant (p > 0.05).
Monocytes and KC are the primary secretors of IL-12 in the skin and there is
evidence for this cytokine having a role in primary immune responses in the skin.
IL-12 is known to stimulate NK cells which are important in immunosurveillance at
cutaneous sites. Individuals with HPV-16 associated neoplasms had decreased NK
cell activity, but whether this is reflected in a decreased IL-12 secretion by the
PBMC of these patients is unclear (Malejczyk et al 1994). The presence of the IL-
12 p40 mRNA in cutaneous warts suggests that the IL-12 protein may be present in
the wart lesion. IL-12 is able to induce the expression of cutaneous lymphocyte
antigen (Leung et al 1995) which increases skin-specific homing. Cells infiltrating
the underlying dermis of cutaneous warts may be activated TH1 cells, but will be
ineffective if these cells are still unable to reach the epidermis.
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4.3.8 HPV infection and y-IFN
No y-IFN mRNA could be detected in either normal skin or warts in this study,
indicating that long-term infection with cutaneous HPV types does not modulate
expression of this cytokine. The absence of this cytokine may play a role in wart
persistence. Gamma-IFN inhibits growth of normal KC and HPV-transformed cells
in vitro (Delvenne et al 1995), and has been shown to reduce HPV gene
transcription in some studies (Woodworth et al 1992) but not in others (Kyo et al
1994). The present study provides no evidence that HPV modulates y-IFN
expression during long-term cutaneous infection.
4.3.9 HPV infection and IL-4
No IL-4 mRNA could be detected samples from warts or normal skin, indicating a
lack of activated Th2 cells secreting IL-4 in cutaneous warts. These data do not
support the theory that chronic cutaneous HPV infection may develop or persist as a
result of an inappropriate Th2 response which is unable to resolve infection.
4.3.10 The role ofUVB in HPV infection
The common warts examined in this study were obtained from hands or face and are
thus exposed to UVB radiation, which may influence the outcome of the infection at
these sites. UVB exposure leads to systemic immunosuppression in mice and
decreased DTH reactions. Pre-exposure of human KC in vitro to UVB prevents
induction of MHC class II and ICAM-1 by y-IFN (Khan et al 1993; Krutmann et al
1990). Individuals who are clinically immunosuppressed presumably have
decreased cutaneous immunosurveillance and are particularly susceptible to
infection with HPV (reviewed by Benton et al 1992). UVB exposure also
predisposes to the development of cutaneous warts in RAR (Boyle et al 1984) and
many of these warts develop into squamous cell carcinomas (Benton et al 1992).
Some of the HPV types in these lesions were found to be HPV 5, 8 or similar types
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associated with EY, a rare genetically determined disease characterised by extensive
flat wart-like lesions on sun exposed areas. Up to 33% of EV patients develop
multiple SCC, and 90 % of these lesions contain HPV 5 or 8 DNA. UVB exposure
may act as a co-factor in the development of cancer in HPV types with an oncogenic
potential. However, there are also cases where warts resulting from infection with
HPV-1 were transformed into squamous cell carcinoma in immunosuppressed
patients (Noel et al 1994), suggesting that the low risk HPV types may have the
potential to promote progression to squamous cell carcinoma when other co-factors
are present.
4.5 Conclusion
This is the first study investigating cytokine mRNA expression in cutaneous warts.
The up-regulation of IL-la mRNA occurs in non-regressing cutaneous warts
compared with normal skin. There are two potential roles for IL-1 a in HPV infected
skin. Firstly, IL-la may begin the chain of events leading to inflammation in the
epidermis, but is blocked at some point down stream of transcription. Hence, the
lack of infiltrating effector cells into the epidermis. Secondly, it may play a role in
the persistence of the virus by maintaining growth of the infected KC, by induction
of KC growth factors such as AR. Therefore IL-la which is often considered to
assist immune responses may actually aid progression of infection with HPV.
The limitations of this study are that the cytokine localisation and protein expression
remain un determined. The advantages of this study are that cytokine expression
was measured in vivo , thus removing any in vitro artefacts which may occur when
measuring cytokine expression in cell lines. Previous studies found a reduced
secretion of cytokines in HPV infected immortalised KC cell lines (Woodworth etal
1993). However, normal cervical KC infected with retroviral vectors containing E6
and E7 did not cause modulation of cytokine secretion, suggesting different effects
of HPV infection and HPV associated carcinogenesis on cytokine modulation.
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Chapter 5
HPV infection of keratinocytes vitro
5.1 Introduction
HPV infection may modulate the epidermal cytokine network and contribute to the
impaired trafficking of T cells to the site of infection. Alternatively, lack of cytokine
production from intraepithelial lymphocytes (such as y-IFN or IL-12) may play a part
in the persistence of infection. Analysis of cytokine mRNA in cutaneous warts
(Chapter 4) demonstrated increased levels of IL-la mRNA and a correlation with
AR mRNA expression. Although these cytokines may not be responsible for the
impaired trafficking into the epidermis, they may play a role in the hyperproliferation
of HPV-infected KC in cutaneous warts.
KC are the major potential source of cytokines within the skin, and the target hosts
for HPV infection, therefore the modulation of KC cytokines may be one way in
which HPV modulates the host response to aid its survival and wart persistence. To
study the direct effects of HPV on cytokine expression in KC requires an in vitro
experimental system to model HPV infection. In vitro, HPV will only productively
infect a stratified epithelium, such as an organotypic raft culture treated with PMA
(Dollard et al 1992). Such an in vitro model provides the ideal situation for analysis
of the virus-host interaction. However, valuable information regarding the early
stages of KC- HPV interaction may still be gained by studying non-productively
infected cells.
The majority of in vitro data concerning cytokine production by KC containing HPV
comes from cell lines immortalised with oncogenic HPV types. Woodworth et al
(1993) showed a reduced secretion of GM-CSF, IL-6, IL-8, IL-1(3 and TNF-a in KC
immortalised with HPV-16. Cytokine production was reduced to a greater extent in
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cell lines derived from carcinomas but remain unchanged in normal cervical KC
infected with retroviral recombinants encoding HPV-16 E6 and E7 oncoproteins
(Woodworth et al 1993). This suggests that a reduction in cytokine production is
due to secondary changes associated with transformation of the cells and progression
to carcinomas rather than HPV infection per se. Malejczyk et al (1991, and 1992)
demonstrated constitutive secretion of IL-6 and TNF-a in tumourigenic HPV-16
containing KC lines. TNF-a has a growth inhibitory effect on normal KC although
tumourigenic cell lines are resistant to the growth inhibitory effects of TNF-a.
Taken together, these data suggest that changes in cytokine production by KC occur
in association with progression to malignancy. Alternatively, long term culture of
transformed KC may lead to changes in secretion and response to cytokines. The
effect of HPV on host cytokine production in benign infections in non-transformed
KC is less clear.
Although productive infection of HPV will not occur in monolayer cultures, KC
infected with HPV-1 particles in vitro retain HPV DNA up to 4 months (Bossens et
al 1992; La Porta et al 1982). Replication of HPV DNA is detected in monolayers of
KC infected with HPV (La Porta et al 1982), and some studies have detected E1AE4
transcripts (Chow et al 1987). Similar experiments using BPV-1 infection of human
monocytes demonstrated BPV DNA up to 28 days after infection (Bonnez et al
1991). IL-la is detected in the supernatant of these cells 3 days after infection.
HPV specific RNAs were found in human bronchial epithelial cells infected with
HPV-1 particles (Christian et al 1987). E1A E4 mRNAs have also been detected in
primary KC cultures from explants of HPV-11 infected normal human foreskin
tissue (Smith et al 1993). These transcripts could be detected in secondary passaged
cells 6 weeks after infection.
Transfection of HPV DNA in KC may mimic early stages of infection. Oncogenic
HPV types (HPV-16, 18, 33) immortalise host cells after integration of HPV DNA
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into cellular genomes (Durst et al 1987; Gilles et al 1993). The linearised genomes
of HPV-11 and 18 replicate transiently for up to 7 days in squamous cell carcinoma
cell lines which do not contain endogenous HPV DNA sequences (Del Vecchio et al
1992). "Low risk" HPV genomes, such as HPV-1 or 11, when transfected into KC
are retained transiently, generally without integration. When HPV-1 does integrate
into the cellular genome in vitro, it does not lead to a transformed phenotype
(Burnett et al 1983). Recircularised HPV-11 DNA, co-transfected into KC cultures
with a selectable marker, remains episomal and replicates (Mungal et al 1992).
Early stages of HPV infection can be mimicked by infection of KC cultured as
monolayers and the cytokine response from infected cells can be studied at various
time points after infection to determine the effect of HPV on cytokine expression.
Similarly the transfection of HPV-1 DNA provides an opportunity to examine host
cell response to viral DNA replication and HPV transcription. If KC are co-
transfected with recircularised HPV-1 genome and a plasmid containing a selectable
marker, such as neomycin resistance, selection of HPV containing cells is possible.
HPV DNA, mRNA and cellular mRNA can then be analysed. In addition assays of
cytokine mRNA in KC transiently infected with HPV would provide information
regarding the KC response to HPV, and whether this might be altered by UVB
irradiation.
5.2 Aim
The aim of this study was to determine whether cytokine mRNA expression in
primary human KC in vitro is modulated by transient infection with cutaneous HPV
types or transfection with HPV DNA.
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5.3 Methods
5.3.1 Primary keratinocyte lines
Sterile instruments were used and procedures were performed under sterile
conditions. Foreskins excised from boys up to age 11, were obtained from the
Western General Hospital, Edinburgh, and placed in Leibowitz medium (Gibco)
containing gentamicin (50 |ig / ml) and amphotericin-B (50 ng / ml ) during
transportation. Tissue was washed 5 X in 0.02% EDTA in PBS, retaining the last
wash to check for tissue culture sterility. Using a sterile petri dish foreskins were cut
along the dorsal axis to form a square. The square of tissue was then trimmed with
scissors to remove extraneous fat and blood vessels and cut into 1 cm squares.
Approximately 5 tissue squares were placed in 5 ml dispase (4 mg / ml in PBS)
(Sigma) and incubated either at room temperature overnight or 4°C for 72 hrs on a
rotary mixer. The epidermis was then easily peeled away from the underlying
dermis. Epidermal sheets were then placed in 10 ml 0.25% trypsin (Gibco) in PBS /
EDTA and vigorously chopped for 3 minutes with scissors to achieve a fine
suspension. This suspension was incubated at 37°C for 30 min on a roller mixer.
Before the addition of 1 ml filtered foetal calf serum to inhibit the trypsin, the
suspension was vigorously pipetted for 2-3 min. To increase the yield in some
preparations, the tissue was incubated for a further 15 min at 37°C in 0.4 mg / ml
collagenase (Sigma). The suspension was pipetted for a further 2 min before passing
rapidly through a stainless steel mesh. The resulting suspension was centrifuged at
1800 rpm for 10 min. The cells were resuspended in 1 ml keratinocyte serum-free
medium (KGM) (Clonetics Corp. San Diego, USA) with insulin (5 p.g / ml), bovine
pituitary extract (0.03 mg / ml), hydrocortisone (0.5 |ig / ml), gentamicin (50 p.g /
ml), amphotericin-B (50 ng / ml), murine EGF (10 ng / ml) and 0.06 mM CaCl2.
Viability and cell yield was determined using trypan blue exclusion, the large,
angular, terminally differentiated squames were not counted.
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Isolated epidermal cells were either stored in liquid nitrogen or dispensed at 1 x 106
cells per 25 cm2 either in T25 flasks (Falcon) with 3 ml KGM or in a 12 well plate
(Costar) with 1 ml KGM / well. Tissue culture plastics were coated with 5 (ig / cm2
fibronectin (Scottish National Blood Transfusion Service, Edinburgh, Scotland) in
PBS at room temperature for at least 20 min and were stored at -20°C after the
fibronectin solution was removed. Fresh medium was added to plates every 2-3 days
and cultures were inspected every day for colony formation. KC colonies formed
after 2 - 20 days in culture. Once colonies had established, medium was aspirated
and replaced with fresh medium as required. Cultures were split 1:3 when 70-80 %
confluent. Any cultures which had contaminating fibroblasts were cleansed with
PBS / EDTA at 37°C for 2 min since fibroblasts are more sensitive to EDTA
treatment than established KC colonies.
5.3.2 Characterisation ofcell lines
To confirm that KC cultures consisted of epithelial cells rather than contaminating
fibroblasts cells were stained for expression of keratin, vimentin, MHC class I and II
and ICAM-1. KC from passage numbers 1-3 were cultures on Thermanox™ plastic
coverslips (Nunc) in 6 well dishes at 4 x 104 cells per disc in 20-50 ql . After KC
became attached 3 ml KGM was added per well and 2-3 days later the discs were air
dried and fixed in acetone for 10 min at room temperature before re-drying. Discs
were rehydrated into TBS and stained using the immunoperoxidase technique as
described in Chapter 3. Primary antibodies were: mouse anti-vimentin 1/200
(Sigma), mouse anti-ICAM-1 1/200 (R and D systems), mouse anti-HLA-DR 1/40
(DAKO), guinea pig anti-keratin 1/40 (Sigma), mouse anti-MHC class I 1/40
(DAKO). Mouse anti-CD3 1/20 (DAKO) was an isotype matched control for
ICAM-1, vimentin and MHC class II. Secondary rabbit anti-guinea pig or anti-
mouse horseradish peroxidase conjugated antibodies were visualised by developing
with diaminobenzidine as described in Chapter 3.
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5.3.3 HPV infection ofprimary keratinocytes
KC cell lines from passage number 1-3 were cultured at 7 x 104 cells per well of a 24
well plate (Costar). Cells were grown in the absence of EGF for 48 hrs prior to
infection and during the course of the experiment. When 30-50 % confluence, was
reached cultures were infected with HPV as described by Bossens et al (1992).
Briefly, 200 jil HPV (isolated as described in chapter 2, but not UV inactivated)
estimated to be approximately 108 particles / ml was added per well to cultures in
PBS containing 1.8 mM strontium chloride, 0.45 mM MgCl2 for 1 hr at 37°C.
Alternatively cultures were mock infected (treated with buffer only). KGM without
EGF was replaced onto these cultures and cells were harvested by trypsinisation on
days 1 and 3 after infection.
5.3.4 Transfection ofKC with plasmid DNA
KC were seeded at 4 x 10 4 per well of a 6 well plate (Costar) in KGM containing all
the additives as described above. KC were grown without EGF for 48 hrs before
transfection and when 50 -60 % confluent were transfected with a eukaryotic assay
vector pCHllO (Pharmacia LTD. Milton Keynes, UK). This plasmid contains a
functional lac Z gene and its product, |3-gal, was assayed to monitor transfection
efficiency. Transfections were performed using Lipofectamine™ (Gibco BRL)
reagent in KGM containing additives described above (without gentamicin and
amphotericin-B) according to the manufacturers' instructions. Briefly, 2 jig pCHl 10
was mixed with 100 ptl KGM (without antibiotics) and incubated for 45 min with 1,
2, 4 or 8 |il Lipofectamine™ diluted in 100|il KGM. This final mixture was placed
on KC for 5 hrs before replacing with KGM containing additives without EGF. In
addition, an epithelial bladder carcinoma cell line (UMUC-3) was transfected as a
positive control since this immortalised cell line can be easily be transfected in vitro.
(3-gal gene activity was assayed 12 hrs later by fixing cultures in 1% glutaraldehyde
for 5 min at 4°C followed by 3 washes in PBS. Staining solution (5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide, 2 mM magnesium chloride and 1 mg /
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ml X-gal (Gibco stock at 20 mg / ml in dimethyl formamide in PBS) was added to
cultures and incubated overnight at 37°C in a humid chamber. Stained cultures
were then visualised by inverted light microscopy, transfected cells with p-gal
activity appeared blue and were counted.
Since transfection of DNA using Lipofectamine™ has been shown to induce IL-1 a
release, due to cell death (Komine et al 1994), transfections were also performed
using polybrene (hexadimethrine bromide) (Sigma). Polybrene induces less cell
death and has been a preferred method for transfection of KC in some studies (Jiang
et al 1991). Two (ig pCHl 10 DNA was mixed with 10 or 40 gig / ml polybrene, and
added to cells in 6 well dishes (KC or UMUC-3). After 6 hrs the transfection mix
was removed and 10% glycerol added for 3 min at room temperature. Cells were
then washed 3 X in PBS and fresh KGM containing additives without EGF was
added.
5.3.5 Outgrowth ofKCfrom cutaneous warts
Wart specimens were washed 5 X in PBS and cut into smaller pieces before
digestion with trypsin and collagenase as described in section 5.3.1. The suspension
was centrifuged at 1800 rpm for 10 min and the pellet resuspended in KGM
containing all additives and in some cases with the addition of 600IU / ml penicillin,
600 gig / ml streptomycin, 250 gig / ml gentamicin and 2.5 (ig / ml fungizone. The
suspension was cultured in fibronectin coated flasks. Cultures were observed for
growth of colonies for up to 20 days after initiation.
5.3.6 Semi-quantitative RT-PCR mRNA analysis
At various time points after transfection/infection with HPV DNA, cells were
harvested for mRNA analysis by lysis in 4M guanidinium isothiocyanate and total
RNA extraction as described by Chomczynski et al (1987). Semi-quantitative RT-
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PCR analysis of IL-la, IL-10, IL-12p40 and IL-8 mRNA was performed using [32P]-
labelled primers as described in chapter 4.
5.4 Results
5.4.1 Characterisation ofKC
The initiation of cultures from infant foreskins had a 68% success rate. Thirteen
percent of cultures became infected before any colonies were established and KC
cultures could not be established from 13% of tissue specimens. Six percent of
tissue specimens gave rise to cultures which became overtaken with fibroblasts. KC
cultures had a doubling time of 24 hrs at optimal growth rate and senesced between
passage 3-5. Figure 5.1 shows the initiation of a KC colony after 2 weeks in culture
and the morphology of a confluent monolayer of KC. Initially, some KC cultures
were phenotyped to characterise the cell population and are shown in Figure 5.2. KC
expressed keratin but had lower vimentin expression, a characteristic of epithelial
cells. Contaminating fibroblasts typically expressed vimentin but not keratin. KC
were MHC class I positive and MHC class II and ICAM-1 negative, as expected for
unstimulated KC in vitro. The anti-CD3 antibody did not stain the KC and neither
did the secondary antibodies.
Figure 5.1 Growth of primary human KC in vitro
Photographs of KC culture under phase contrast microscopy, magnification = 100 X. A = initiation of
a KC colony after 2 weeks in culture. B = confluent KC after 3 weeks in culture at passage number 1
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Photomicrographs (magnification = 100 X) of KC cultured on Thermanox™ plastic coverslips and
stained using immunoperoxidase for keratin (A), vimentin (B), MHC class I (C), MHC class II (D),
ICAM-1 (E) and isotype matched control (F). KC stained widi secondary antibodies were negative.
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5.4.2 Cytokine mRNA expression in KC infected with HPV
Using the methods described in chapter 4, the optimum cycle number for expression
of cytokines in KC were determined and results for IL-la and G3PDH are shown
below.
Figure 5.3 Optimum cycle number determination
Cycle number
16 18 20 22 24 26
G3PDH
20 22 24 26 30 32
IL-1 a
Autoradiographs of amplicons separated by SDS-PAGE, from PCR amplifications at increasing cycle
number are shown for IL-la and G3PDH primers. Optimum cycle numbers were determined as 20
cycles for die G3PDH, 30 for IL-lra, IL-12p40 and IL-8, 25 for IL-la, 40 for IL-10.
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Cytokine expression in KC cultures infected with HPV isolated from clinical
samples are shown at 1 and 3 days after infection in Figure 5.4. Expression of
G3PDH mRNA remained constant throughout the experiment whereas IL-loc and IL-
8 mRNAs were induced at day 1 after infection with HPV. IL-12p40 mRNA
remained at a constant low level throughout the experiment whereas IL-10 mRNA
could not be detected at any of the time points. When PCR products were quantified
and the cytokine : G3PDH ratios were compared, IL-la was induced 17 fold on day
1 after infection compared with day 0 samples. IL-8 mRNA was not present in day 0
samples but was induced maximally on day 1, which was 11 fold the amount seen on
day 3.
5.4.3 Absence of IL-10 mRNA in human KC in vitro
Stimulated KC were anticipated to be a positive control for expression of IL-10.
r
However when KC were treated with PMA (50 ng / ml), UVB (100 J / m2, Phillips
TL12, broad band UVB source), NiS04(200 mg / ml) or SDS (0.1%), no IL-10
transcripts could be detected. This led to a more thorough investigation of the time
course and dose dependent induction of IL-10 mRNA expression in KC. Modulation
of cytokine expression in KC by UVB irradiation is of particular interest because of
the conversion of cutaneous papillomas to squamous cell carcinomas exposed to
sunlight in immunosuppressed patients. The results from 4 experiments are shown in
Table 5.1 A-D. KC were either exposed to 100 J / m2 UVB radiation and harvested
at 1,3, 6, 10 and 24 hrs later, or were subjected to increasing doses of UVB from 50-
300 J / m2 and harvested 24 hrs later. Table 5.1 A indicates that IL-10 mRNA could
not be detected by Southern blot at any time up to 24 hrs after UVB exposure.
However, IL-12p40 mRNA which was not expressed in unstimulated KC was
induced maximally 3 hrs after UVB, thus indicating that the cells were responsive to
UV treatment.
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Figure 5.4 Cytokine mRNA expression in HPV infected KC







Autoradiographs of 32 P labelled PCR products of mRNA expression detected by RT-PCR on day
(mock infected) days 1 and 3 after infection. Positive controls (+) were as per chapter 4.
Table 5.1 A-D Lack of IL-10 in human KC
A KC UVB irradiated
hrs a
with 100 J / m2
fter UV dose
0 1 3 6 10 24 POS detection
G3PDH + + + + + + + EtBr
IL-10 - - - - - - + Southern
IL-12 p40 - + ++ - - - + Southern
TNF-a + +/- +/- + +/- +/- + EtBr
B KC 24 hrs after I
UV c
JVB irradiation
ose (J / m 2)
0 50 75 100 200 300 POS detection
G3PDH + + + + + + + EtBr
IL-10 - - - - +/- + + Southern
IL-8 + + + ++ + + + EtBr
IL-8 (pg / ml) 234 991 1688 1890 1483 935 + ELISA
C KC 24 hrs after doses of UVB (J / m 2) or IL-la treatment in low or high
calcium. low calcium 0.06 mM high calcium 2 mM
0 50 75 100 IL-l 0 50 75 100 IL-l detection
G3PDH + + + + + + + + + + EtBr
IL-10 - Southern
IL-8 - - - + - + + + ++ +/- EtBr
D KC 24 hrs after treatment with
NiSQ4 (200ttg / ml) or SDS (0.1%)
0 NiS04 SDS POS detection
G3PDH + + + + EtBr
IL-10 - +/- +/- + silver stain
IL-10 - - - + Southern
IL-8 - +/- + + Southern
Non quantitative cytokine mRNA analysis by RT-PCR detected by ethidium bromide staining of
agarose gels, Southern blotting and hybridisation with digoxigenin labelled specific riboprobes or
silver staining of SDS-PAGE gels. - = not detected, +/- = weak band, + = clearly visible band, ++ =
intense band, POS = positive control. No IL-10 protein was detected by ELISA (R and D systems) in
any of the supernatants tested. IL-8 protein was detected by ELISA (kindly performed in the
laboratory of Dr. J. Ross, University of Edinburgh, Department of Surgery)
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TNF-a mRNA expression was present in KC before treatment (Table 5.1 A) but
following UVB radiation its expression decreased during 1-3 hrs, and subsequently
increased to a maximum at 6 hrs. Table 5.1 B shows IL-8 mRNA and protein
expression from KC were both were induced maximally at 100 J / m2. However, IL-
10 mRNA was only induced after exposure to high doses of UVB (200 and 300 J /
m2), but IL-10 protein could not be detected in the supernatants from these cells. No
IL-10 protein or mRNA could be detected after exposure to 50 -100 J / m2 UVB
when the calcium concentration in the medium was increased to 2 mM (Table 5.1 C),
although IL-8 mRNA was induced to a greater extent after UVB exposure in high
calcium medium. IL-10 mRNA was induced after treatment of KC with either
irritant or sensitiser chemicals (Table 5.1 D), although it was on the limit of detection
since a weak product band was detected by silverstain but was not detected by
Southern blot.
5.4.4 KC transfected with pCHllO
Results from preliminary studies using transfection with pCHllO showed a low
efficiency of transfection in primary human KC (Table 5.2).





UMUC-3 2 pg pCHl 10 + 2 pi Lipofectamine™ 10
KC 2 pg pCHllO +1 pi Lipofectamine™ 0
KC 2 pg pCHl 10 + 2 pi Lipofectamine™ 1
KC 2 pg pCHl 10 + 4 pi Lipofectamine™ 3
KC 2 pg pCHl 10 + 8 pi Lipofectamine™ 4
KC 8 pi Lipofectamine™ 0
KC no treatment 0
Many cells became unattached and exhibited a change in morphology in cultures
treated with 4 and 8 ql of Lipofectamine™. No transfectants were produced in
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experiments using 2 |ig pCHllO DNA and polybrene (10 or 40 p.1) with a 10%
glycerol shock.
5.4.5 KC outgrowth from cutaneous warts
No KC were successfully cultured from disaggregated cutaneous warts. One
problem was contamination of the tissue in culture, thus requiring higher levels of
antibiotic and antimycotic. These high antibiotic levels may have inhibitory effects
on KC growth. In addition, digestion of wart specimens with trypsin and collagenase
was inefficient at releasing cells from the tissue. The cells which had been released
from the wart were often large angular cells which were similar to the terminally
differentiated squames seen in normal skin preparations.
5.5 Discussion
5.5.1 Transfection ofKC
Primary human KC are typically resistant to DNA transfection (Fenjves, 1994), thus
transient expression studies are difficult. Transfection efficiencies of 20 -30 % in
KC have been described using liposome formulations of cationic lipopolyamines
(Staedel et al 1994). Preliminary transfections of pCHllO into primary KC using
Lipofectamine™ were of low efficiency. Thorough optimisation of DNA
transfection procedures in these primary cultures is necessary before HPV DNA
transfections for experimental studies. Important considerations include the
observation that transfections using Lipofectamine™ induces cell death and the
release of preformed IL-la from KC (Komine et al 1994). The release of IL-1
resulting from the transfection alone is an undesirable feature when investigating
cytokine expression in short term cultures as IL-la may in turn promote the
production of other cytokines. Retroviral vectors have been used for DNA delivery
to primary human KC with 100 % transduction rates after selection (Garlick et al
1991). However, the-proviral DNA is integrated into the cellular genome and thus is
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less representative of the early stages of a benign HPV infection where DNA remains
episomal. Alternatively, replication deficient adenovirus vectors have been used
(Setogucho etal 1994) and may provide a more efficient way of transfecting KC.
5.5.2 HPV infection ofKC
HPV infection of KC resulted in increased levels of expression of IL-la and IL-8,
but not IL-10 or IL-12p40 mRNA. The induction of IL-1 a mRNA correlated with in
vivo data from warts which had increased levels of IL-la mRNA compared with
normal skin (chapter 4) but this is a preliminary observation. Since the preparation
of HPV is likely to contain other contaminating proteins, possibly keratins, a CsCl
preparation of normal foot skin would make an appropriate control. Further
experiments to block the entry of virus, such as with antibodies (Zhou et al 1995;
Smith etal 1993) or by trypsinisation of the KC before infection (Muller et al 1995),
are needed to demonstrate unequivocally that the increased level of cytokine mRNA
expression is due to HPV infection.
5.5.3 Absence ofIL-10 production by human KC
IL-10 protein could not be demonstrated in supernatants of human primary KC,
either after UVB radiation or the addition of irritant and sensitiser chemicals. IL-10
mRNA was not detected by RT-PCR (40 cycles) at 0, 1, 3, 6, 20 and 24 hrs after 100
J / m2 UVB exposure. Only when KC were exposed to high doses (200 - 300 J / m2)
of UVB could IL-10 mRNA be detected. The viability of the cells at these high
doses were 69% and 34% respectively, whereas KC were >99% viable when lower
doses were used. The abundance of IL-10 PCR product was close to the limit of
detection since no amplicons could be detected by Southern blot. Despite the lack of
IL-10 protein in KC supernatants after UVB radiation, both IL-8 mRNA and protein
were detected. A 4.5 fold induction of IL-8 mRNA and an 8 fold induction of IL-8
protein was observed 24 hrs after 100 J / m2 UVB irradiation, indicating that the KC
were responsive to the UVB stimulus. IL-8 mRNA was also observed after
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increasing doses of UVB and in cultures containing high and low calcium. IL-12
p40 mRNA was also induced after 1-3 hrs post UVB radiation with 100 J / m2.
Since the weak induction of IL-10 mRNA was not accompanied by a similar increase
in detectable IL-10 protein it is possible that the protein was masked by a soluble
receptor. Alternatively, the levels of IL-10 protein could be below the sensitivity of
the ELISA.
In studies on normal murine skin, Enk et al (1992) found IL-10 mRNA and protein
after treatment with irritant chemicals or contact sensitisers. IL-10 has been
proposed to have a role in the initiation of contact sensitivity in mice (reviewed by
Enk, 1994). IL-10 is also induced after exposure of murine KC to UVB radiation,
and is involved in the systemic immunosuppression of DTH responses caused by
UVB exposure (Rivas et al 1992).
In agreement with this study, IL-10 mRNA was not found in human KC either 1-72
hrs after exposure to 15 - 200 J / m2 UVB radiation or after exposure to PMA, y-IFN,
TNF-a, IL-l-a or NiSCL (Teunissen et al 1995). Similarly Ried et al (1994) could
not detect IL-10 mRNA between 3-24 hrs after treatment of KC with either IL-1 (3,
IL-6, IL-8, TNF-a or exposure to 10 and 30 mJ / cm2 UVB. However, Grewe et al
(1995) have shown IL-10 production by human KC in vitro after exposure to UVA
and UVB. Using a more sensitive ion-exchange chromatography method, Grewe et
al (1995) detected maximal IL-10 mRNA at 18 hrs after exposure to 100 J / m2
UVB, while the levels of protein peaked at 24 hrs. In contrast to data presented here,
70 pg / ml IL-10 protein was found after UVB exposure which increased to 120 pg /
ml when the calcium in culture medium was increased to 2 mM.
Enk et al (1995) showed that IL-10 mRNA was both constitutively expressed by
some human KC lines in vitro and up-regulated 24 hrs after exposure to 200 J / m2
UVB. Although the same primer sequences were used as in this study, Enk et al
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(1995) used poly A mRNA, a highly purified source of starting material for cDNA
synthesis. IL-10 protein was detected (19-34 pg / ml), but the supernatants were
concentrated 10 X before assay by ELISA.
The absence of significant levels of IL-10 protein detected in this present study,
indicates either that IL-10 mRNA remains untranslated in KC, or levels of protein
remain below the sensitivity of the assay (1.5 pg / ml). Either interpretation suggests
differential regulation of IL-10 expression between human and murine KC. The data
presented here may reflect differences in cytokine repertoire between murine and
human KC, as has been shown for IL-3 (Kondo et al 1995).
5.6 Conclusion
These preliminary experiments suggest that 1L-Ia and IL-8 mRNA expression are
modulated by HPV in vitro, although this requires further confirmation. An
interesting observation from this in vitro study is that IL-10 protein secretion was not
found in human KC, and its mRNA was only detected after high doses of UVB
exposure. This finding has implications for the understanding the host response to
infections of epithelial surfaces, particularly in sites exposed to sunlight.
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Summary and Further Work
Proliferative T cell responses to purified HPV found in some individuals suggest that
systemic cell mediated immunity towards HPV occurs in vivo. However, clonal
populations of HPV-specific T cells could not be isolated from peripheral blood of
these subjects. Evidence for the modulation of local immunity was found using
immunohistochemical analysis of wart lesions. The density of epidermal LC was
significantly reduced in warts compared with normal skin. Increased vascular
expression of ICAM-1 and E-selectin was detected in cutaneous warts and may
partly account for the increased numbers of memory T cells in the dermis of warts
compared with normal skin. However, few intra-epidermal T cells were found in
cutaneous warts. ICAM-1 expression on KC could not be found in normal skin or
wart epidermis.
In a frozen section adhesion assay designed to model T cell trafficking in vivo, fewer
activated T cells bound to sections of warts and normal skin than to an inflammatory
skin disease such as psoriasis. This may suggest that although there are histological
changes associated with HPV infection in warts, there is not a significant increase in
adhesive ligands available to promote epidermal trafficking. Taken together these
findings suggested a defect in the trafficking of immune effector cells to the
epidermis in cutaneous HPV infection.
Preliminary non-quantitative RT-PCR analysis found a reproducible increase in the
numbers of wart samples expressing IL-la mRNA and indicated changes in
numbers of warts and normal skin samples expressing IL-8, IL-12 and IL-10 mRNA.
There was no apparent difference in the numbers of samples expressing TGF-P,
TNF-a, GM-CSF or IL-ip between warts and normal skin. IL-4 and y-IFN were not
detected in either skin type. Semi-quantitative RT-PCR analysis showed a
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significant increase in IL-1 a mRNA expression in warts compared with normal skin,
and a decrease in IL-10 mRNA expression in warts compared with normal skin.
Woodworth et al (1995) found that IL-la promoted the growth of KC containing
HPV in vitro and its action was mediated by AR. Although this phenomenon could
be associated with cellular transformation it may also play a role in the self-limiting
hyperproliferation observed in benign cutaneous warts. Semi-quantitative RT-PCR
analysis showed that warts which expressed IL-1 a mRNA also expressed AR and
there was a significant correlation between the expression of these cytokines.
Although a causal relation ship between IL-la and AR was not demonstrated in this
study, the results indicate that the IL-1 a/AR growth promoting autocrine loop may
contribute to the epidermal hyperproliferation observed in cutaneous warts
(represented diagrammatically in Figure 6.1).
The presence of additional co-factors such as UVB exposure, immunosuppression,
and genetic predisposition in conjunction with the type of HPV may promote the
cellular transformation and development of squamous cell carcinoma. Without the
presence of these "risk factors" the majority of HPV infections in the
immunocompetent host will regress. Some features of plane wart and genital wart
regression are known, but it is not clear what initiates this regression. The study of
IL-la and AR protein expression in cutaneous warts is required to clarify the
potential role of these cytokines in wart growth and persistence
The increase in IL-la mRNA expression in cutaneous warts was reproduced in
initial experiments in which KC monolayers were infected with HPV. Further study
is needed to determine if this effect is due to HPV infection alone and not a
contaminant of the HPV preparation.
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It would also be interesting to determine whether AR is upregulated in HPV infected
cells in vitro. In addition other KC growth factors such as transforming growth
factor-a and EGF may also be up-regulated in HPV infection and may play a role in
promotion of HPV infected KC. Optimisation of KC transfection should provide
another method to dissect the effects of HPV on cytokine expression. Experiments
using organotypic raft cultures to mimic HPV infection would provide an ideal in
vitro system to investigate the effects of HPV on cytokine expression either by RT-
PCR, in situ hybridisation or immunohistochemistry.
Finally, the role of cytokines and KC growth factors, such as AR, in the progression
of benign HPV infections to carcinoma, could be determined by analysis of cytokine
mRNA expression in specimens of squamous cell carcinomas containing HPV. RT-
PCR analysis of cytokine expression in regressing cutaneous warts would also
provide valuable information regarding the role of cytokines and growth factors in
controlling the duration of the infection and regression.
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Thirty percent of cutaneous warts caused by human papillomavirus (HPV) infection regress
spontaneously within 6 months [4], Others may persist for years, prove recalcitrant to treatment and
may recur. Persistence of infection in an immunocompetent host suggests evasion of local cutaneous
immune surveillance. Cell mediated immunity is important in the regression of plane warts (24).
genital warts [8] and Shope rabbit papillomas [20]. Previous histological studies have examined
phenotypic changes in warts compared with normal skin. A reduced density of Langerhans' cells in
the epidermis of non-regressing cutaneous [6,13,28], and mucosal [12,25,28] warts was found.
Increased expression of intercellular adhesion molecule -1 (ICAM-1) and E-selectin on vascular
endothelial cells and an increased infiltrate of memory T cells were observed in the dermis underlying
cutaneous warts compared with normal skin. However, few T cells were detected in the lesional
epidermis [ 13]. These observations suggest a defect in cell trafficking to the site of the HPV infection
in the epidermis.
Altered cytokine expression in the skin may be responsible for the absence of immune effector
cells at the site of infection. In vitro epidermal keratinocytes (KC) are capable of synthesising many
cytokines, although there is very little secretion in normal skin. Epidermal Langerhans' cells, dermal
libroblasts, and infiltrating cells also secrete and respond to cytokines. Previous studies indicate that
infection with certain HPV types may modulate tumour necrosis factor-a (TNF-a) and transforming
growth factor-(3 (TGF-(3) expression in vivo [1,18] and in vitro [3,19,31]. Reduced secretion of
interleukin-1 (IL-1) a, [3 , IL-1 receptor antagonist (IL-Ira), IL-8, granulocyte macrophage-colony
stimulating factor (GM-CSF), TNF-a and TGF-(3 in HPV-16/18 immortalised KC cell lines has been
observed [31], Whether these changes are due to transformation or a direct consequence of HPV-16
infection is not clear. It is also uncertain whether these changes in cytokine expression occur in
infections with cutaneous HPV types. It is possible that HPV infection may lead to alterations in the
cutaneous cytokine network, thus preventing the influx of T cells and other immune effector cells to
the local lesion.
In theprescnt study we have examined the expression of the mRNAs of IL-1 a, IL-1 [3,
intracellular IL-1 ra (icIL-1 ra), IL-10, IL-12 (p40), IL-8, GM-CSF, TNF-a, TGF-(3, IL-4 and y-
intcrferon (y-IFN) by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)
analysis in cutaneous warts. IL-1 a mRNA was significantly up-regulated and IL-10 mRNA
3
on nylon membrane (Zetaprobe GT Biorad). To confirm the identity of the PGR products. Southern
blots were hybridised with specific digoxigenin-labellcd riboprobes. The cDNA tor each cytokine was
cloned into Bluescript II plasmid and riboprobes were generated using the digoxigenin RNA labelling
kit (Boehringer Mannheim, Germany). Plasmids containing cDNAs for the cytokines investigated
were provided by : Dr. A. Singh, Genentech, CA. USA (TGF-J3 and TNF-oc), Dr. P. Lomedico.
Hoffman-La Roche, NJ, USA.(IL-la), Dr. S. Wolf, Genetics Institute. MA, USA (IL-12 p40). Dr. G.
Wong, Genetics Institute. MA, USA (GM-CSF ), Dr. J. Oppenheim. National Cancer Institute. MD.
USA (IL-8) and IL-10 cDNA was cloned and sequenced from a PCR product using a TA cloning kit
(Invitrogen, San Diego, CA, USA). Digoxigenin was detected with anti-digoxigenin alkaline
phosphatase antibody (Boehringer) and developed with nitrublae teirazolium and 5-bromo-4-chloro-3-
indolylphosphate. The positive control for cytokine expression was RNA extracted from peripheral
blood mononuclear cells (PBMC) stimulated with phytohaemagglutinin (1 pg/ml) and phorbol
myristatc acetate (PMA) (50 ng/ml) for 24 hrs, except in the case of IL-10, IL-12 p40 and AR where 4
hr stimulated PBMC, a bladder carcinoma cell line (SD), and PMA treated MCF-7 cells were used
respectively. Negative controls consisted of RNA prepared without the reverse transcriptase (RT)
enzyme in the cDNA synthesis reaction, and PCR reactions with water instead of RT reaction.
Semi-quantitative PCR
Primers were 32P end-labelled with y [-^2P] -dATP (7000 Ci / mrnol. ICN Biochemicals, Thame, UK)
using polynucleotide kinase (New England Biolabs, Beverly, MA, USA). PCR using radiolabelled
primers was performed as above. Optimum cycle numbers were determined for each primer pair
which were in the linear part of the curve of product accumulation versus cycle number. The
housekeeping gene, G3PDH, was used to control for differences in abundance of cDNA in RT
reactions [26], Radioactive PCR products were separated by sodium dodecyl sulphate polyacrylamide
gel electrophoresis (SDS-PAGE) followed by exposure of the gels to Kodak X Omat AR
autoradiography film, as described previously [ 14], Autoradiographs were visualised on the Seescan
system image analyser (Seescan Pic, Cambridge, UK) and integrated OD units were obtained using gel
analysis software vl.O 1D (Seescan). Ratios of integrated OD units for each cytokine to G3PDH were
used to compare the relative abundance of cytokine mRNA between waits and normal skin and were
subject to statistical analysis. For each cytokine, all warts, normal skin samples and controls were
amplified within the same run, separated on gels and autoradiographed simultaneously. All PCR
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quantitative RT-PCR lor IL-la, IL-10, IL-8, IL-12 and iclL-lra mRNA are shown in Fig. 1. In the
normal skin samples IL-la mRNA was either absent or present at very low levels, whereas 33°Ic warts
expressed this cytokine at high levels, and others not at all. In the majority of warts expressing IL-la
mRNA, iclL-lra mRNA was also detected, and most normal skin samples expressed iclL-lra mRNA.
IL-12 p40 mRNA was found at varying levels in both warts and normal skin with no consistent
difference between these two. Confirming preliminary experiments, 1L-10 mRNA was shown to be
present at low levels in all normal skin samples, whereas in many warts this cytokine was not detected.
IL-8 mRNA was found in only one normal skin sample and 5 warts, although in 3 warts it was at
barely detectable levels.
Fig. 2 shows cytokine mRNA expression relative to G3PDFI expression in warts compared with
normal skin samples. Many warts have increased mRNA for IL-1 a, iclL-lra and IL-12 p40 compared
with normal skin. However, only IL-la expression is significantly greater in warts than normal skin
(p = 0.002). IL-10 mRNA is significantly greater in normal skin than cutaneous warts (p < 0.05).
Although HPV DNA typing was not included in this study, the location and clinical type of the warts
was known. Therefore to determine whether variations in cytokine mRNA expression were dependant
on wart location and morphology, IL-la expression in common hand warts was compared with that in
normal skin and plantar warts (Fig. 3). Common hand warts had significantly greater IL-la mRNA
(p = 0.019) expression than normal skin, while plantar warts had a significantly greater expression
than common warts (p = 0.003). This difference in cytokine mRNA expression between warts at
different sites was only observed for the expression of IL-la mRNA. Warts which were positive for
IL-la mRNA were also positive for icIL-ira mRNA. A positive correlation was found between the
expression of IL-1 a and icIL-lra mRNAs in plantar warts (Pearson correlation r = 0.846. p < 0.05:
data not shown). There was no significant correlation between the abundance of IL-la and icIL-lra
mRNA in cither normal skin or common warts. Warts were grouped into high, medium and negative
for IL-1 a expression. The expression of AR mRNA in cutaneous warts was determined and the
autoradiographs are shown in Fig. 4. Warts which were negative for IL-la were also negative for AR
mRNA expression. The expression of AR mRNA was positively correlated with IL-la mRNA
expression in warts (Pearson correlation r = 0.590, p < 0.05: data not shown). No such correlation was
observed in normal skin.
7
KC but is inhibitory to the growth of normal KC in vitro [31]. This induction ol proliferation is
mediated by autocrine AR expression. Although a causal relationship cannot be assumed from
mRNA expression in cutaneous warts, one speculation is that IL-la may induce the observed AR
nrRNA expression in cutaneous warts and thus promote the growth of HPV-infected KC. An increase
in EGF receptor mRNA expression in condyloma has also been observed [29]. In addition, HPV-16
E5 interacts with the EGF receptor when expressed on fibroblasts in vitro [21]. This interaction
renders the cells more sensitive to exogenous EGF, and thus increases their proliferative activity. This
phenomenon could explain the hyper-proliferative nature of epidermal KC in cutaneous warts.
If IL-la is not released from KC, it is possible that it could act in an intracellular autocrine way.
by signalling receptors from within the cell. Intracellular autocrine action has been described for
several cytokines including GM-CSF, IL-6, IL-3 and platelet derived growth factor in immortalised
cells [17],
Up-regulated IL-10 expression has been shown to contribute to the persistence of parasitic and
retroviral infections [23], In this study IL-10 mRNA is expressed in 9/11 normal skin samples at low
levels in the majority. Elowever, IL-10 mRNA expression was significantly lower in cutaneous warts
compared with normal skin. Thus, HPV persistence in cutaneous warts is not due to up-regulated IL-
10 mRNA expression.
Preliminary non-quantitative experiments found no qualitative differences between TNF-a,
TGF-(3, IL-ip or GM-CSF mRNA expression in warts and normal skin. IL-4 ory-IFN amplicons
could not be detected by agarose gel electrophoresis. Although expression of these cytokines has not
been investigated previously in cutaneous warts, TGF-p and TNF-a mRNAs are induced in
epidermodysplasia verruciformis (EV) lesions [18], A decrease in TGF-[3 mRNA expression in HPV
6/11 condylomata was observed compared with normal tissue [ 1 ], and no change in TGF-P mRNA
expression was seen in HPV 16/18 immortalised cell lines in vitro [3], The induction of TGF-fi
mRNA reported in EV lesions was more marked in samples showing signs of malignancy. This
difference may therefore be associated with progression to malignancy. TNF-a mRNA is expressed
in HPV-16 tumourigenic cell lines [19], In contrast Woodworth and Simpson [31] found a reduced
secretion of TNF-a in HPV 16/18 immortalised cell lines in vitro. Discrepancy in these in vitro
results may be associated with differences between tumourigenic cell lines and non-tumourigenic cell
lines.
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COla Ifi 5' CTACTTCTCCCTGACATTCT 3'5' TGGTCTATTCCGTTGTGTC 3' 269 [321
icIL-1 ra






AR 5' = TCCTCGGGAGCCGACTATGAC 3'
3' = GGACTTTTCCCCACACCG 3'
329 [10]
PCR was performed using the above primer pairs which spanned at least one intron to distinguish
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Induction of JK-10 Expression in Human
Keratinocytes
LETTER TO THB EDITOR
We read with intercut the report by Grewe d al (4J discusivng tho
induction of IL-10 following ultraviolet B (UV-B) and ultraviolet
Al irradiation ofhuman keraanocytes (KC) in primary culture. We
too have performed similar LTV-B experiments, and have also
treated human KC and A4ji epidermoid carcinoma cells with
sensitizing and irritant cnemicaia. We were unable, however, to
detect any IL-lO protein in the culture supernatant* by an anzyme-
linked immunosorbent assay (EL1SA) with a sensitivity of 1.5 pg/nil
before or after any of the above treatments. Furthermore, we could
not detect IL-10 mRNA except 24 h after UV-B doses of 200 and
300 J/m2. Generally, our results agree with those ofTeurussen rt al,
who were unable to detect incerleujtin 10 (IL-10) mRNA (35
thermal cycles) or IL-10 protein in KC after UV-B (15-200 J/m2),
or treatment with nickel sulfate, IL-ta//3, tumor necrosis factor-a,
intcrfaroD-y, lipopolyiaccharide, phorbol ester, or supernatant!
from phytoheiiugglutiju'u-stimuUted T cells (Teunisien MBM,
Koomen CW, de Waal Malefyt R, Bos JD: Human kemtinocyxes
are unable to produce IL-10. (abstract) J Invest Dermatol 102:632,
1994).
The experiments chat we performed utilized KC derived from
either foreskin or abdominal skin from five different donors. The
sensitivo reverse transcription polymerase chain reaction (5) was
employed using ethidium bromide to detect amplified producti
resolved on 1.5% agarose gels and silver staining with a commercial
kit (Bio-Rad laboratories Ltd), or 53P-labeled primers to visualize
products on 12.5% polyacrylaniidc gels. We also carried out
southern blotting of the agaroia gels and hybridized IL-10 ampli-
coni with a digoxiganin-labeled human IL-10 probe, wliich was
detected with an onti-digoxigemn antibody conjugated to alkaline
phosphatase. The primers were obtained from Cloncech and suc¬
cessfully detected abundant IL-10 mRNA in RNA derived from
lipopolysaccharido- or phorbol-eiter-stimuiated peripheral blood
monocytes.
The KC from four different donors were negative for IL-10
mRNA for up to 24 h following irradiation with 100 J/m3 of
broadband UV-B, (280-320 nm). IL-10 mRNA was detected 24 h
after UV-B irradiation with 200 and 300 J/ns2 only; however, we
had to extend the thermal cycling to 40 cycles to detect even t
weak bond. In Grewc'i study, 28 cycles wene typically used. In
contrast to the result* presented in Grcwe's study, 100 J/m1 and
timepoint* earlier than 24 h did not induce IL-10 mRNA. Densi¬
tometry of the IU-10 southern bloti probed with digosrigenin
showed a 24-fold increase in IL-10 mRNA with 300 J/m3, but no
detectable IL-10 protein was found in the culture supematants.
Although no IL-10 mRNA induction w*i observed, a 4.5-fold
induction of IL-8 mRNA and an 8-fold increase in IL-8 protein
(measured by ELISA) war noted 24 h after irradiation with 100
Vm* and • 30-fold induction of inRNA for the p40 subunit of
IL-12 was seen 3 h after 100 J/m2. Thui, tho celli were clearly
responsive to UV-B. Changing the calcium content of the medium
from 0.06 mM to 2 mM for 48 h prior to irradiation or stimulating
the KC with 10 ng/ml IL-lor, 200 U/mJ 1L-2, 0.01% sodium
dodecyi sulfate, or 200 u-g/ml nickel sulfate had no effect on the
induction of IL-10 mRNA. Furthermoro, treatment at a431 ceUa
with irritants [sodium dodecyi sulfate (0.0001-0.01%) or nonanoic
add (0.0001-0.01%)], sensitizers [nickel sulfate (10-200 /ig/ml) or
Diphenylcyproce (0.000003-0.003%)], or phorbol ctter (10 ng/ml)
were all Ineffective in inducing IL-10 mRNA or protein. Phorbo)
ester treatment, however, did induce tumor necrosis frctor-a
mRNA, and irritants induced IL-8 mRNA showing chat the cells
were capable of rcjpondinf so stimulation with cytokine gene
expression.
L'ur -. ervatiens and those ofTeuxuisen et al raise several points.
Hrst, if IT -1mRNA ii induced but no protein is detected in the
culture supemacant, is the JL-10 protein being sequestered, postibly
by a soluble receptor, or is this another cose that illustrates die
pitfalls of measuring only mRNA abundance? Second, the induc¬
tion of IL-10 mRNA [1] and protein [2] by sensitizers and IL-1 in
murine KC could not bo reproduced ill human KC. either in our
studies or in those of Teunijsen et al. This suggests that IL-10 may
be another example, like 1L-3 m which human and murine KC
express different cytokines [7]. The induction of IL-10 in murine
KC and epidermis by sensitizer* but not irritantj has been demon¬
strated bodi in virro [1,2] and in vivo [6]. It has bccu proposed that
this property may be a useftil means of distinguishing sensitizers
from irritants in vitro. Clearly, this test may be inappropriate if
human KC do not respond to sensitizers. Finally, i* die discrepancy
in result* betweaa different studies due to differencas in the primers
or ELISA kits used (Stratagene primer* md ELISA kit* from
Genzymc and Laboscrve in [4] and Clontech primers and ELISA
lac* from RAD systems in our study), or does it represent true
phenotypic difference* in the expression of IL-10 in human cells? In
support of the latter is a recent study [3), which showed that only
five out of nine KC cultures from human rubjects showed comti-
tutive IL-10 mRNA expression and that culture supernatant! had to
be concentrated 10-fold before low (<30 pg/rnl) levels of IL-10
protein were detected, in four inadiatcd cultures. These questions
require resolution before epidermal IL-10 expression can be effec¬
tively integrated into the skin cytokine network In human subjects.
Melany Jackson
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PANCREATIC BETA CELL-SPECIFIC HUMORAL AUTOIMMUNITY
TRIGGERED BY A UNIQUE RETROVIRAL PEPTIDE J -W Yoon. H -
C. Liang, and H.-S. Jun. Fac. of Med., Univ of Calgary. Calgary. Alberta.
Canada
LDDM results from destruction of pancreatic beta cells by beta cell-specific
autoimmune processes: however, what triggers this beta cell-specific
autoimmunity is unknown. We recently found that retrovirus particies are
present in only beta cells from 4 deceased, recent-onset IDDM patients, but
not in any cells of 10 non-diabetic control subjects.This investigation was
initiated to determine if retroviral proteins may trigger beta cell-specific
autoimmunity in humans. RNA was exuacted from the islets of these 14
individuals and a cDNA library was constructed for each. The conserved
retroviral pol gene region from the cDNA libraries was amplified with mixed
oligonucleotide primer which is the highly conserved sequence of the
retroviral reverse transcriptase N-terrrunal coding region.The amplified
fragments were cloned into the pCR™ II vector and sequenced. The
sequences were compared to known retroviral sequences on file at the NTH
GenBank. Through this analysis, we identified a 48 nucleotide region of the
pol gene (which encodes a 16 amino acid peptide) in only the islets of the 4
deceased IDDM patients, but not in the islets of the 10 control subjects, nor
in any other tissues of either group. We synthesized this IDDM-specific 16
amino acid peptide and found that sera from nearly 70% of 260 new onsei
IDDM patients reacted with it (titer range: 1:10-1:1280). while less than 1%
of sera from 515 non-diabetic control subjects reacted with the peptide (titers
less than 1:10). On the basis of the above observations, we conclude that
this IDDM-specific retroviral peptide may trigger beta cell-specific
autoimmunity, at least at the humoral level.
2178
IDENTIFICATION OF T-CELL EPITOPES IN VACCINEES WITH
HBsAg. M.C. Honorati*. P. Dolzani*. E. Manani*. A. Piacentini*'. L
Cattini* and A. Facchini*"L "Lab. Immunol. Genet.. 1st. Codivilla Putti.
IOR, Bologna; §Ist. Clin. Med. Gastroenterol. Univ. Bologna, Italy.
In order to identify the immunodominant region of HBsAg involved in
the recognition by CD4+ cell, we analyzed the in vitro response of T
lymphocytes against whole HBsAg or partial peptidic sequences of this
antigen. T lymphocyte clones (TLC) were obtained by limiting dilution
assay from PBMC of 10 healthy volunteers immunized with recombinant
HBsAg. TLC were CD4 + CD25 + by cytofluorimetric analysis.
Recombinant HBsAg or 10-20 mer synthetic peptides in linear format
representing HBsAg residues were used for antigen stimulation in vitro
which was evaluated by 3H-thymidine incorporation. The 21-30 sequence
was the HBsAg region able to stimulate in vitro TLC from all subjects
examined. On the basis of the panel of cytokine produced, antigen
specific TLC clones resulted to belong to Th2 subset. We conclude that
the sequence 21-30 represents the major immunodominant epitope of
HBsAg in vaccined subjects.
This work was supported by grants from P.F. Ministero della SanitA
"Protezione dall'infezione da virus dell'epatite B in operaton ospedalien:
risposta immunitaria cellulare ed anticorpale e valutazione della memona
immunologica" and IOR Ricerca Corrente.
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Molecular analysis of cellular immune response in cervical cancer associated to
human papillomavirus 16 J M. Alcocer-Gonzalez, R, Tamez, and V Madnd-
Manna. School of Biological Sciences. University Autonomous of Nuevo Leon
and Molecular Virology Division. Instituto Nacional de Salud Publica
Cuemavaca. Morelos. Mexico
Cervical cancer is a disease with very high frequency, around 500 000 women
are affected every year worldwide, and in the developing countnes represent
30% of all malignant tumors. Epidemiologic studies suggest that this cancer is
related to chemical compounds, smoking, and sexual habits In the ongen and
development of th;s cancer are involved. 1) mutations in some oncogenes (c-
myc rasi 2) tumor supressor genes (p53 Rb). 3) association to human
papillomavirus (HPV16 18. 33), and 4) the immunologic status of the host
Recently, .t has been demonstrated that local cellular immune response play an
important role in the development of cervical cancer The aim of this study is to
analyze the local gene expression of cytokines and surface molecules that
participate in activation of T-cell in biopsies of cervical cancer
The presence of HPV in biopsies of cervical cancer was done by DNA
amplification by PCR. and the HPV typification by restnction analysis of the
PCR product. So far we have analyzed 50 biopsies. 35 were positives to
HPV16. indicating that HPV16 is the most prevalent. In this samples we studied
the mRNA expression of CD3 CD4. and CD8. the cytokine expression
produced by T-lymphocytes. Th1 (IL-2. INF-gamma): Th2 (IL-4 IL-5 and IL-10).
as well as inflammatory cytokines (IL-6 ana TNF-alpha) by RT-PCR These
tumors show differential expression of mRNA of CD4 and CD8; while 40%
express CD4 all of them express CD8 More of 80% did not express IL-2. IL-6
and TNf-aipha: and all express IL-4 INF-gamma and TGF-beta
Our results indicate a differential expression of cytokines from Th1 and Th2.
warn a predominant expression of Th2 cytokines, as well as there is not
expression of inflammatory cytokines.
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THE FACTORS AFFECTING ANTIBODY DEPENDENT ENHANCEMENT IN
DENGUE VIRAL INFECTION Li-Jung Cluen', Mo-Jane Wu'. Mav C Chu'. Denius W
Trent*, Chun Chin1,' Institute of Preventive Medicine, National Defense Medical Center.1
Division of Vector-Borne Infectious Diseases, Center for Disease Prevenuon and Control
Incidences of dengue fever (DF) and dengue hemorrhagic fever / dengue shock syndrome
(DHF'DSS) have increased worldwide The causes of DHF/DSS are subjects of research
interest There are two major hypotheses have been postulated (1) it is due to the virulence
difference m different virus strain or 12) it is due to pre-existing antibody in the host, i e the
antibody dependent enhancement (ADE) The ADE theory is based on observations that
most reticuloendothelial cells express varying degiee of Fc-recepiors (FcRs) for
immunoglobulins, hence, circulating antibodies combine with infectious viruses and emer
the cell via ine attachment of the antibodies to the FcRs. How even different population
infected with the same serotypes do not always develop equally severe disease, therefore,
viral and'or host factors may also play a role m disease pathogenesis We conduct this studv
by. (1) collecting peripheral blood leukocytes (PBL) from dengue immune and non-immune
donors 10 infect with dengue viruses in anabody dependent assay and i2» using their sera as
andbodv source to proceed ADE experiments in cell lines Experimental results
demonstrated that (1) ADE data on human PBL showed that host variation aLo played u
decision role. (2) the BHK-21 had FcR-I, FcR-Il and FcR-111 and could demonstrate ADE
phenomena. (3) the enhancing oter of Ab and enliancing folds of viral yields vaned with
virus strain In general 16681 (DEN-2 Thailand DHF strain) could produce higher peak viral
yields at lower Ab concentration than PL046 (DEN-2 Taiwan DF strain), paralleled with the
seventy of clinical symptom, and (4) the differences of E region deduced amino acid
sequence between PL046 and 16o81 might cause the changes of envelope pTOtein
secondary structure which will influence the entry of virus and the binding of virus and Ab
It is interesting to figure out whether the ongmal susceptibility of PBL to dengue vims or the
enhancing ability or the viral virulence is mote important m DHF'DSS pathogenesis
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RESPIRATORY SYNCYTIAL VIRUS-INDUCED
INTERFERON-a INHIBITS CELL IMMUNITY IN VITRO.
F.M. Preston. P L. Beier and J.H. Pope. Sir Albert Sakzewski
Virus Research Centre, Herston Rd, Herston, Qld, Australia
4029.
Respiratory syncytial virus (RSV) has been found to suppress T-
cell mitogenesis and the proliferative response to RSV. We have
previously found that this inhibition was mediated by an
extracellular RSV-induced factor.The factor has now been
clearly identified as interferon (IFN)-a. The RSV-induced IFN-c*
bound strongly to the cells and inhibited the anti-RSV response
only when added within the first few days of stimulation. The
proliferation of primary antigen-specific T-cell lines was not
affected by either RSV-induced or purified EFN-a. However, no
inhibition of IL-2 production nor cell surface expression of
various activation markers was observed. Previous studies have
shown that RSV induces an IL-1-inhibitor but we were unable
to detect this activity. Inhibition by RSV-induced IFN-<* was
unrelated to the levels of EL-1, IL-2, IL-6, or U^N-y induced by
RSV in vitro, nor to the presence of TNF-a, prostaglandin or
IL-10. Although RSV has been considered a poor inducer of
INF in vitro and in vivo, the results of this study clearly suggest
a re-examination of the possible role of IFN-a in the
pathogenesis of RSV infection and disease.
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CYTOKINE mRNAS IN CUTANEOUS WARTS.
M.Jackson. E.C. Benton. M.Norval,
University of Edinburgh, Edinburgh. Scotland. United Kingdom.
There arc over 70 types of human papillomavirus (HPV). of which HPV •
1 causes plantar warts and HPV-2 common mosaic warts on cutaneous
sites. Cell mediated immunity (particularly at a local level) plays a major
role in determining the duration and regression of HPV infections.
Previous studies in our laboratory provided evidence thai there is an
infiltrate of CD3+ and CD45RO+ T cells in the dermis of cutaneous warts,
but this infiltrate is not found in the epidermis . A defect in the normal
epidermal cytokine network within cutaneous warts could have a role in
inhibiting the trafficking of T cells into the site of the viral infection. The
following study aims to investigate the expression of cytokines in HPV
lesions using the RT-PCR technique to detect mRNA transcripts in
biopsies of warts, and to compare this expression with cytokine mRNA in
normal skin biopsies. Constitutive expression of TNFu mRNA was
detected in 83% of normal skin biopsies, and was also present in 69%; of
the warts . ICAM-1 mRNA was found in 83% of normal skin and 50% ot
wart samples. IL-lu and 6 mRNAs were not detected in normal skin, but
both were upregulated in 62% of the wart lesions. No IL-8.1L-10.
GMCSF. IFN y or IL-4 mRNAs have been found in any samples tested.
The IL-1 which is expressed in many of the wans could potentially initiate
an inflammatory response, but the up-regulation of IL-1 has not led to the
induction of IL-8. If IL-8 is not present, perhaps this may account lor the
lack of T cells in the epidermis of cutaneous warts and contribute to the
frequent persistence of these lesions.
CYTOKINE PRODUCTION BY HUMAN KERATINOCYTES.
Hunter N.R'. Jackson M2, Wadhna M3, Carter-McCann M.C1.
'Scottish National Blood Transfusion Service, National Science Laboratory,
2 Forrest Road, Edinburgh, department of Medical Microbiology,
University of Edinburgh Medical School, Teviot Place, Edinburgh,
"National Institute of Biological Standards and Control, South Mimms.
Biological dressings comprising a living layer of keratinocytes supported
by a matrix of fibrin sealant has been proposed for the treatment of chronic
leg ulcers. However, this technique is both labour intensive and expensive
in both production and cryogenic storage of grafts.
An alternative therapy would be to use karatinocyte supernatant which is
rich in cell derived growth factors and cytokines to induce native wound
healing in such patients.
Here, we have investigated cytokine production in keratinocytes at
different stages of differentiation.
Using RT-PCR technology to detect cytokine mRNA for IL-1 and B and
TGF and B, we examined three different keratinocyte lines over a period of
one week. Differentiation was induced by the addition of CaT
TABLE 1:
Cell Line K290 CYTOKINE PCR PRODUCT DETECTED
Conditions IL-1 IL-1B TGF TGFB
undifferentiated 24 hrs + + + +
post differentiated 24 hrs + + + +
96hrs + + + +
144hrs + + + +
Our results show that the mRNA message is present in all samples
irrespective of their differentiation status. Similar results were observed in
the three different cell lines examined.
To conclude, our data implies that keratinocytes produce supernatants
containing growth enhancing cytokines which if combined with a fibrin
sealant matrix could be used in the treatment of chronic leg ulcers.
Additionally, these data could be used as a template for formulating a
synthetic mixture of cytokines.
Investigative report
Eur J Dermatol 1 994; 4: 399-404
Local immune responses in cutaneous warts:
an immunocytochemical study
of Langerhans' cells,
T cells and adhesion molecules
MELANY JACKSON, E. CLAIRE BENTON, JOHN AA. HUNTER, MARY NORVAL
Cutaneous warts, caused by infection with human papillomavirus (HPV) frequently persist
for months or years; it is nof clear what aspects of the immune system are most imporfant in
their control and resolution. The present study concentrated on an immunocytochemical ana¬
lysis of Langerhans' cells and T cells in cutaneous warts together with an assessment of
adhesion molecule expression (ICAM-1 and ELAM-1). Comparisons were made throughout
with skin from normal subjects and from patients with psoriasis. There was an increase in
numbers of CD3+ (pan T), CD45RO+ (memory T) cells in the dermis of warts compared with
normal skin. In addition ICAM-1 and ELAM-1 expression were increased in the dermis of
warts compared with normal skin which may be responsible for the influx of T cells into this
site. However, a large reduction of CD3+ CD45RO+ T cells was seen in the epidermis of
warts compared with normal skin, and epidermal ICAM-1 was not observed in warts. In
75% of the warts studied epidermal Langerhans' cell numbers were reduced in comparison
with normal or psoriatic skin. Thus, a decrease in Langerhans' cells and a lack of adhesion
molecule expression in the epidermis of warts may lead to a reduced influx of T cells into
the lesion itself, although T cells are evidently present in the dermis underlying the infected
site. It is possible that these local effects are induced by factors produced from keratinocytes
as a result of HPV infection.
The role of acquired immunity in the control and regres¬sion of cutaneous warts remains unclear. Clinicalobservations suggest that cell mediated immunity (CMI)
is more important than the humoral response. Thus, patients
with depressed CMI caused by tumours, drugs or HIV infec¬
tions show an increased prevalence of human papillomavirus
(HPV) infection [1, 2], whereas patients with defective antibo¬
dy production do not generally develop extensive or persistent
HPV infections. Experimentally it has proved difficult to mea¬
sure the cell mediated immune response towards HPV: for
example, individuals with warts showed little response to puri¬
fied HPV 1 or 2 viral antigens in in vitro lymphoproliferation
assays, and no correlation between lymphocyte proliferative
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response and the clinical course of the wart has been
found [3],
Although in vitro evidence for a systemic cellular immune res¬
ponse is poor, there is however, histological evidence to sup¬
port a local role for cellular immunity in warts. In non-regres¬
sing warts a decrease in the density of epidermal Langerhans'cells (LC) has been reported in some cutaneous [3-5] and
mucosal [5-7] HPV lesions and was more marked in the
lesions of immunosuppressed organ allograft recipients [5],
This decrease of LC could contribute to the non-responsiveness
of these patients to HPV as LC are the major antigen presen¬
ting cell of the skin. Moreover, Chardonnet et al. found an
increase of LC in the epidermis of a regressing wart together
with an intense mononuclear infiltrate into the dermis [4], In
regressing plane warts, an infiltrate of T and mononuclearcells was found adjacent to damaged keratinocytes [8].
However, T cell infiltration of dermis has also been observed
in non-regressing cutaneous warts [4, 9] and mucosal
lesions [9, 10] and might be due to changes in adhesionmolecule expression within the HPV lesion, which could alter
the trafficking of immunologically important cells to the wart.
Inter-cellular adhesion molecule 1 (ICAM-1) is constitiutively
expressed on vascular endothelial cells and is upregulated onthese cells and induced on epidermal keratinocytes in psoria¬
sis and other inflammatory reactions of the skin [1 1-14], The
expression of ICAM-1 on vascular endothelial cells promotes
strong attachment of LFA-1+ T cells and their subsequent
egression into the tissues. ICAM-1 has also been suggested as
a mechanism of T cell binding to keratinocytes in vitro and is
a likely candidate for epidermotropism of T cells in vivo.
Endothelial leukocyte adhesion molecule-1 (ELAM-1, E-Selec-
tin) not normally expressed on human skin is induced on the
surface of activated endothelial cells [15] and has been impli¬cated in the binding of polymorphonuclear cells (PMN) in
vitro [16]. It has now been demonstrated that a subset of
memory cells bind to ELAM-1 in vitro [17], These cells are
characterised by high expression of CD58 (LFA-3) and
CD45RO together with the expression of cutaneous lymphocy¬te associated antigen (CLA). ELAM-1 has been implicated inthe homing of these T cells into the skin [1 7, 1 8],
To clarify further the immune response in cutaneous warts,
expression of ELAM-1 and ICAM-1 has been examined in
HPV-induced lesions. In addition, infiltration of T cells (CD3)and the memory T cell phenotype (CD45RO) in the dermis
and epidermis has been studied. Finally, the density of LC inthe epidermis of these lesions has been measured. A compari¬
son was made with normal skin and lesional skin from chro¬
nic plaque psoriasis.
Methods
Viral warts were obtained from 8 patients aged 17-55 years.Five were papuliferous facial warts which had been presentfor less than 1 year (numbers 1-5). The remaining three were
a plantar wart (number 6) and two hand warts (numbers 7 +
8) all of which had persisted for at least two years. None ofthe warts had been treated prior to their removal by curetta¬
ge. All specimens were bisected, half being formalin-fixed for
routine histological examination, the remainder being snapfrozen in liauia nitrogen and stored at - 70° C until proces¬
sing. Control specimens consisted of 6 mm punch biopsiesfrom normal forearm skin of six volunteers (age 20-57 years)and from involved skin of four psoriatic patients (age 21-46 years). Five pm cryostat sections were cut and air dried
overnight before fixing in acetone for 20 min at room tempe¬
rature. Slides were air dried and stored at - 20° C until used.
Indirect immunoperoxidase staining was performed using theantibodies listed in Table I.
Sections were immersed in tris-buffered saline (TBS) pH 7.6,and endogenous peroxidase blocked with 0.6% peroxide inethanol for 5 min, followed by 20% rabbit serum in TBS for
20 min. Sections were washed three times in TBS after each
step. Primary antibodies, diluted as shown in Table I, in 10%
human serum in TBS, were added to the slides and they wereincubated in a humid chamber at 4° C overnight. The human
serum used throughout was from the same pooled batchwhich had been heat inactivated. Ten % human serum in TBS
was used as a control and additional controls contained irre¬






anti-CD3 Dako M 835 1/20
anti-CDl a Dako M 721 1/20
anti-CD45R0 Dako M 742 1/200
anti-ICAM-1 British Biotech BBA 3 1/200
anti-ELAM-1 British Biotech BBA 1 1/100
used in Table I. The slides were washed in TBS and peroxide
se conjugate (Dako PI 61), diluted 1/100 in 10/6 huma
serum in TBS, was layered on top of the slides which wer
incubated for 30 min at room temperature. The developingsubstrate was one lOmg diaminobenzidine tetrahydrochloride tablet (Sigma D-5905) dissolved in 15 ml TBS containin;
12 pi 30% hydrogen peroxide solution filtered through <
0.2 urn filter. Slides were lightly counterstained with haema
toxylin to enable visualisation of the dermis and epidermibefore dehydrating the slides through 30%, 70% and 1003
ethanol and finally immersing in xylene and mounting in DPXQuantification of the stained areas was carried out using csemi-automated method on an image analyser (Seescan pic -Salandra system). Areas of dermis and epidermis were tracec
on the video screen and numbers of positively stained cell:and area of positive staining was calculated per mm2 dermis
or epidermis, based on at least three fields of view at x 1C
magnification (mean of three separate measurements) depen¬ding on the size of the section. Expression of adhesion mole¬
cules was calculated as area stained per area measured, a;
positively staining cell numbers were difficult to determine.
CD3+ and CD45RO+ T cells and CDla+ LC were expressed asnumber of cells stained per area measured. Standard devia¬
tion from the means was calculated in all cases and statistical
analysis was performed using the Mann-Whitney U test. Non¬specific staining was not observed in any of the controls
which were incubated with diluent instead of primary antibo¬
dy or with irrelevant antibodies.
Results
On histopathology, the morphological features of the wart
specimens were confirmed. None snowed evidence of specific
inflammatory changes or resolution.
Adhesion molecule expression
The expression of ICAM-1 and ELAM-1 in the dermis of nor¬
mal skin, warts and psoriasis is shown in Fig. 2. Positive stai¬
ning is expressed as area stained (pm2) per area measured(mm2). Normal skin demonstrated small stained areas of
ICAM-1 and ELAM-1 on vascular endothelial cells (Fig. la)which was not observed elsewhere (with a range of 2 ± 1 pm2
to 4 ± 1 pm2 for ICAM-1 and 0 to 3 ± 0 pm2 for ELAM-1). In
contrast, warts showed a significant increase in the areas of
ICAM-1 and ELAM-1 stained (Figs, lb and lc). The areas
stained ranged from 13 ± 4 pm2 to 48 ± 17pm2 for ICAM-1
and 12 ± 8pm2 to 35 ± 17 pm2 for ELAM-1.
Positive staining for both ICAM-1 and ELAM-1 was in longitu¬dinal or circular strands typical of vascular endothelium in the
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Figure 1 Photomicrographs of stained sections at a
magnification of X SO show ELAM-1 expression
in normal skin (a), and a wart lesion (specimen
number 1) (b). ICAM-1 expressed in wart dermis of specimen 1 is
shown in fcj. CD la* LC are shown in normal skin (d). A wart demonstra¬
ting high numbers of CD la* LCfe) and a wart demonstrating low numbers
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Figure 2. Expression of adhesion molecules in the
dermis of 6 normal subjects, 6 with warts and 4
with psoriasis. Bars depict standard deviation from the mean. M =
ICAM-1, □ = ELAM-1. The area of ICAM-1 and ELAM-1 staining in the
dermis was significantly increased (p < 0.005 in both cases) in wart der¬
mis compared with the dermis of normal skin. The ICAM-1 and ELAM-1
staining was also significantly greater in the dermis of psoriatic skin com¬
pared with normal dermis (p < 0.05 in both cases). No significant diffe¬
rence was observed in the expression of these adhesion molecules in the
dermis of warts and psoriatic skin.
Figure 3. CD la* Langerhans' cells in the epidermis
of 6 normal subjects, 8 with warts and 4 with
psoriasis. Wart patients 1-5 had papilliferous lesions, patient 6 had
plantar warts and 7 + 8 had common hand warts. Bars depict standard
deviation from the mean. Numbers of CD 1 a* LC were significantly greater
in the epidermis of normal skin compared with wart epidermis or with pso¬
riatic skin (p < 0.05 in both cases). No significant difference was obser¬
ved between the numbers of LC in the psoriatic epidermis and wart epi¬
dermis.
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dermis. The warts were more highly vascularized than the
normal skin, and a high proportion of the vascular endothe¬
lial cells was positive in the warts. The dermis of psoriatic
lesions also expressed ICAM-1 and ELAM-1 on the vascular
endothelium with siqnificantly hiqher staininq than in normal
■ • i'Tr i i • r II
skin. No difference was seen between the expression of adhe¬
sion molecules in the wart dermis and psoriatic dermis.
ICAM-1 positive keratinocytes were not detected in the epi¬
dermis of any sections tesfed in this study, although ICAM-1
positive kerafinocytes were detected in the epidermis of one
patient with chronic atopic eczema (not shown).
Langerhans' cells
CDla (T6) positive cells with dendritic morphology typical of
LC were strongly expressed in the epidermis of normal skin
(Fig. id). Fig. 3 shows quantification of CDla expression as
number of positive cells per total area of epidermis measured
(mm2). Stained cells were observed throughout the depth of
the epidermis of normal skin, the number of positive cells
varied from 314±8to981 ±318 per mm2. In contrast the
warts contained variable numbers of CDla+LC. Warts 1 and
4 showed CDla expression with a wide distribution throu¬
ghout the epidermis (Fig. ie); staining was also observed infhe papillary dermis although these cells had a rounded mor¬
phology, and some CDla+ cells with dendritic morphology
were seen around the blood vessels in the dermis. Warts 3
and 5 showed a much sparser staining of CDla, although it
was still evenly distributed throughout the epidermis (Fig. If).
The other four warts had a few LC in the epidermis with
CDla staining only in the basal and mid-epidermis; there
was no detectable staining in the dermis. The CDla expres¬
sion in the epidermis of alf 8 warts was significantly different
from CD1 a expression in the epidermis of normal skin. CDla
expression in the epidermis of psoriatic lesions was also signi¬
ficantly decreased in comparison with normal epidermis
(Fig. 3). No significant difference was observed between the
CDla expression in the epidermis of patients with warts and
with psoriasis.
T cells
Fig. 4 shows the numbers of CD3+ and CD45 RO+ T cells per
mm2 of dermis and epidermis. Normal skin had little or no
mononuclear cell infiltrate into the dermis or epidermis. CD3+
T cells in the dermis were in the range 26 ± 6 to 140 ±88
per mm2 and were not significantly different from the numbersfound in the epidermis (0 to 1 66 ± per mm2). Cells bearing
the CD45R0 marker were present at similar frequencies to the
CD3 marker in both the dermis and the epidermis, suggesting
that most of the T cells present were of the memory phenoty-
pe. Both cell markers were observed in the perivascular area
of the dermis. The CD3+ infiltrate varied in the wart patients
from a minimal dermal infiltrate (53 ± 36 cells/mm2] to a
large dermal infiltrate (654 ± 242 cells/mm2). Many of these
T cells were CD45 R0 positive. Interestingly, the numbers of
CD3+ and CD45R0+ T cells decreased significantly in the epi¬
dermis of wart patients compared with the dermis (p < 0.005,
Mann-Whitney U Test). Psoriatic lesions had comparable
numbers of T cells infiltrating the dermis as the warts but
more in the epidermis (Fig. A). The wart epidermis was more




As warts display increased dermal vascularity and epiderma
hyperplasia in comparison with normal skin, biopsies of invol¬
ved psoriatic lesions, representing a persistent inflammatory
skin condition were chosen as appropriate controls. T cell:
and LC were enumerated per mm2 of cross-sectional area ir
order to remove variations resulting from differences in epi
dermal thickness. This procedure has been recommended pre
viously for the quantification of LC [1 9],
This study showed that the low numbers of intraepidermal
cells in cutaneous wart lesions were comparable with norma
skin. However, the numbers of T cells in the dermis of wart:
were comparable with numbers found in psoriatic dermis anc
adhesion molecule expression was up-regulated. Unlike nor
mal skin, the LC found in the epidermis of 6 out of 8 wart:
were very sparse.
Adhesion molecules and T cells
Most of the endothelial cells present in the dermis of wart:
expressed ICAM-1 and ELAM-1 at high levels. It has beer
suggested that ELAM-1 and other selectins initiate the adhe
sion of resting T cells and neutrophils to activated endofhelium. The CLA marker on T cells has been proposed as the
ligand for ELAM-1 [17], and this interaction may represent c
skin-specific homing mechanism, to traffic memory T cells tc
cutaneous sites. The results presented in this study suggest tha
ELAM-1 may be important in the initiation of adhesion o
memory T lymphocytes to vascular endothelium in the war
dermis. The upregulation of integrins on the T cell surface
mediates strong adhesion to the endothelium via VLA-4 anc
VCAM-1, LFA-1 and ICAM-2 and LFA-1 and ICAM-1 inter
actions, which then proceeds to egression into the tissues
Only the expression of ICAM-1 has been considered here
although ICAM-2 was expressed on the vascular endotheliurr
of wart dermis (data not shown). The expression of ICAM-1 a
high levels in the dermis shows that this adhesion molecule
also has a role in the homing of T cells into the dermis o
wart lesions. ELAM-1 and ICAM-1 were both expressed a
low levels in the dermis of normal skin, which may indicate
that they play a role in the normal surveillance of cutaneous
sites.
ICAM-1 was not observed on keratinocytes in the epidermis
of warts. This could be one explanation of why there were
low numbers of T cells in the epidermis of warts, as the
ICAM-1+ KC interaction with LFA-1+ T cells has been sugges
ted as having a role in the epidermotropism of T cells. After
natively the repertoire of integrins expressed on the local 1
cells may be abnormal. The epidermal keratinocytes in pso
riatic lesions were also negative for ICAM-1, although man)
intraepithelial T cells were found, which indicates that there is
most likely another mechanism for this movement into the epi
dermis, for example epidermal derived cytokines.
ICAM-1 has been demonstrated in the keratinocytes of pso
riatic lesions [1 2-14] but Shevnius et al. found only 45% o
patients tested demonstrated this [20]. ICAM-1 has been seer
on the keratinocytes of laryngeal HPV-induced lesions bu
only when intensely infiltrated [9], This may suggest tha
ICAM-1, although it is involved in epidermotropism of T cells
may not be the initiator of such a movement. Indeed in one
study, normal skin was found to contain some epidermal
cells which were not localised to ICAM-1+ keratinocytes [21 ]
Other candidates for the movement of leukocytes into the epi
dermis are cytokines such as IL-8 and monocyte chemotactii
and activating factor, or the adhesion molecule LFA-3, whicl
is present on epidermal LC and keratinocytes of normal skit
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We have no clinical or histopathological evidence that the
warts, which showed no decrease in LC, were regressing. An
increase in LC numbers has been observed in regressing
warts and it has been suggested that LC play a role in this
regression [4, 8, 24] but factors triggering the repopulation of
the epidermis with LC have not yet been defined. Regressing
plane warts show many LC in the dermis and epidermis with
T cells observed adjacent to LC, and lymphocytes next to
damaged keratinocytes in the epidermis [81. This suggests a
specific cell mediated immunity against virafly infected kerati¬
nocytes.
It has been reported that non-viral skin tumours show an
increase in LC numbers in the epidermis [25, 26] which could
mean that HPV may reduce LC numbers specifically. However,
in other studies, a reduced density of CDla+ cells was found
in such tumours [27-29], It is possible that different HPV types
may have differing immunogenicities which could affect the
numbers of LC present. It still remains to remains to be shown
whether HPV infects LC and has a direct cytotoxic effect on
the numbers present in the epidermis. The reduction of LC in
the ep idermis of many skin warts may promote tolerance to
viral antigens at this site and contribute to the persistent natu¬
re of these lesions. ■
Figure 4 CD3* ■ and CD45R0* W phenotypes in the
dermis (A) and epidermis (B) of 6 normal sub¬
jects, 6 with warts and 4 with psoriasis. Significantly
greater numbers of T cells (CD45R0* and CD3* cells) were seen in the
dermis of warts compared with normal dermis fp < 0.05 in both cases).
No significant difference in the numbers of T cells was seen in the epider¬
mis of warts and normal skin. Numbers of T cells in the dermis were signi¬
ficantly greater in psoriatic skin than in normal skin (p < 0.05 for both
CD3* and CD45 R0* cells). T cell numbers were significantly greater in
psoriatic epidermis as compared with wart epidermis (p < 0.05 for both
CD3* and CD45R0* cells).
and whose ligand is CD2 on T cells. However, it has been
claimed that the ICAM-1 - LFA-1 pathway is most important
in the adhesion of keratinocytes to T cells, at least in
vitro [22].
Langerhans'cells
Six out of 8 of the warts in the present study showed a reduc¬
tion in LC numbers in the epidermis compared with normal
skin. Both of the warts which did not have reduced numbers
were facial and papuliferous but the others of the same clini¬
cal type and from the same site had low counts. Chardonnet
et at. [3] using a large number of warts from different anato¬
mical sites, have shown a similar picture with many, but not
all lesions containing lowered numbers of LC or none. This
did not depend on the clinical type of papilloma but there
was some indication that the location of the wart could
influence the number of LC to some extent, with none being
found most frequently in plantar warts (47%). It was demons¬
trated that depletion of LC in the epidermis correlated with the
presence of HPV antigen. Detection of HPV antigen or typing
of HPV was not included in the present study. Our control
skin, normal and psoriatic, was taken from the forearm of
volunteers due to the ethical difficulty of biopsying the face.
Berman et al. [231 gave evidence of little difference in the
density of LC in different anatomical sites, the head and neck
having a mean density of 489 LC per mm2 and the forearm
having a mean density of 560 LC per mm2.
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ADHERENCE OF ACTIVATED T CELLS TO CUTANEOUS
WARTS
Melany Jackson *, Tinekc Herrcmans Claire Benton - ,
Steven Keohane 2 and Mary Norval'.
1 Departments of Medical Microbiology and 2 Dermatology,
University of Edinburgh Medical School, Scotland, U.K.
It has been shown previously that adherence of activated lymphocytes
to both the dermis and epidermis of psoriatic skin is increased
compared with normal skin, and the adherence is dependent on LFA-1
expression on lymphocytes and ICAM-1 expression in the skin. In
this study adherence of activated lymphocytes to cutaneous warts was
studied using a frozen section adherence assay. No increase in
adherence was found in either the dermis or the epidermis of warts in
comparison to normal skin. The cells which adhere were
predominantly T cells (CD3+) which were LFA-1+ (CD18+) .
Previous work has demonstrated an increase in ICAM-1 expression
and increased T cell numbers in the dermis of warts but no expression
of ICAM-1 and reduced T cell numbers in the epidermis compared
with normal skin. Thus, human papillomavirus infection of
keratinocytes does not lead to the up regulation of ICAM-1 in the
epidermis, which may be partly responsible for the poor influx of T
cells into the lesion in vivo and the poor adherence in vitro. Reduced
adherence to the dermis is not be explained by the lack of ICAM-1
expression, perhaps an indication for the involvement of other





humoral immunity to malassezla furfur serov-
•nrs a. b and c in patients with pityriasis
versicolor and controls. H.R.Ashbee. E.Ingham.
A.Fruin1. K.T.Holland. W.J.Cunliffe2, Skin Research Centre.
University of Leeds. Leeds. UK.
The aim of this study was to determine whether patients with
pityriasis versicolor exhibited different humoral immune
responses to M.furfur serovars A, B and C when compared to
age and sex matched controls. A Transferable Solid Phase
ELISA was used for the measurement of total immunoglobulins.
IgM. IgA and IgG (Cunningham et al. Br J Dermatol
1992:127:476-481). A modification of this method was used to
determine the titres of IgG subclasses specific to M.furfur
serovars A, B and C (Fruin et al. Br J Dermatol 1992:127:433).
The mean reciprocal log, antibody titres were analysed by
.Analysis of Variance and individual means compared using the
T-method. Titres or" total immunoglobulins (range 6.2-8.2), Ig.M
(range 3.9-4.61 and IgG (range 4.8-8.4) did not vary
significantly either between patients and controls or between
serovars. However, titres of IgA were lower to serovar C in
both the patient and control groups (2.4 and 3.2 respectively)
than serovar A (6.1 and 6.61 or serovar B 15.0 and 6.2).
The titres of IgG subclasses varied between the subclasses,
with generally lower titres of IgG3 (3.4) compared to IgG, -, 4
(4.4. 5.4 and 4.5 respectively!.
In conclusion, although the distribution of serovars differs
over the body, they were all presented to the immune system
and elicited similar levels of primary and secondary responses.
The production of IgG subclasses 1-3.in patients and controls
suggests that both protein and carbohydrate antigens are
present on M.furfur. The relative enrichment of IgGy indicated
chronic antigen exposure in both groups. Thus, this study did
not demonstrate any significant differences in humoral immunity
to M.furfur terovars A. B and C In patients with pityriasis
versicolor when compared to normal controls.
27.
CYTOKINE PRODUCTION AND T CELL PROLIFERATION H
PSORIASIS: ALTERATION OF C04+- LYMPHOCYTES IN THE
AUTOLOGOUS MIXED LYMPHOCYTE REACTION
T.S. Dobmever. "j.M. Dobmeyer. B. Morsches. R £._ School
Department of Infectiology. University of Frankfurt._ Department j
Internal Medicine, University of Heidelberg, Department
Dermatology, University of Heidelberg, Germany.
We examined the importance of CD8 - and CD4- lymphocyte
for the stimulation of autologous mixed lymphocyte cultures anc
autologous mixed lymphocyte epidermal cell cultures in patients with
psoriasis and healthy controls. Furthermore, we investigated the
Influence of CD4+ cells on the production of TNF-i , IL-6 and IFN-v
Mononuclear leukocytes were isolated from the periphery
blood of 7 patients with psoriasis and 7 nealthy controls by density
nradient centrifugation. T lymphocytes and non-T lymphocytes then
were enriched by Dassage over nylon wool columns. CD4^ and CD8-
cells were positivly selected by immunobeads. Cell enrichement arxi
depletion were ascertained by flow cytometry. Epidermal cells were
isolated by suction blister technique and trypsinization. 1x10° CD4-
cells. CD8 + cells or unseparated T ceils were incuoated Tor 6 days win
1x104 non-T lymphocytes or epidermal ceils. Ceil proliferation vas
measured by H-TdR uptake. Cytokine concentration was determineo
in ceil culture supernatants by ELISA technique.
Compared to ceil reactions with unseparated T cells, cultures
with CD4r ceils showed in healthy individuals a significantly (p = 0.C4I
higher proliferation in both autologous mixed lymphocyte cultures and
lympnocyte epidermal' ceil cultures. By contrast, the proliferative
"esponse with 004 - cells was not enhanced in patients with psoriasis
Furthermore, CD4- cells clearly increased iL-o. TNF-a and decreased
FN-y production n autologous mixed lympnocyte epidermal ceil
cultures n patients with psoriasis but not :.n neaithy controls. In the
autologous mixed lymphocyte reaction with CD8* cells we found a
significantly diminished ceil proliferation compared to unseparated T
ceils omy in psoriatics out not in neaithy inaividuals.
These findings indicate an altered CD4 - cell function in
psoriasis resulting in aimimsnea ceil proliferation and enhanced
cytokine secretion n autologous mixed lympnocyte cultures and
autologous mixed lymphocyte epidermal ceil cultures.
26.
EPIDERMAL IMMUNITY: INFLUENCE OF HLA-DR " AND
CD1a* EPIDERMAL SUBPOPULATIONS ON THE
STIMULATION OF LYMPHOCYTES
T.S. Dobmever. 'J.M. Dobmeyer, "B. Morscnes, "R.E.
Schopf. DeDartment of Infectiology, University of Frankfurt.
"Department of Internal Medicine, University of Heiaeiberg,
"Department of Dermatology. University of Mainz.
Germany.
We examined the importance of CDia" HLA-DR"
Langerhans ceils and CDia" HLA-DR" epidermal ceiis r'cr
the stimulation of allogeneic and autologous T ceiis.
Mononuclear leukocytes isolated from the peripheral
biood of 7 healthy inaividuals and 7 patients with psoriasis
were enriched to 96% by passage over nylon wool
coiumns. Epidermal cells were isolated from the roofs of
suction blisters by trypsinization and depleted of CDia"
and HLA-DR* cells by immunoDeads. Ceil enrichement and
depletion were ascertained by FACS analysis. 1x10D
enriched T cells were incubated for 6 days with 1x10*
allogeneic and autologous epidermal ceils. Cell proliferation
was measured by 3H-TdR uptake.
We found no significant difference between healthy
controls and patients with psoriasis. In both grcucs
depletion of CD1 a" epidermal ceils had no significant erfec:
on stimulation of T cells, both in the allogeneic ana
autologous system. Compared to CDia* ceils, depletion of
HLA-DR* epidermal ceils further significantly diminished T
ceil proliferation in controls and oatients.
We conclude that HLA-DR* epidermal ceils are mere
important than CD1a" Langerhans cells for stimulation of
both allogeneic and autologous T ceils ,n normal ccntrcis
and patients with psoriasis. Moreover our results ncicate
that there exists a CDia' HLA-DR* eoicermal ceil
peculation oacacie to stimulate T ceils.
28.
local immune responses in cutaneous
warts
M. Jackson. E.G. Benton. J.A.A. Hunter. M. Norval.
University ot" Edinburgh. U.K.
Cjtaneous warts, caused by infection with human
paDiilomavirus (HPV) frequently persist tor months or
years: it is not clear what aspects of the immune system are
most important in their control and resolution. The present
study concentrated on an immunocytochemical analysis ot
Langernans' cells and T cells in cutaneous warts, together
with an assessment of adhesion molecule expression
ICA.M-1 and ELAM-1). Comparisons were made
throughout with skin from normal subjects and from
patients with psoriasis. There was an increase in numoers
of CD3*. CD45RCT T cells in the dermis of warts
compared with normal skin. In addition ICAM-1 an
ELAM-1 expression were increased in the dermis of *ar^
compared with normai skin which may be responsible o
;he influx of T ceils into this site. However, a .ar-
reduction of CD3* CD45RCT T ceils was seen in the
epidermis of warts compared with normal skin,
eoiuermal ICAM-i was not observed in warts. In ' '
the wans studied epidermai Langerhans' ceil numbers w .
reduced in comparison with normal or psoriatic s
Thus, a decrease in Langerhans' cells and a '?c" s
adhesion molecule expression in the epidermis ot w •
may lead to a reduced influx of T cells into the lest ^
itself, although T cells are evidently present in the
underlying the infected site. It is possible that these io1-^
effects are induced by factors produced from keratinou
as a result of HPV infection.
